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academic and industrial application.
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Chapter 1. Introduction
1 General Methods for Amine Synthesis
Asymmetric catalysis is one of the most important approaches to introduce one or 
more new and desired chiral elements to a prochiral substrate.1'6 It is very important in 
the field of synthesis of enantiomerically pure compounds because different 
enantiomers or diastereomers of a molecule often have completely different biological 
activities.2'4 As an important element of drugs, most of chiral amines were generated by 
efficient catalytic enantioselective reactions. ’ ’ Synthesis of chiral amines by 
asymmetric catalysis will provide solution to industry in particular and society in 
general. In this chapter, a brief introduction of the concept of asymmetric catalysis, 
asymmetric hydrogenation, importance of chiral amines, and general synthetic routes 
will be given. An overview of the state of art enantioselective hydrogenation to chiral 
amines will also be presented.
1.1 Asymmetric Catalysis and Asymmetric Hydrogenation
Synthesis of enantiomerically pure compounds is one of the big challenges in 
organic chemistry and a major goal in the industrial synthesis of pharmaceuticals, 
agrochemicals, and fine chemicals.2'4,6 In the past few decades, numerous chiral 
compounds have been obtained based on three strategies: chemical transformation of 
an enantiomerically enriched precursor, resolving a racemic mixture of the two 
enantiomers, or asymmetric catalysis.2,4 The former two approaches suffer from 
potentially severe drawbacks, requiring stoichiometric amounts of a suitable precursor 
or affording only up to 50% yield of the desired enantiomer. Asymmetric catalysis, in
1
which each molecule of chiral catalyst, by virtue of being continually regenerated, can 
yield many molecules of chiral product, has significant potential advantages over the 
two older approaches. Bredig, the pioneer of investigation of enantioselective catalysis 
in 1908, reported the first preparation of enantiomerically enriched mandelonitrile 
from benzaldehyde and HCN by using an alkaloid as a chiral catalyst. A major 
contribution of asymmetric catalysis has been achieved by three famous chemists, 
William Knowles, Ryoji Noyori and Barry Sharpless, who work on asymmetric 
hydrogenation and asymmetric oxidation. In recognition of their achievements, they 
shared the 2001 Nobel Prize in chemistry. Partly due to their effort, numerous efficient 
enantioselective catalytic systems have been developed for synthesis of chiral products 
in the past few decades.2'4,8,9
There is no doubt that asymmetric hydrogenation is a major branch of asymmetric 
catalysis.6 Asymmetric hydrogenation is one of the most straightforward and 
efficient methods to produce enantiomerically pure compounds in both industrial scale 
and laboratory scale. Asymmetric hydrogenation generally refers to addition of H2 to 
one of the faces of a prochiral, unsaturated C=C, C=0 or C=N double bonds to 
generate a chiral products with high enantioselectivity. The first major breakthrough 
occurred in the early 1970s, when Knowles and Homer et al independently 
demonstrated that rhodium complexes containing chiral phosphine ligands were able to 
catalyze the enantioselective hydrogenation of a prochiral olefinic substrate, generating 
a chiral product with excellent enantioselectivity (ee’s up to 88%).10-13 Following the 
discovery of asymmetric hydrogenation, the first industrial process for the synthesis of
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L-dopa, an anti-Parkinson drug, was generated by using a chiral Rh-phosphine 
catalyzed hydrogenation of a prochiral enamide.14 Subsequently, thousands of 
publications have recorded the development of catalytic systems containing chiral 
ligands for asymmetric hydrogenation of a wide range of prochiral alkenes, ketones 
and ketimines, and up to 100% ee of products have been obtained. ’ ’ ’ ’ 
Simultaneously, notable understanding of mechanistic pathways of asymmetric 
hydrogenation has been made by several groups.6 Although noteworthy progress has 
been achieved in asymmetric hydrogenation, further extension of its utility is desired, 
particularly in the area of amine synthesis.
1.2 Importance of Chiral Amines
Chiral amines are one of the most important functionalities in fine chemical, 
agrochemical, and pharmaceutical products (Scheme l- l ) .16 Because
nitrogen-containing amines have the properties of hydrogen bonding, basicity and 
nucleophility, structurally less complex chiral amines have frequently been used as 
chiral auxiliaries, ligands and catalysts. For instance, MacMillan’s organocatalyst 
(2i?,5i?)-2-tert-butyl-3-methyl-5-phenylmethyl-4-imidazolidinone, 
(i?)-(+)-2-(diphenylmethyl)pyrrolidine, and (S',S)-DPEN are employed as a chiral 
organocatalyst,17’18 chiral solvating agent,19 or chiral ligand,20 and (15',2lS)-ephedrine 
and (Z?)-methylbenzylamine are usually used as chiral auxiliaries16 or resolution 
reagent.21 On the other hand, chiral cyclic amines, such as tetrahydroisoquinoline and 
tetrahydro-p-carboline frequently appear in natural products and biologically important 
molecules which display high bioactivity. For example, marine alkaloid Et 743, a
3
22potent antitumor drug target, contains three chiral tetrahydroisoquinoline rings. 
Containing one tetrahydroisoquinoline ring and one tetrahydro-P-carboline ring, 
tubulosine also displays high antitumor activity.23 A further example is yohimbine, 
which contains similar units and is an antagonist for the serotonin
n h 2PH 3
N
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c h 3 H Ph P iT ^ N H 2 Me’
MacMillan's (R)-(+)-2-(Diphenylmethyl)
Organocatalyst pyrrolidine (S,S)-DPEN (1R,2S)-Ephedrine (R)-Methylbenzylamlne
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Scheme 1-1. Representative examples of chiral amines.
2B receptor.24 In addition, a-branched acyclic amines also ubiquitously exist in chiral 
amine-containing pharmaceutical drug targets. a-Branched amine referes to amine 
having a-carbon sterocenters. Representative examples include the natural product
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Taxol,25 pharmaceutical target Rivastigmine26 and billion-dollar drug Flomax 
(Tamsulososin).27 Owing to chiral amines widely existing in pharmaceuticals and 
natural products, the development of efficient methodologies to generate chiral amines 
is still desired, particular in generating on an industrial scale. The processes for the 
synthesis of chiral amines are generally based on three chemical strategies; resolution 
of racemic amines, chemical transformation from a chiral precursor in which the chiral 
auxiliary group could be removed after formation of diastereoisomers, and 
enantioselective catalysis.
1.3. Methods of Chiral Amine Synthesis
Enantiomerically enriched amines can be generated by diastereoselective 
carbanion addition to chiral aldimines or ketimines, asymmetric catalytic synthesis or 
reduction of ketimines with a chiral stoichiometric reagent.2,8 Based on these chemical 
transformations, numerous approaches have been developed in the past few decades. 
The following section provides a summary on methods for synthesis of 
enantiomerically enriched amines.
Synthesis of Chiral Amines by Auxiliary Controlled Reaction
Addition to C=N double bonds with a chiral auxiliary provides an effective 
approaches for the development of synthetic route to enantiomerically enriched amines. 
Several types of chiral ¡mines have been developed so far, such as chiral 
TV-acylhydrazones, SAMP hydrazone, p-tolylsulfinyl ¡mine and a-MBA 
imine. ’ ’ ’ ’ ' These chiral ¡mines have served important roles in the early
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development of synthetic route to produce chiral amines. The chiral jV-acylhydrazone 
could go through addition reaction with a range of partners, including radicals, 
allylsilanes, allyindiums, siyl enol ether, and hydride donors with up to 99% de, the 
resulting diasteroisomers can be converted to chiral amines by using samarium 
diiodide (Smk) or borane cleavage of the N-N bond (Scheme 1-2).28 Chiral amines 
with up to 99% ee also can be generated from chiral SAMP hydrazone, 
jV-iert-butanesulfinyl imines and /Kolylsulfinyl imines via the addition of 
organometallic reagents to C=N bonds followed by deprotection of chiral auxiliary 
groups.29 Chiral amines were also obtained from enantioselective reduction of a-MBA 
imines and sequent deprotection.16
N -X
+ Nuor R
no catalyst or 
achiral catalyst
H N -X H N -X
or
X: stereocontrol and activation
R1 J*'R2 ..
Nu R
up to 99% dr
n
A/-acylhrazone SAMP hydrazone A/-ferf-butanesulfinyl p-tolylsulfinyl a-MBA ¡mine
¡mine ¡mine
Scheme 1-2. Synthesis of chiral amines from chiral precursors.
Synthesis of Chiral Amines by Stoichiometric Hydride Reduction
Chiral borane-based hydride reagents are generally used for the reduction of cyclic 
and acyclic ketimines to generate enantiomerically enriched amines. ’ , : These 
reagents can be prepared from commercially available amino acids or amino alcohols
6
with borane.31 Good to excellent ees of cyclic and acyclic amines have been obtained 
by using preformed chiral borane-based hydride reagents in the reduction of ketimines 
(Scheme 1-3).
R
N -R 3
A R
COO
5 ^ 4r5h n  r 4
BH °  or
RSHN R4 /3
BH
© H N -R 3
R ^ R 2
+
up to 100% ee
Scheme 1-3. Synthesis of enantiomerically enriched amines from chiral reagents.
Synthesis of Chiral Amines by Asymmetric Catalysis
Catalytic systems have displayed advantages in the synthesis of enantiomerically 
enriched amines in the past few years. Owing to the importance of chiral amines, a lot 
of enantioselective catalytic systems have been developed in order to generate amines 
with excellent enantioselectivity. However, there are only several direct and common 
approaches to generate chiral amines, which include catalytic enantioselective 
alkylation of imines, Mannich-type reactions, cyanation of imines, hydrosilylation of 
¡mines, transfer hydrogenation of ketimines, and hydrogenation.2,8 The following 
section provides an introduction to the catalytic enantioselective systems except for 
transfer hydrogenation and hydrogenation of ketimines, which will be dealt with 
separately.
The asymmetric alkylation of imines is one of the fundamentally important reactions, 
in which nucleophiles selectively add to one of the faces of prochiral C=N double 
bonds in the presence of a catalytic amount of catalyst (Scheme 1-4). ’ 1 ■ ■ In this 
reaction, the nucleophiles are generally organometallic reagents, such as, organozinic,
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organolithium, and organoaluminum, or electron rich aromatic compounds, such as,
indole, pyrrole, furan, and thiophene; and chiral organocopper complexs are normally 
used as catalysts.33 Although the best enantioselectivity can reach up to 99% ee, only a 
few asymmetric catalysts are available for this reaction, and application of enolizable 
¡mines is still sometimes problemtic.
N
• Fc
■A.
HN
H
+ Nu" . A
Nu
chiral [Cu] catalyst
up to 99% ee
Scheme 1-4. Synthesis of chiral amines by asymmetric alkylation reaction.
Asymmetric Mannich reactions are one of the most powerful approaches to access 
chiral p-amino carbonyl compounds and other chiral amino derivatives.2,3’8’34'37 Chiral 
amines can be produced by nucleophile addition to electrophilic C=N double bonds in 
the presence of a chiral organometallic catalyst or organocatalyst with up to 99% ee 
(Scheme 1-5). Asymmetric organocatalysis of this reaction has greatly enlarged the 
scope of nucleophiles from silyl enolates, nitro-substrates, nucleophile with electron 
withdrawing group, and aldehydes which can form enamine as a nucleophile in the 
presence of catalytic amount of amine.
Scheme 1-5. Synthesis of chiral amines by asymmetric Mannich reaction.
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The cyanation of ¡mines, generally called the Strecker reaction, is also one of the 
most useful reactions. Chiral a-amino nitriles can be obtained by enantioselective 
addition of cyanide to C=N double bonds with up to 99% ee (Scheme 1-6).2,3’8’38'40 The 
cyanide source could be Bu3SnCN, HCN or TMSCN, and the catalyst could be chiral 
Lewis acids, organometallic catalysts or hydrogen bonding organocatalysts. The 
resulting a-amino nitrile can be converted to an a-amino acid via acid hydrolysis of the 
nitrile group to carboxylic acid.
n-r
„A + RCN
Organometallic catalyst
or organocatalyst 
R = Bu3Sn, TMS, H, etc
,R 2
HN
AR1 * CN 
up to 99% ee
Scheme 1-6. Synthesis of chiral amines by asymmetric cyanation of imines.
Asymmetric hydrosilylation of ketimines is another direct method to produce chiral 
amines. The ketimine can be reduced by polymethylhydrosiloxane (PMHS), HSiCl3 or 
C6H5SiH3 in the presence of a catalyst promoting and inducing chiral hydrosilylation 
(Scheme 1-7).2,3,8,41,42 Chiral titanocene, iridium and copper complexes have shown 
excellent enantioselectivity for cyclic and acyclic ketimines, the highest ee being up to 
99%. ’ Hydrogen bonding organocatalysts also showed excellent enantioselectivity for 
reduction of ketimines, the highest ee being again up to 99%.43
NM . Organometallic catalyst
R1 R2 + or organocatalyst
R3SiH = PMHS, HSiCI3, C6H5SiH3, etc;
HN'
R1 * R2 
up to 99% ee
Scheme 1-7. Synthesis of chiral amines by asymmetric hydrosilylation of ketimines.
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2. Asymmetric Hydrogenation of Imines and Imino Esters
2.1 Introduction
Catalytic asymmetric hydrogenation (including transfer hydrogenation) of imines, 
oximes, hydrazones, and imino esters is one of the most direct and efficient methods 
for the synthesis of chiral amines and their derivatives.6 Fourty years ago, there were 
only a few methods to synthesize enantiomerically enriched amines via 
enantioselective heterogeneous hydrogenation of oximes or dioximes; the method uses 
Pt black, Pd/C or Raney nickel together with chiral auxiliaries.44,45 However, the 
approach was only applied to a very few substrates, and gave amines in low 
enantioselectivities and the results could not always be reproducible.44,45 Boyle, 
Scorrano and Botteghi et al independently reported the first example of 
Rh/Ru-phosphine complex-catalyzed asymmetric hydrogenation of a carbon-nitrogen 
double bond to produce enantiomerically enriched amines with less than 22% ee 
during 1974-1975.46'48 In 1984, a remarkably improved enantioselectivity was 
achieved by using Rh-BDPP complex-catalyzed hydrogenation of acetophenone 
jV-benzylimine to give the corresponding amine in 72% ee.49 In the 1990s, several 
remarkable progresses on asymmetric hydrogenation of a range of imines were made 
by Noyori, Buchwald and Blaser et al by using Ru-Ts-DPEN,50 Ti51'53 and 
Ir-diphosphine complexs,54-56 respectively. The first successful manufacture of the 
herbicide (iS)-metolachlor was achieved by using Ir-diphosphine-catalyzed 
hydrogenation of corresponding ¡mine in 1999.54
Although some remarkable progress has been achieved so far, only a few chiral
10
catalysts have found successful applications in enantioselective hydrogenation o f C=N
functions. Several chiral Ru, Rh, Ti, Ir, Pd, and Au complexs have been developed for 
the hydrogenation of C=N functions so far. Since the earliest application of 
[Rh(NBD)(DIOP)]+ClC>4' and H4Ru(CO)8(DIOP)2 in asymmetric hydrogenation of 
imines and oximes, a few chiral Rh/Ru complexes have been developed,47,48 such as 
RuCl2(diphosphine)(diamine), Ru(Cymn)(diamine)Cl, and cationic 
[CpRu(diphosphine)]+ and [Rh(COD)(diphosphine)]+ with different anions.6 In these 
catalysts, Noyori’s complex Ru(Cymn)(Ts-DPEN)Cl showed good enantioselectivity 
and activity for transfer hydrogenation o f imines.50 Chiral titanocene complexes, one 
of the successful catalysts, showed high enantioslectivies for TV-alkyl ketimines 
hydrogenation; however, the catalysts were difficult to handle and the activity of 
catalysts was not so high for hydrogenation of imines.51'53 Thus far, a few chiral 
iridium complexes have been developed and become more popular a choice for 
hydrogenation of imines since the first Ir-BDPP complex-catalyzed imine 
hydrogenation was reported in 1990.6,56 Recently, Pd complexs have been employed 
for imine and imino ester hydrogenation to give amines and amino esters with good to
cn
excellent enantioselectivies. And more recently, Au-Me-DuPhos also showed good 
acitivity and enantioselectivity for hydrogenation o f acetophone vV-benzylimine.58 
However, all of these catalysts generally show either unsatisfactory ee’s or narrow 
scope o f substrates.
More highly active and selective catalysts are desired for asymmetric 
hydrogenation of imines. It has been known that the catalytic property o f a chiral metal
11
catalyst is determined by the metal, chiral ligand and the anion of the complex. 
Transition metals are generally utilized for preparing catalysts for hydrogenation of 
imines. Different transition metals usually show special activities and selectivies in the 
catalytic hydrogenation. For most chiral complexs, chiral ligands also play a very 
important role in the asymmetric catalytic systems because the product chirality is 
transfered from the chiral ligand and the catalytic activitiy of complex highly depends 
on the coordinating ligand. Recently, some research groups have found that the anion 
of a complex can highly affect catalytic activities and selectivies in many asymmetric 
reactions, and even a chiral anion of achiral complex could efficiently transfer chirality 
from the anion to the product.59 Therefore, metal, ligand and anions are considered to 
be three very important parts of the strategy in the development of highly efficient 
catalyst.
Highly selective and wide scope reductive amination via hydrogenation of imines 
is still considered a big challenge in asymmetric catalysis. Asymmetric hydrogenation 
of imines is far less developed than the hydrogenation of ketones and olefins, because 
there are more unsolved problems in imine hydrogenation.6 There are numerous 
successful chiral catlysts for diverse ketone and olefin hydrogenation. However, most 
of those catalysts are less effective for the various C=N functional groups in terms of 
enantioselectivity (ee, %), productivity (turnover number, TON), substrate to catalyst 
ratio (SCR) or activity (turnover frequency, TOF). This is probably because several 
aspects affect the hydrogenation of C=N functions. The first is that the catalysts might 
be poisoned by the imine substrate, or amine product, because the nitrogen atom may
12
strongly coordinate to the metal centre, resulting in catalyst deactivation. The second is 
that the C=N functional groups are easy to tautomerize to syn/anti isomers. The third 
is that acyclic C=N functional substrates often easily undergo hydrolysis during the 
reduction. The following sections provide a summary on the state of the art 
enantioselective hydrogenation (including transfer hydrogenation) of various classes of 
C=N functions by using special chiral metal complexs.
2.2 Transition Metal-catalyzed Asymmetric Hydrogenation
2.2.1 Asymmetric Hydrogenation of Imines with Ti Complexes
Buchwald and coworkers demonstrated a highly efficient, enantioselective 
hydrogenation of imines by using a chiral titanocene precatalyst l ,51'53 first synthesized 
by Brintzinger.60 The titanocene catalyst showed good to excellent enantioselectivities 
for a range of acyclic and cyclic imines, especially for cyclic ones. Representative 
results are listed in Table 1-1.51,52 Produced from precatalyst 1, titanocene (III) hydride 
species 2 was assumed to be the active intermediate in the catalytic cycle. Acyclic 
amines were obtained in good ee’s under 138 bar hydrogen pressures; however, the 
enantioselectivities were significantly decreased when lowering the hydrogen pressure 
(entries 1 and 2). Conversely, cyclic amines were obtained in excellent ee’s and good 
yields under either high or low hydrogen pressure (entries 3-5). Compared with 
acyclic imines, some higher ee’s were obtained for cyclic imines by using the catalyst 
1. Aprobable explanation is that cyclic imines only exist as a single anti isomer; on the 
contrary, acyclic imines exist as a mixture of syn and anti-isomers during the reaction.
13
Notably, the catalyst showed good enantioselectivity for different types of cyclic and 
acyclic ¡mines, and could tolerate different functional groups, such as alkene and
TBDMS. However, its potential application is rather low, because TOF is rather low 
and the catalyst is difficult to operate.
Table 1-1. Asymmetric hydrogenation of ¡mines with chiral Ti Complex
anti/syn
P(H 2)
(bar)
catalyst
equiv.
yield
(%)
ee
(%)
3.3:1 138 0.1 64 62
17:1 138 0.05 93 76
34 0.05 85 43
/ 138 0.05 77 98
34 0.05 86 99
6 0.01 84 99
/ 138 0.05 82 98
6 0.05 79 95
/ 6 0.05 82 99
entry substrate
a The catalyst precursor 1 was activated in situ by treatment of 2 equiv. of BuLi and 3 
equiv. of PhSiH3
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Although chiral titanocene catalyst has shown good enantioselectivities for various
2.2.2 Asymmetric Hydrogenation of Acyclic Imines with Rh Catalysts
acyclic and cyclic imines, chiral Rh and Ir complexs are still preferred in industrial 
processes and academic research. So far, several late transition metals including Rh, Ir, 
Ru, Pd and Au have been investigated for asymmetric hydrogenation of imines, and 
imino esters to generate chiral amines with good ee’s.
The earliest report on asymmetric hydrogenation of acyclic imines was from 
Scorrano’s group in 1975 and used a chiral rhodium catalyst (Scheme 1-8).47 
Enantiomerically enriched amine 4a was obtained in 22% ee and 67-80% yield by 
using catalytic amount of [Rh(NBD)(5a)]+[ClC>4]' to hydrogenate 3a in isopropanol 
(IPA). A lower ee of 4a was observed when ethanol or methanol was used as a solvent.
[Rh(NBD)(5a)]+CI04- 
H2, /-PrOH
3a
22% ee 
4a
DIOP
5a
Scheme 1-8. The earliest asymmetric hydrogenation of 3a with Rh-5a.
PPh2
PPh2
Although the first example of hydrogenation of acyclic ¡mine did not achieve good 
ee, significantly improved ee’s were subsequently obtained from several research 
groups (Table 1-2). Takach and King et al investigated a series of chiral diphosphine 
ligands; they found the corresponding chiral amine 4a could be obtained in 66% ee 
(100% conversion) and 72% ee (98% conversion) from 3a by using the in situ catalyst 
derived from [Rh(NBD)Cl]2 and ligand 6 and 7, respectively (entries 1 and 2).49 
Bakos and coworkers also explored the imine 3a hydrogenation by using a chiral
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Rh-BDPP complex (Table 1-2).61,62 In Bakos’s system, they found the reaction highly 
depended on solvent and temperature. A 13% ee was obtained in a mixture solvent 
(benzene/methanol = 4:1); but a 73% ee was obtained in pure methanol (entries 3 and 
4). Lowering the reation temperature, the ee of amine 4a was improved to 83% at 0 °C 
in methanol (entry 5).
Table 1-2. Improved enantioselectivities of hydrogenation of 3a
Ph2P
PPh2
(R)-Valphos
6
(R)-Benzphos
7 (S.S)-BDPP8a
entry ligand additive
temperature 
and solvent
conv.
%
ee
%
config.
1° 6 / 25 °C, benzene/methanol (1/1) 100 66 S
2° 7 / 25 °C, benzene/methanol (1/1) 98 72 S
3* 8a Et3N 20 °C, benzene/methanol (4/1) 100 13 R
4b 8a Et3N 20 °C, methanol 100 73 R
5b 8a Et3N 0 °C, methanol 55 83 R
a The in situ catalyst was used; b prepared catalyst was used.
In Bakos’s catalytic system, the enantioselectivity highly depended on solvent and 
reaction remperature. Further studies by 3IP NMR of the complex 
{Rh(NBD)[(iS,S)-8a]}Cl in solution indicate that the complex structure was sensitive to 
solvent and temperature (Scheme 1-9).62 The equilibrium of 9a and 9b exists in
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benzene at room temperature; and the complex might be converted into the square
planar 9c in methanol. Furthermore, the equilibrium between 9b and 9c also exists 
when the solution changes from benzene to the polar methanol. The low optical yield 
is caused by the mixture o f quasi-symmetrical 9a and 9b when 3a was hydrogenated in 
benzene (Table 1-2, entry 3). Conversely, The C2 symmetric 9c was considered to be a 
stable intermediate in methanol, which led to high optical yield o f amine 4a (Table 1-2,
entries 4 and 5).
■ • n i
methanol
benzene
Ph2P + \
Rh
*  Ph2P 
(9 c)
cr
trigonal bipyramidal 
in benzene
trigonal bipyramidal 
in benzene
square planar 
in methanol
Scheme 1-9. Bakos’s investigation o f the conformation of {Rh(NBD)[(5',5)-8a]}Cl in 
various solvents.
Several water soluble chiral ligands 8b, 8c, 8d and 8e, containing partially or fully 
sulfonate salt, were examined for asymmetric hydrogenation o f acyclic imines in a 
two-phase system by Sinou,63 Bakos64 and de Vries’s65 research groups independently. 
They demonstrated that ee’s of amine are strongly dependent on sulfonation degree of 
the diphosphine ligands (Table 1-3).63'65 Bakos et al found that phosphine ligand with 
about 1.65 sulfonation degree, which is composed of a mixture of epimers, afforded 
the best enantioselectivities, whilst around full sulfonation showed the lowest 
enantioselectivities for 3a hydrogenation. Several enantiomerically riched amines were 
obtained in 89-96% ee’s by using Rh-8 complexes of 1.65 sulfonation degree.
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Table 1-3. Asymmetric hydrogenation of acyclic imines with catalyst Rh-8
8a: n = 2, m = 2; 
8b: n = 1, m = 2
3a : X = H 
3b: X = o-OMe
8c: n 
8d:n 
8e: n
= 1, m = 1 
= 0, m= 1 
= 0, m = 0
3c: 
3d: 
3 e :
X = m-OMe 
X = p-OMe 
X = p-CI
entry substrate
sulfonation
degree
solvent
conv.
(%)
ee a 
(%)
config. ref
1 3a 4 (8e) EtOAc-H20 100 34 6 R 63
2 3a 1.86 EtOAc-H20 100 58 6 R 63
3 3a 3.75 EtOAc-H20 55 19 R 64
4 3a 1.41 EtOAc-H20 96 96 (88)* R 64
5 3a 1.65 EtOAc-H20 94 96 (95) b R 64
6 3b 1.65 EtOAc-H20 96 95 (86) b R 64
7 3c 1.65 EtOAc-H20 93 89 (86)* R 64
8 3d 1.65 EtOAc-H20 94 91(92)* R 64
9 3a 1 (8b) EtOAc-H20 85 94 R 65
10 3d 1 (8b) EtOAc-H20 >98 92 R 65
11 3e 1 (8b) EtOAc-H20 >98 92 R 65
° Ee was determined by 1 H NMR; 4 Ee was determined by HPLC
de Vries and coworks separated the mixture of epimers by column chromatography, 
and the mono- and di-sulfonated 8b and 8c were obtained and characterized. Rh-8b 
complex showed a similar enantioselectivity to the Rh-8 complex of 1.65 sulfonation 
degree in hydrogenation of 3a (entry 9). Furthermore, FAB-MS spectra showed the
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SO3' group of 8b acts as a counteranion of catalyst Rh-8b.
Table 1-4. Halide effect on enantioselective hydrogenation of acyclic imines 
-Bn
X-rr
H2
1 mol% [Rh], additive „  
solvent A
'Pr
Ph2P ^  *
(R)-Valphos
Ph2P PPh2 
(R)-Cyphos
3 4 6 10
entry substrate ligand additive
temperature 
and time
conv.
(%)
ee
(%)
config. ref
l a 3a 6 / 50 °C, 8h 90 15.5 R 49
2 a 3a 6 KC1 50 °C, 8h 100 35.5 S 49
3 a 3a 6 KI 50 °C, 8h 93 47.8 S 49
4 b 3a 10 / 20 °C, 18h >99 67 S 66
5 b 3a 10 KI 20 °C, 90h >99 79 S 66
6 b 3b 10 KI 20 °C, 120h >99 71 S 66
1 b 3d 10 KI 20 °C, 72h >99 84 S 66
8 b 3d 10 KI -25 °C, 144 h >99 91 S 66
0 Prepared catalyst [Rh(NBD)(6)]C104; b Catalyst in situ prepared from [Rh(NBD)Cl]2 and 10.
Takach and King et al found that a halide additive exerted a marked influence on 
catalytic activity and enantioselectivity in the Rh-phosphine catalyzed hydrogenation 
of imines. (Table 1-4, entries 1-3).49 As shown, the catalyst [Rh(NBD)(6)][C104] 
displayed a low enantioselectivity for hydrogenation of 3a, affording the amine 4a with 
only 16% ee. However, both KC1 and KI significantly improved the ee’s of amines 4a, 
from 16% to 36% and 48%, respectively. Interestingly, the configuration of 4a was 
reversed in the presence of halide additive. A 67% ee was obtained by using the in situ
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neutral catalyst Rh-10, and the enantioselectivity was improved to 79% ee in the 
presence of KI (entries 4 and 5).66 Using the chiral Rh-10 catalyst with co-catalyst KI, 
two enantiomerically enriched amines 4b and 4d were obtained in up to 91% ee 
(entries 6-8).66
Osborn et al investigated the additive effect of the reverse aggregation of sodium 
bis(2-ethyl-hexyl) sulfosuccinate (AOT) on the hydrogenation of ¡mine 3a (Scheme
1-10).67 They found the AOT greatly enhanced enantioselectivity in the 
[Rh(NBD)(8a)]+[C104]' catalyzed hydrogenation of 3a, the ee of 4a being increased 
from 68% in neat benzene to 89% in the presence of 0.1 M AOT and 0.1 M 
15-crown-5. Further studies with 31P NMR and MS revealed that the sulfonate anion 
was bound to the Rh1 center in a bidentate fashion 11 but was rapidly exchanging on 
and off the catalyst. They considered that the reaction took place in a monohydride 
pathway in the presence of sulfonate in nonpolar solvent.
RS03' binding 
rhodium catalyst
H? ( 72 bar) HN
,Bn
1 mol% [Rh(NBD)(8a)]CI04 
AOT (0.1 M), benzene
15-crown-5 (0.1 M), 8 °C 89% ee, 98% yield
H
. I
Rh
3a 4a
Ph2
P ' \
Rh jjls ' H 2 ,
P h 2 h r Ph2
PS V  R V  -b 3sR
Ph2 11 Ph2 . Ph2
©
+ Base H+
0 3SR 
sulphonate labile
Scheme 1-10. Asymmetric hydrogenation of 3a by using Rh-8a with additives.
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Bomer and coworkers explored a range of Rh(I)-diphosphine and diphosphinite 
complexes for 3a hydrogenation (Scheme 1-11).68 In their studies, they found that 
rhodium complex with five and six-membered chelates or electron-rich 
alkylphosphines showed low activity for ¡mine 3a hydrogenation. However, 
Rh-complex based on the chiral diphosphite 12 could rapidly transform the imine 3a to 
the desired amine 4a in 72% ee within 5 hours.
3a
H2( 50 bar)____________ ^
0.2 mol% [Rh(COD)(12)]BF4 
BnNH2 (5 equiv to Rh)
MeOH
HN
^Bn
4a
72% ee, 99% conv.
Ph2P C f 'X ^ \
Ph2PO
BDPCH
12
Scheme 1-11. Asymmetric hydrogenation of imine 3a with Rh-12.
James et al explored a range of Rh-diphosphine complexes for the hydrogenation of
an important acyclic imine 13a (Scheme 1-12).69 They found that the combination of a
Rh (I) precursor with (i?)-10 showed the best enantioselectivity for 14a. Osborn and 
coworkers also investigated the same hydrogenation by using various combination of 
diphosphine or diphosphite with Rh(I) or Ir(I) precursor (Scheme 1-12).70 In their 
investigations, the Ir-15 complex presented the highest activity and enantioselectivity
for 13a hydrogenation.
H?
1 mol% catalyst 
solvent MeO
N
OPPh2 OPPh2 
(R,R)-15
Osborn's results:
[Rh], 41% ee, 9% yield 
[Ir], 55% ee, 31% yield
Scheme 1-12. Asymmetric hydrogenation of imine 13a.
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Recently, chiral Ir catalysts have been widely used for enantioselective 
hydrogenation of imines both in academic research and industrical process, because 
chiral Ir catalysts are stable and easy to handle and show high activities and good 
enantioselectivities in hydrogenation of imines.6 Classified according to the type of 
chiral complex, four types of Ir-complexes have been developed for a range of of 
imines, which show good conversion and moderate to excellent ee’s.
Chiral Diphosphine Ligands
Blaser and coworkers discovered a highly efficient, enantioselective catalytic system 
for the hydrogenation of TV-arylketimines 13a and 13b to produce the corresponding 
chiral amines 14a and 14b in 84% ee (98% conversion) and 62% ee (100% 
conversion) by using an in situ chiral Ir-diphosphine catalyst (Scheme 1-13).56 The 
amine 14b is an important intermediate for the herbicide Metolachlor. A range of chiral 
diphosphine ligands in combination with [Ir(COD)Cl]2 were investigated. They found 
that the conformationally flexible six or seven memberred metallacycle (BDPP 8a, 
DIOP 5a, BPPM) diphosphinoiridium complexs presented higher activities and 
enantioselctivities. A further investigation found that the anion of halide additive also 
markedly influenced the enantioselectivities and activities of the reaction.
2.2.3 Asymmetric Hydrogenation of Acyclic Imines with Ir Catalysts
13a, R = Me 
13b, R = Et
H2 (20 bar)________ ^
1 mol% [lr(COD)CI]2 
1.1 mol% ligand 
TBAl.MeOH / benzene
14a, R = Me; (S,S)-8a
84% ee, 98% conversion 
14b, R = Et; (S,S)-5a
62% ee, 100% conversion
Scheme 1-13. Asymmetric hydrogenation of 13 by using Ir catalysts.
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Following their breakthrough in ¡mines hydrogenation, Blaser et al applied their 
catalytic system to an industrial process by using an iridium catalyst containing 16a 
with small amount of acetic acid and iodide as additives (Scheme 1-14).55 The catalytic 
system offered a good enantioselectivity and a very high activity with the SCR 
reaching up to 1000000.
MeO
H2 (80 bar)
lr-16a ,TBAI 
acetic acid M e O v ^ \  Et 
78% ee (SCR = 1000000)
13b 14b 16a (R)-(S)-xyliphos
Scheme 1-14. Blaser’s catalytic system for asymmetric hydrogenation of 13b.
Simultaneously, Osborn and coworkers independently developed a well-defined 
chiral [Ir(III)(P-P)Hl2]2 complex for enantioselective hydrogenation of 
iV-arylketimines 13a (Scheme 1-15).71 Prepared from [Ir(COD)(P-P)]BF4 and excess 
Lil in acetone, the preformed catalyst showed good activities (SCR = 4000) with 
moderate to good enantioselectivity for the hydrogenation of 13a to the corresponding 
amine 14a.
100 bar H2, [lr(5a)Hl2]2 
S/[lr]2 = 4000, 20 °C 
THF / DCM (3/1, v/v)
13a 14a 63% ee, 99% conv. 5a (S.S)-DIOP
Scheme 1-15. Asymmetric hydrogenation of 13a with [Ir(5a)HI2].
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Although some remarkable progresses in diphosphinoiridium complex-catalyzed 
hydrogenation of imines have been achieved by Blaser and Osborn, only a few imines 
were successfully hydrogenated in high ee’s.55,71 Zhang and co-workers developed a 
new chiral ligand (R,R)-11 for enantioselective hydrogenation of both aromatic and 
alphatic A-arylimines, generating amines with up to 99% ee (Table 1-5).72 The catalyst 
showed high activities and enantioselectivities for aryl methyl ketimines, but lower 
enantioselectivities of 8% ee to 31% ee for alkyl methyl ketimines. Iodide additives 
also promoted the reduction and improved enantioselectivities. The observation was 
consistent with the results of Blaser and Osborn et al. A proposed mechanism suggests 
that iodide plays two roles during the reduction, one being oxidation of Ir(I) to Ir(III) 
and activation of the catalyst, another being assisting heterolytic splitting of hydrogen.
Table 1-5. Enantioselective hydrogenation of acyclic imines with the catalyst Ir-17
N'
Ar’ 7 bar Ho _____^ HN'A|J
i l l
J  Fe f  
(R,R)-17
-CO
lr-(R,R)-17 (1%) ' 1  
" DCM.rt R
f i f
t j p l
entry R Ar’ t
( h )
conv.
(%)
ee
(%)
1 Ph Ph 40 100 84
2 Ph 2,6-dimethyl-C6H3 44 77 >99
3 4-CF3-C6H4 2,6-dimethyl-CeH3 44 80 99
4 /-Pr 2,6-dimethyl-C6H3 44 29 23
5 Ph 4-MeO-C6H4 14 100 81
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Quiet recently, Gosselin and Zhang et al developed a more efficient
73enantioselective catalytic system by using the Ir-(1S',1S')-17 catalyst (Table 1-6), 
which hydrogenates unprotected N-H ¡mines to form free amino salts. A range of pure 
or mixture solvents and counteranions of iminium salts were investigated for the
optimization of conditions.
Table 1-6. Enantioselective hydrogenation of unprotected N-H ¡mines with Ir-17
NH2CIA 2
R1 R2
H2 (10 bar) _
lr-(S,S)-17 (5%) ’ 
MeOH/DCM (2:1) 
rt
, NH3CI 
R1 * R2 
17-95% ee
CO
03—! Fe r 
(S,S)-17
-CO
00
entry R 1 R2 yield(%) ee (%) config.
1 4-MeC6H4 Me 95 95 R
2 c 6h 5 Et 92 86 R
3 c 6h 5 t-Bu 90 80 R
4 4-CF3C6H4 Me 93 93 R
5 2-MeC6H4 Me 92 81 R
6 i-Bu Me 90 17 R
7 cyclohexyl Me 91 73 R
They found that the mixture solvent of methanol and dichloromethane (2:1) and 
chloride as counteranion of iminium salts were benefical to enhancement of reactivity 
and enantioselectivity of the reaction. A series of aryl alkyl and alkyl alkyl unprotected 
N-H amines were obtained under the optimized conditions in 17-95% ee and 90-95% 
isolated yield.73 They found the bulkiness of the R2 group and the methyl or chloro 
substituent on R group at the or/7zo-position slightly reduced the ee. However,
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substrates having both electron-donating and withdrawing substitutents on the 
aromatic ring in R 1 were obtained with similarly high enantioselectivities. Their 
catalyst showed lower enantioselectivities for akyl alkyl imines, however.
Since Osbom et al reported the first [Ir(C0 D)(P-P)][C104] complex-catalyzed 
enantioselective hydrogenation with modest activity and enantioselectivity,70 Imamoto 
and Dervisi et al have developed competent chiral cationic complexes 18 and 19 with 
noncoordinating BARF' and PFg' anions for hydrogenation of ayclic imines.74’75 In 
Imamoto’s study, a series of coordinating anion Cl', weakly coordinating anion O T f, 
noncoordinating anion BF4', PFe’ and BARF' and various diphosphine ligands were 
explored for imine hydrogenation.74 The cationic complex 18 showed the best 
enantioselectivity and good activity at 1 bar hydrogen pressure. Based on these 
conditions, a range of aryl methyl amines were obtained in 91-99% yield and 69-99% 
ee (Table 1-7).74 However, catalyst 18 showed no activity for the hydrogenation of 
alkyl methyl imines (entry 3). Dervisi et al explored solvent and pressure effect by 
using their catalyst 19.75 They found that coordinating solvent lowered the catalyst 
activity and high hydrogen pressure inhibited the catalytic activity as well due to 
formation of dimeric and trimeric Ir(III) polyhydrides. A range of aryl alkyl amines 
were obtained in 98-100% conversion and 81-94% ee. However, catalyst 19 showed 
lower activity and enantioselectivity for hydrogenation of A-benzyl imine, affording 
only 20% conversion and 5% ee. These results show that cationic catalysts with 
non-coordinating anions have higher activity than the complex containing coordinating 
anions.
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Table 1-7. Enantioselective hydrogenation of acyclic imines with cationic 
Ir-diphosphine complexes
N' R2 H2(1 bar)
X  18 or 19
R1 ^  DCM, rt
entry R 1 R2 catalyst yield (%) ee (%) config.
1 Ph Ph 18 91 86 R
2 Ph 4-CF3-Ph 18 95 99 (-)
3 /-Bu Ph 18 0 / /
4 Ph Ph 19 99 84 R
5 Ph 4-MeO-Ph 19 99 94 (+)
6 Ph PhCH2 19 20 5 R
° 0.5%; of catalyst 18; b 1%; of catalyst 19.
Chiral P, N Ligands
Pfaltz and co-workers reported the first chiral cationic Ir-phosphanodihydrooxazole 
complexes 20a for enantioselective hydrogenation of imines (Scheme 1-16).16 The air 
stable 20a showed good activities and enantioselectivities for the hydrogenation of 
TV-alkyl and iV-aryl imines (Table 1-8, entries 1 and 2). Coordinating anion and solvent 
significantly decreased the catalyst activity and enantioselectivity. In their 
investigation, they also found that the activity and enantioselectivity of the cationic 
20a was markedly influenced by the concentration of substrate and catalyst loading. 
Thus, the substrate 29 was hydrogenated to the corresponding amine with the ee value 
improved from 71% to 86% when the concentration of 29 was lowered from 0.22 M to
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0.035 M .76 Catalyst 20a showed good activity and enantioselectivity for a wide scope 
of acyclic ¡mines. However, it was less efficient for dialkyl and cyclic imines.
+ X'
a: Ar = Ph,X = PF6- 
b: Ar = C6F13CH2CH2C6H4, 
X = BARF-
BARF-
BARF
a: Ar = Ph
b: Ar = 3,5-(Me)2Ph
Ph
o V \  1PPho
PFS
0.
Et
/
,lr,
24
BARF-
+ BARF-
P 
Ph2
(R,S)-28a: R = /-Pr; 
28 (S,S)-28b: R = /'-Bu;
Scheme 1-16. Chiral cationic irdium complexes with P, N ligand.
Subsequently, they explored cationic iridium catalysts for imine hydrogenation in 
supercritical carbon dioxide (scCC^) (Table 1-8). A catalyst 20b with increased 
solubility in scCCh was synthesized by introduction perfluoroalkyl groups in the ligand
28
and anion (Scheme 1-16).77
Table 1-8. Enantioselective hydrogenation of acyclic imines with cationic Ir complexes
3a, R = Bn 
29, R = Ph
n ' r
0 ^
h 2
catalyst, solvent rj'
h n ' r
4a, R = Bn 
30, R = Ph
entry substrate catalyst S/C
conv.
(%)
ee
(%)
config. ref
1 3a 20a 25 100 76 R 76
2 29 20a 27 100 71“ R 76
3 29 20a 1000 99 86* R 76
4 29 20b 1000 100 80 R 77
5 3a 20b 333 28.9 n.d. / 77
6 29 21 1000 99 86c R 78
7 3a 22a 200 63 98 R 79
8 29 22a 200 98 90 R 79
9 29 22b 200 99 92 R 80
10 3a 23 100 44 11 (+) 81
11 29 23 100 100 51 (-) 81
12 3a 24 25 97 63 5 82
13 3a 25a 50 100 81 S 83
14 29 25b 50 100 90 s 83
15 29 26 100 >99.5 93 R 84
16 29 27 100 >99.5 84 R 85
17 3a (S,S)-28b 100 >99 91 S 86
18 29 (i?,5)-28a 100 >99 91 R 86
° [29] = 0.22 M; b [29] = 0.035 M ;c[29] = 0.03 M.
They found that the anion BARF dramatically affected the enantioselectivity of the
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hydrogenation. The use of SCCO2 instead of CH2CI2 allowed the catalyst loading to be
lowered significantly, owing to a change in the rate profile of the reaction. Utilizing the 
selective extractive properties of scCC>2, the product could be readily separated from 
the catalyst, which could be recycled several times without significant loss of activity 
and enantioselectivity. Apart from Pfaltz’s work, several groups also developed chiral 
cationic iridium complexes containing P, N ligands for acyclic ¡mines hydrogenation 
(Scheme 1-16). Cozzi and coworkers developed a cationic heterocyclic 
phosphinooxazoline iridium complex 2 1  and its analogues for hydrogenation of imine 
29, affording the corresponding amine with 86% ee and full conversion (entry 6). 
Andersson et al reported a range of new cationic phosphine-oxazoline iridium 
complexs 2 2 a, 2 2 b and their analogues for acyclic aromatic iV-arylimines 
hydrogenation (Scheme 1-16).79,80
Afterward, Claver,81 James,82 Agbossou-Niedercorn,83 Zhou,84 Knochel85 and Ding86 
reported similar chiral cationic iridium complexs 23, 24, 25, 26, 27 and 28, with all 
containing P, N ligands (Scheme 1-15). In particular, Ding and coworker developed the 
iridium catalyst 28a, 28b and their analogues containing chiral phosphine-oxazoline 
ligand based on the spiro [4,4]-l,6-nonadiene backbone, which showed good activity 
and enantioselectivity for a wider scope of aliphatic and aromatic TV-aryl and jV-alkyl 
¡mines (Table 1-8, entries 17 and 18).86
Recently, Bolm and coworkers reported a neutral iridium complex containing a new 
Ci-symmetric sulfoximine for acyclic imine hydrogenation.87 A series of 
phosphine-substitited sulfoximine ligands were synthesized and explored for the imine
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hydrogenation. They found that the complex Ir-31 showed excellent activities and 
enantioselectivities for a range of aromatic vV-aryl imines in the presence of 2.0 mol% 
iodide additive. A series of protected aryl methyl, aryl ethyl and tetralone amines were
obtained in 75-98% ee and full conversion (Table 1-9).87
Table 1-9. Enantioselective hydrogenation of acyclic imines with catalyst Ir-31
N 'Ari .H? (20 bar), \ ,  (2.0 mol%) fl M
[lr(COD)CI]2 (0.5 mol%) 
31 (1.1 mol%), toluene, rt A r ^ R
p fy S -N  PPh2 
f-Bu
31
entry Ar Ar’ R conv. ee (%) config.
1 Ph 4-MeO-C6H4 Me full 96 (-)
2 Ph 4-MeO-C6H4 Et full 92 (-)
3 2-Me-C6H4 4-MeO-C6H4 Me full 94 (+)
4 2-Tetralone a 4-MeO-C6H4 / full 91 (-)
° 2-Tetralone-derived ¡mine.
Phosphite Ligands
de Vries and coworkers reported the first example of iridum complex bearing chiral 
monodenate phosphine oxide ligands for enantioselective hydrogenation of acyclic 
imines (Scheme 1-17).88 A neutral complex, Ir-32, combined with pyridine showed 
good enantioslectivity for the model imine 3a hydrogenation, the corresponding amine 
being obtained in 78% ee (Table 1-10, entry l ).88 An improved 82% ee of the amine 
was obtained when lowering the reaction temperature to 0 °C (entry 2). However, the 
catalyst Ir-32 showed no enantioselectivity for hydrogenation of imine 29 (entry 3). 
Pizzano and coworker reported a chiral phosphine-phosphite ligand 34 and its
31
analogues for exploring hydrogenation of ¡mine 29 (Scheme 1-17).89 The imine was
hydrogenated in 84% ee by using an Ir-34 complex (entry 4).89
Scheme 1-17. Phosphite and phosphine ligands.
Recently, Reetz and Bondarev reported a combinatorial strategy to form 
numerous catalysts by homo-combination of the monodenate phosphite 35 with 
itself or hetero-combination of 35 with achiral phosphites or phosphines.90 They 
found that the hetero-combination catalysts generally were more efficient than 
homo-combination catalyst by varying the ratio of chiral to achiral ligands 
(entries 5-8).90 3a was hydrogenated to the corresponding amine with 88% ee 
when the catalyst was formed from [Ir(COD)Cl]2, 35 and 39 in a ratio of 
1:1.5:0.5 (entry 8).90 Chiral phosphite iridium complexes were also explored for 
acyclic imines hydrogenation. Claver and coworkers developed a catalytic 
system by using a chiral cationic Ir-33 complex with the ligand derived from 
xylose suger.91 The catalyst showed moderate enantioselectivity for imine 29 
hydrogenation (entry 9).
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Table 1-10. Enantioselective hydrogenation of acyclic imines catalyzed by Ir-phosphite 
complexes
3a, R = Bn 
29, R = Ph
s J C  *n 1 catalyst, solvent
■ * 0
,R
4a, R = Bn 
30, R = Ph
conv. ee
entry substrate catalyst S/C ref
(%) (%)
1 3a [Ir(COD)Cl]2+ 32 + Py 20 100 78° S 88
2 3a [Ir(COD)Cl]2+ 32 + Py 20 75 82 °’b S 88
3 29 [Ir(COD)Cl]2+ 32 + Py 20 100 0° 88
4 29 [Ir(COD)Cl]2+ 34 100 full 84 S 89
5 3a [Ir(COD)Cl]2+ 35 + 37 100 100 43 CS 90
6 3a [Ir(COD)Cl]2+ 35 + 37 100 100 80 dS 90
7 3a [Ir(COD)Cl]2+ 35 + 39 100 100 60 eS 90
8 3a [Ir(COD)Cl]2+ 35 + 39 100 100 88f S 90
9 29 [Ir(COD)(33)]BF4 100 83 57 S 91
10 3a [Ir(COD)2]BF4 + 38 100 85 73 (-) 92
11 29 [Ir(COD)2]BArF + 36 100 full 87 R 93
° [Ir(COD)Cl]2+ 32 + Py = 1:2:2; ^Temperature = 0 °C; c [Ir(COD)Cl]2: 35 : 37 =
1:1:2; d [Ir(COD)Cl]2: 35 : 37 = 1:2:2;e [Ir(COD)Cl]2: 35 : 39 = 1:1:1;f  [Ir(COD)Cl]2: 
35 :39= 1:1.5:0.5.
Subsequently, Castillon and co-workers developed a chiral diphosphite 
ligand 38 derived from the suger D-glucosamine (Scheme 1-17).92 The Ir-38 
catalyst showed good activity and enantioselectivity for the model imine 3a 
reduction, with the corresponding amine obtained in 73% ee (entry 10).92 More 
recently, Minnarard, Feringa and de Vries et al developed an efficient 
hydrogenation by using an Ir-36 complex bearing the BARF anion as catalyst.93
33
The bulky noncoordinating BARF was found to be beneficial for
enantioselectivity. The catalytic system was sensitive to coordinating solvents 
and hydrogen pressure (entry l l ).93
Olefin Ligands
Grutzmacher and coworkers reported the first example of chiral olefins as steering 
ligands in catalytic enantioselective hydrogenation of imines (Scheme 1-18).94 The 
chiral complex 40 was prepared from [Ir(COD)2]OTf and the chiral olefin phosphane 
ligand. Catalyzed by prepared catalyst 40, ¡mine 29 was hydrogenated to the 
corresponding amine in 86% ee and 98% yield.94 The results suggest that chiral olefins 
could be used as ligands for asymmetric hydrogenation.
2.2.4 Asymmetric Hydrogenation of Acyclic Imines with Ru Catalysts
Chiral ruthenium complexes are also recognized as an effective catalyst for 
asymmetric hydrogenation of imines.6 So far, two types of chiral ruthenium complexs 
have been reported. Cobley and co-workers reported the use of 
RuCl2(diphosphine)(diamine) for several cyclic and acyclic imines hydrogenation,
34
Cobley's results:
30, R = Ph, 94% ee,
RuCI2[(R,R)-43a][(R,R)-42]; 
4a, R = Bn, 62% ee,
R uC l2[( S)-45a][(S, S)-41 ].
Jackson’s results:
30, R = Ph, 71% ee,
RuCI2[(R,R)-44][(S,S)-41]; 
4a, R = Bn, 82% ee,
RuCI2[(R,R)-44][(S,S)-41 ].
which is a well known catalyst for ketones hydrogenation (Scheme 1-19).6,95
,R
Jlj H2 (15 bar) (
„R
HN
' ^ ruci2(p -p )(n-n ) (1%) r
f ]f-BuOK, /-PrOH, 50-65 °C
n ' r h n ' r
II H2 (10 bar) i
> ' "  RuCI2(P-P)(N-N) (0.5 %) * f rf-BuOK, /-PrOH, 60 °C
[RuCI2CfiHfi] 
DMF(hot), N2
P/ Cl
I chiral diamine
^ R u(DMF)2 DCM, rt
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Scheme 1-19. Asymmetric hydrogenation of imines with Ru catalysts.
The catalyst was generally prepared under inert conditions by treatment of 
[RuCl2(benzene)]2 with a chiral diphosphine in hot DMF to produce the intermediate 
RuCl2(diphosphine)(DMF)2, and then the intermediate was reacted with a chiral 
diamine at room temperature to replace DMF, yielding easy to handle, stable 
precatalyst.95 A library of chiral ruthenium complexes bearing different chiral 
diphosphines and chiral diamines were investigated for hydrogenation of acyclic 
imines. Imine 3a and 29 were hydrogenated in 94% ee and 62% ee by using 
RuCl2[(/?,i?)-43a][(i?,R)-42] and RuCl2[(S)-45a][(S,5)-41] with excess /-BuOK,
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respectively.95
Recently, Jackson and coworkers explored similar catalysts system for ¡mine 
hydrogenation by using the ligand 44 in combination with (5',S)-41 and excess t-BuOK 
(Scheme 1-19).96 Compared to Cobley’s results, a lower ee of 30 was obtained, but the 
ee of 4a was slightly higher. The results indicate that ruthenium complexes bearing 
various combinations of chiral diphosphine/diamine are needed in order to obtain a 
higher enantioselectivity for diverse substrates.
H2 (4 bar)_________
2 mol% CpRu(P-P)H 
CH2CI2, RT, 1 day
46a, X = H
46b, X = CI
47a, 38% ee (R), (49) 
47b, 56% ee (R), (49) 
47a, 48% ee (S), (48) 
47b, 60% ee (S), (48)
,,\PPh2
PPh2
(R,R)-Norphos
48
PPh2
PPh2
(S.S)-Chiraphos
49
Scheme 1-20. Norton’s asymmetric hydrogenation.
Different to RuCl2(diphosphine)(diamine), a catalytic system operating via an ionic 
pathway was developed and the detail of mechanism was studied by Norton and 
coworkers (Scheme 1-20).97,98 The prepared Ru-H hydride directly transfered the 
hydride from the metal to the ¡minium salt and catalyzed the reduction. Chiral amines 
47a and 47b were obtained in 48% ee and 60% ee by using CpRu[(i?,i?)-48]H.97,98 
More detailed mechanism will be described in the Section 2.5.
2.2.5 Asymmetric Hydrogenation of Acyclic Imines with Au Catalyst
Gold complexs as catalysts have shown high activities for the formation of C-C,
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C-0, C-N and C-S bonds." Recently, Corma et al reported the first example of a chiral
58dinuclear gold complex-catalyzed asymmetric hydrogenation of 3a (Scheme 1-21). 
Bearing the same ligand 43b, gold, platinum and iridium complexes were compared 
for the reduction. The results show that the chiral gold complex gave the highest 
enantioselectivity and a similar catalytic activity, which are comparable with those of 
the platinum and iridium complexes at the same conditions.58 Up to now, this is the 
only example of gold-catalyzed asymmetric hydrogenation of ¡mines. A more wide 
application of gold catalyzed asymmetric hydrogenation could be expected.
3a
Au: TOF = 1005, 75% ee; 
Pt: TOF = 1365, 15% ee; 
Ir: TOF = 1118, 15%
Scheme 1-21. Asymmetric hydrogenation of 3a with [Au] catalyst.
2.2.6 Asymmetric Hydrogenation of Cyclic Imines
i c
Chiral cyclic amines can show high biological activities. ’ Especially, 
tetrahydroisoquinoline, tetrahydro-p-carboline and indoline widely exist in natural
*y\product synthesis and pharmaceutical products. Buchwald’s titanocene catalyst 
showed high selectivies for cyclic imine hydrogenation; however, their catalyst was 
difficult to handle.51'53
Several chiral Ir and Ru complexs associated with chiral phosphorus ligands were
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explored for the hydrogenation of cyclic imines to tetrahydroisoquinoline and
tetrahydro-p-carboline with moderate to good ee’s, but they generally have limited 
substrate scope (Table 1-11). Achiwa and Morimoto reported the synthesis of 
tetrahydroisoquinoline and tetrahydro-P-carboline by using an Ir-5b complex and it’s 
analogues.100 A range of Ir-complexs were screened for cyclic imines 50a, 50i and 50j. 
The best ee’s for 51a, 51i and 51j were 28% ee, 30% ee and 20% ee by using Ir-5b 
with BU4NI, Ir-52 with Bih and Ir-52 with BU4NI, respectively (entries 1-3) .100 
Immediately afterwards, an improved enantioselectivity was obtained by using Ir-52 
with phthalimide as a co-catalyst. Cyclic imines 50a and 50b were hydrogenated to the 
corresponding tetrahydroisoquinoline 51a and 51b in 93% ee and 79% ee, respectively 
(entries 4 and 5) .101 Subsequently, Achiwa and coworkers employed their catalyst to 
the hydrogenation of 50g to give tetrahydroisoquinoline 51g, which is a precursor to 
alkaloid calycotomine; the benzyl group can be easily removed by Pd-catalyzed 
hydrogenation. Compounds 51g and 51h were obtained in 86% ee and 89% ee by 
using an Ir-45b complex with F4-phthalimide and parabanic acid as additive (entries 6 
and 7) .102 Similarly 51c, 51d, 51e and 51f were obtained in 31%-88% ee by using 
Ir-diphosphine complexes in the presence of co-catalyst phthalimide (entries 8- 12 ) .103 
RuCl2(diphosphine)(diamine) is also efficient for hydrogenation of 50a. Cobley and 
Jackson independly reported the hydrogenation of 50a, obtaining 79% ee and 89% ee 
by using RuCl2[(R,R)-43a][(R,i?)-42] and RuCl2[(i?,7?)-53][(5,5)-41] as catalyst, 
respectively (entries 13 and 14).95’96
38
Table 1-11. Enantioselective hydrogenation of cyclic imines to tetrahydroisoquinoline 
and tetrahydro-P-carboline
MeO
MeO
50a R = Me
51 R2
vj^ -N
R
50b R = Et
50c R = 3,4-(MeO)2C6H3 
50d R = 3,4-(MeO)2C6H3CH2 
50e R = 3,4-(MeO)2C6H3CH2CH2 
50f R = (E)-3 ,4-(MeO)2C6H3CH=CH 
50g R = BnOCH2 
50h R = BnOCH2CH2CH2 50j R = Et
entry ¡mine Ir(I)-ligand cocatalyst
conv.
(%)
ee
(%)
ref
1 50a 5b Bu4NI 91 28(5) 100
2 50i 52 Bil3 97 30 (R) 100
3 50j 52 Bu4NI 100 20 (R) 100
4 50a 52 phthalimide 95 93 (5) 101
5 50b 52 phthalimide / 79(5) 101
6 50g (7?)-45b F4-phthalimide 85 86(5) 102
7 50h (5)- 45b parabanic acid 99 89(5) 102
8 50c (5)-45b phthalimide 50 31(*) 103
9 50d 52 F4-phthalimide 84 88(5) 103
10 50e 52 phthalimide 75 87(5) 103
11 50e (5)-45b phthalimide 89 82(5) 103
12 50f 52 phthalimide 85 86(5) 103
13 50a catalyst0 none 80 79 95
14 50a catalyst6 none 100 89 96
0 RuCl2p,R)-43a][(R,/?)-42] as catalyst;b RuC12[(/?,/?)-53][(5,^ )-41] as catalyst.
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s P ' A  PAr2
At = p-MeO-3,5-Me2C6H2
(4R, 5R)-M0D-DI0P 
5b
Ph
(R.R)-Ph-BPM
53
Asymmetric hydrogenation of 2,3,3-trimethylindolenine 54 was investigated by 
using chiral iridium and ruthenium complexes (Table 1-12). Although the highest 
enantioselectivity for 55 was obtained by using chiral titanocene catalyst,51'53 Ir-8a ,71 
Ir-5b,104 Ir-56105 and RuC12[(jR,jR)-57][(S',S)-58]95 also showed good enantioselectivity 
(entries 1-4). When the reaction medium was ionic liquid, Ir-52 also displayed good 
activity in the absence of phthalimide (entry 6).106
Table 1-12. Enantioselective hydrogenation of 2,3,3-trimethylindolenine 54
entry catalyst cocatalyst
conv.
(% )
ee
(% )
ref
1 [Ir(S,S)-8a)HI2] / 99 80 (+) 71
2 [Ir(COD)Cl]2+ 5b BU4NI 99 81 (+) 104
3 [Ir(COD)Cl]2+(i?,R)-56 phthalimide 100 95 (+) 105
4 RuCl2[(R,R)-57][(S,S)-5S] / / 88 95
5a [Ir(COD)Cl]2+52 / 98 84 106
° [Ciomim][BF4] as solvent
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Cyclic imine 59 was hydrogenated to the corresponding amine 60 with up to 90% ee 
by using chiral Ir-45a in the presence of a protic amine, benzylamine (Scheme 
1-22) .107 2-Methyl-l,2,3,4-tetrahydroquinoxaline 62 was obtained in 90% ee and 54%
conversion by a preformed orthometallated Ir dihydride complex 63 (Scheme
1-22).76,77
61
H2 (62 bar)
lr-(S)-45a (1mo!%) 
BnNH2 (5 mol%)
H? (5 bar)________
63 (1mol%), 100 °C 
MeOH, 24 h
Scheme 1-22. Asymmetric hydrogenation of cyclic ¡mines.
2.2.7 Asymmetric Hydrogenation of C=N-X Substrates
Isolated pure E, Z-isomer of 1-acetonphthone oxime 64 was hydrogenated to amine 
65 in 30% ee and 66% ee by using a chiral cationic Rh-45b complex, respectively 
(Scheme 1-23).108 This result suggests that the C=N bond isomerization markedly 
influences enantioselectivity in the hydrogenation of ¡mines. Jiang and coworker 
reported the hydrogenation of ketone oximes by using a neutral catalyst Ir-68 complex
with iodide as an additive. Amino ester 67 was obtained in 93% ee and 22%
conversion (Scheme 1-23).109
E-isomer, 30% ee (S) 
Z-isomer, 66% ee (S) 
65
66
OH
n h 2 Plr Ph
H? (48 bar)
u u u t i  [|r(68)CI]2 * [ P Y ^ ^ C O O E t h 3c - n 0 1 ?
rt, 46 h
93% ee, 22% conv. 
67
Ph2P PPh2 
DPAMPP 
68
Scheme 1-23. Asymmetric hydrogenation of oximines.
Burk and co-workers developed an efficient catalytic system for the hydrogenation 
of TV-acylhydrazone substrates by using a chirla cationic Rh-43a complex (Table 
1-13).110’111 In their investigation, they found low temperature (-10 °C to -15 °C) and a 
protic solvent isopropyl alcohol were more beneficial to improve enantioselectivity 
(entries 1-4) .110,111 Various A-acylhydrazones of aromatic ketone, alphatic ketone and 
keto ester were hydrogenated to form V-benzoylhydrazones in up to 97% ee (entries 
5-7). Their catalytic system showed high selectivities for various functional groups, 
such as alkene, alkyne, ketone, aldehyde, imine and so on.110,111 The resulting chiral 
products could be easily converted into free amines by treatment with samarium 
diiodide or converted into free amines by treatment with 3N HC1.110,111 The carbonyl 
function of the hydrazones is crucial to achieve high selectivities and good activities.
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Table 1-13. Enantioselective hydrogenation of ./V-acylhydrazone
N ' V Ph H2(4bar>------------ -  H N 'V Ph
li o [(Rh-43a)(NBD)]OTf I 0
r i - ^ r 2 (0.2 mol%), ¡-PrOH R1"">R2
43a
entry R1 R2
temperature
(°C)
time
( h r
ee
(%)
config.
1 c 6h 5 Me 20 2 7 b 5
2 c 6h 5 Me 20 1 88 S
3 c 6h 5 Me 0 12 92 S
4 c 6h 5 Me -10 24 95 S
5 4-N02C6H4 Me 0 12 97 S
6 Cy Me -15 36 72 S
7 C 02Me Et 0 36 91 S
0 Time allowed for complete conversion to product;b Toluene as solvent.
In 2001, Spinder and Blaser reported the asymmetric hydrogenation of 
iV-diphenylphosphinyl ketimines by using a cationic catalyst Rh-16b in situ prepared 
from [Rh(NBD)2]BF4 and ligand 16b.112 Several jV-diphenylphosphinyl ketimines were 
hydrogenated to the corresponding amines in 30% to 99% ee at 60 °C under 70 bar 
hydrogen pressure (Table 1-14, entries 1-3). The strong basicity of the ligand 16b was 
important for the hydrogenation to achieve good reactivity and enantioselectivity, and, 
the enantioselectivities of product showed high sensitivity to ligand, metal and 
substrate structure.112 Subsequently, hydrogenation of a wide scope of 
iV-diphenylphosphinyl ketimines was successfully realized by using Pd-69
43
complex.113,114 A range of A-diphenylphosphinyl ketimines of aromatic ketones were 
hydrogenated in 87%-99% ee at room temperature under 69 bar hydrogen pressure 
(Table 1-14, entries 4-7).113,114 The products can be hydrolyzed to unracemized free
amines in acidic conditions.
Table 1-14. Enantioselective hydrogenation of A-diphenylphosphinyl ketimines
9
N.PPh2 __ ü>_
■A. catalystsolvent R
HN'
1"^
9
PPh2
PCy2 
"Me
Fe ' P°y2 
16b
entry R1 R2 catalyst conv (%) ee (%) config.
1 c 6h 5 Me Rh-16b 100 99 R
2 4-CF3-C6H4 Me Rh-16b 98 95 R
3 4-Cl-C6H4 Me Rh-16b 53 30 R
4 c 6h 5 Me Pd-69 >95 96 S
5 4-C1-C6H4 Me Pd-69 94 94 S
6 c6H5 Et Pd-69 95 87 S
7 2-Furyl Me Pd-69 62 87 S
2
Asymmetric hydrogenation of A-tosylimines was earliest realized by using a Ru-45b 
catalyst.115 Good ee’s were obtained in the presence of 5% preformed catalyst at 40 °C 
under 72 bar hydrogen pressure in THF (Table 1-15, entries 1 and 2).115 However, the 
catalytic system showed low reactivity and enantioselectivity for A-tosylamines 
derived from alphatic ketones. The chiral cationic Pd-70 complex showed excellent 
enantioselectivity for hydrogenation of A-tosylamines (entries 3-5).57,114 A range of 
A-tosylimines of aromatic ketones and alphatic ketones were hydrogenated to
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jV-tosylamines in up to 99% ee at 40 °C under 77 bar hydrogen pressure (entries 3-5).57 
Subsequently, Zhou et al reported a cationic Pd-71 catalyzed hydrogenation of 
iV-tosylamines, obtaining excellent results as well (entries 6 and 7).114 Notwithstanding 
these excellent results, the high pressure and catalyst loading and the difficulty to 
remove the protect group are still problems for this type imine hydrogenation.
Table 1-15. Enantioselective hydrogenation of jV-tosylimines
45b 70 71
entry R1 R2 catalyst
conv.
(%)
ee
(%)
config.
1 Ph Me Ru-(R)-45b 82 a 62 R
2 2-tetralon / Ru-(i?)-45b 77 ° 82 R
3 Ph Me Pd-70 >99 99 R
4 1-naphthyl Me Pd-70 >99 99 (-)
5 t-Bu Me Pd-70 >99 98 R
6 Ph Me Pd-71 84 96 S
7 t-Bu Me Pd-71 94 91 S
a isolated yield
2.2.8 Asymmetric Hydrogenation of Imino Esters
Enantioselective hydrogenation of fluorinated a-imino esters was successfully 
realized by using a chiral cationic Pd-45b complex.116 The less coordinating solvent
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2,2,2-trifluoroethanol (TFE) dramatically improved the reactivities and 
enantioselectivities in the hydrogenation of a-imino esters.116 A series of a-imino 
esters were hydrogenated to form a-fluorinated amino esters with ee values ranging 
from 30% to 91% at room temperature under 103 bar hydrogen presure (Table 1-16, 
entries 1-4).
Table 1-16. Enantioselective hydrogenation of a-imino esters
entry
R1 R2 catalyst
conv.
(%)
ee
(% )
config.
1 c f 3 Et Pd-45b 99 88 a R
2 c c if 2 t-Bu Pd-45b 69 81 R
3 C 7 F 15 Bn Pd-45b 98 61 R
4 c h f 2 Bn Pd-45b 75 30 R
5 Ph c h 3 Rh-70 >99 95 S
6 4-Br-Ph c h 3 Rh-70 >95 92 (-)
7 2-MeO-Ph c h 3 Rh-70 >95 95 (-)
8 2-naphthyl c h 3 Rh-70 >95 90 (-)
9 cyclohexyl c h 3 Rh-70 84 94 (+)
a 91% ee was obtained, when 5 equiv o f n-BuiNHSCh was added.
It was suggested that TFE coordinated weakly to palladium and thus was replaced 
by less coordinative fluorinated ¡mines. TFE could also affect the imino group by
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protonation or hydrogen bonding.116 Recently, Zhang and coworkers reported a new 
catalytic system based on a cationic rhodium complex bearing diphosphine ligand 70 
for the hydrogenation of a-imino esters.117 A range of a-imino esters were 
hydrogenated to form glycine with excellent ee values ranging form 91% to 95% 
(entries 5-9).117
Knochel and co-worker reported an enentioselective protocol to synthesise chiral 
lactam 74 via asymmetric hydrogenation of ¡mine 72 bearing a remote ester group 
followed by deprotection by using CAN. The protected amino ester was obtained in
98% ee and 96% yield by using the complex 27 at room temperature under 10 bar
o c
hydrogen pressure (Scheme 1-24).
BARF'
Scheme 1-24. Asymmetric hydrogenation of imino esters.
2.2.9 Asymmetric Transfer Hydrogenation of Imines with Metal 
Catalysts
Asymmetric transfer hydrogenation is one of the most common and direct methods 
to reduce C=0, C=C and C=N bonds. Other than hydrogenation, transfer 
hydrogenation generally employs hydrogen donor as hydrogen source, such as formate 
salt, IPA or Hantzsch ester. In catalytic transfer hydrogenation, the hydrogen source
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is normally transferred into a byproduct which could affect the activity and 
enantioselectivity of catalyst.119 However, catalytic transfer hydrogenation is still a 
good choice for industrial processes and academic research, because of its operational 
simplicity and versatility.
Compared to asymmetric hydrogenation of ¡mines, only a few cases of
metal-catalyzed transfer hydrogenation of acyclic and cyclic ¡mines have been
successfully realized.2’6,8,118,120 Table 1-17 summarises the major results.
Table 1-17. Transfer hydrogenation of ¡mines with diamine ligated-metal catalysts
n ' r3
2
R1 R2
chiral catalyst 
HCOO', solvent
.R 3
HN
R ^ R 2
entry imine catalyst
time
(h)
yield
(% )
ee
(% )
config. ref
1* 3a (S,S)-75b 36 72 77 S 50
2 a 50a (/S,5)-75a 3 >99 95 R 50
3 a 50c (S,S)-75c 8 >99 84 R 50
4° 50i (S,S)-75c 5 86 97 R 50
5° 3a (S,S)-76 10 min 88 8.4 S 121
6* 50a (S,S)-76 10 min 96 89 R 121
1 b 50c (S,S)-76 3 89 3.2 R 121
8 b 50a (R,R)-77 10 97 95 S 122
9 b 50b (R,R)-77 25 68 92 S 122
I 0 b 50i {R,R)-77 8 97 99 S 122
11* 3a (i?,/?)-78b 2 (100) 91 / 123
12 6 50a (R,R)-7Sa 2 (100) 88 / 123
13* 3a (R,R)-80 15 min 70(100) 44 S 124
14* 50a (R,R)-79 15 min 72(100) 87 s 124
15* 50i (R,R)-79 15 min 69 (100) 88 s 124
“ S/C = 200; b S/C =100;e Conversion is state in parentheses.
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ri - arene = p-cymene; 
Ar = 4-CH3C6H4 
: n6- arene = benzene; 
Ar = 2,4,6-(CH3)3C6H2 
n6- arene = benzene; 
Ar = 1-naphthyl
a : 
b
(R,R)- 78
n6- arene = p-cymene; 
n6- arene = 1 ,2 ,3,4,5,6- 
hexamethylbenzene (R ,R )-79 (R ,R )-80
Scheme 1-25. Diamine-ligated catalysts for asymmetric transfer hydrogenation.
a
b
c
Noyori and coworkers demonstrated the first enantioselective transfer 
hydrogenation of ¡mines by using diamine ligated chiral Ru(II) complexes (S,S)-75 in 
the azeotropic mixture of formic acid and triethylamine (HCOOH: Et3N = 5:2) 
(Scheme 1-25).50 Cyclic ¡mines 50a and 50i were reduced to tetrahydroisoquinoline 
51a with 95% ee and tetrahydro-P-carboline 51i with 97% ee (entries 2 and 4), 
respectively. However, replacing the substituent group methyl with aryl, 50c was 
completely reduced to produce 51c, but with a lower ee value of 84% in a prolonged 
time of 8 h (entry 3). Furthermore, the activity of catalyst was significantly lowered 
when the diamine ligated catalyst 75 encountered acyclic ¡mine 3a (entry l).The 
catalyst 76 showed higher activity for the reduction of cyclic and acyclic imines, but 
lower enantioselectivity for acyclic imine 3a and aryl substituted imine 50c (entries
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1 *y i
5-7). Recently, Deng and coworkers reported a catalytic transfer hydrogenation of 
cyclic imines and iminium salts in water by using the water-soluble Ru(II) complex 77 
with CTAB as additive.122 The catalyst show slightly higher enantioselectivity but 
lower activity for the reduction of cyclic imines (entries 8-10). The more electron rich 
catalyst 78 showed excellent enantioselectivity for acyclic imine reduction (entry 
13),123 and Will’s tethered catalysts 79 and 80 showed high activity for cyclic and 
acyclic imines (entries 13-15).124,125
2.3 Metal-free Catalytic Asymmetric Hydrogenation
Recently, Stephan and coworkers found a new type of bulky Lewis acid-base pair 
consisting o f borane B(C6F5)3 and phosphine, which could catalyze hydrogenation of 
ketones, imines, nitriles and aziridines.126-131 For dihydrogen cleavage, they suggested 
that the Lewis acid BR3 interacted with H2, resulting in polarization of H2 and thus 
facilitating protonation o f phosphine. Both the Lewis acid and base interacting with 
hydrogen are also possible in splitting hydrogen (Scheme 1-26).129 Unsaturated
substrates might be reduced by the resulting phosphonium borate salt.
5+
PR3
PR3 + BR3
I---.BR3
H
8‘
5“ 5+
H— H— PR3
[R3PH]+[HBR3]-
r
b r 3
Scheme 1-26. Possible mechanism for heterolytic cleavage o f H2 by phosphine and 
borane.
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Further studies by Stephan and coworkers showed that the combination of vV-Lewis 
base and Lewis acid BR3 could also split hydrogen (Scheme 1-27).127,128 The Lewis 
acid B(C6F5)3and imine might form iminium hydridoborate ion pair under hydrogen 
pressure, which was confirmed by spectroscopy and X-ray crystal structure. The 
hydridoborate transfers the hydride to the protonated imine, and dissociation of BR3 
releases the amine product.
r1'NH
r 2^ r3
'N
J1
H2 + R2 R3
B(C6F5)3
©
r L n -B(C6F5)3
r2" ^ r3
f n 1 ®  H 1
R V H ’ © '
A  ,
HB(C6F5)3
R2 R3 . .
Scheme 1-27. Possible mechanism for catalytic hydrogenation of imine.
Based on this concept, Klankermayer and coworker employed a chiral 
(+)-a-pinene derived borane as a catalyst for acyclic imine enantioselective 
hydrogenation (Scheme 1-28).128 Although only 13% ee was obtained, this is the first 
example of metal-free catalytic asymmetric hydrogenation of imines under mild 
conditions. This finding will encourage further extension of the use of chiral Lewis 
acid-base pairs asymmetric hydrogenation.
H2(20 bar) g r
13% ee
81, toluene, 65 °C
29 30
Scheme 1-28. Asymmetric hydrogenation of imine 29 with bulky Lewis acid-base pair.
B(C6F5)2
81
51
2.4 Organocatalytic Asymmetric Transfer Hydrogenation
In the organometal-catalyzed enantioselective hydrogenation or transfer 
hydrogenation, transition-metal catalysts generally play two roles: enabling hydride 
transfer from a hydrogen source, such as molecular hydrogen, isopropyl alcohol or 
formate salt, to a unsaturated substrate, and chirality transfer from a chiral ligand to the 
prochiral substrate.2’6,8’118 Owing to their high activity and enantioselectivity, various 
chiral transition metal catalysts have been applied to asymmetric reduction of olefins, 
ketones and C=N functions.2,6,8 However, asymmetric organocatalysis has shown 
better enantioselectivity and wider scope in the reduction of C=N functional groups in 
many case.119 In particular, chiral Bronsted acids as a catalyst and Hantzsch 
dihydropyridine as the hydrogen source have been combined for enentioselective 
reduction of C=C and C=N double bonds.119
2.4.1 Reduction of Imines
The earliest enantioselective organocatalytic reduction of imines was reported by 
Singh and Batra in 1989 (Scheme 1-29).132 Chiral Bronsted acids and Hantzsch esters 
were selected for the reduction of iV-phenyl ketimine 29 prepared from acetophenone 
and aniline. A range of chiral acids were examined for optimum conditions. One of 
the amino acids, cysteine was selected as an effective catalyst to reduce 29 to produce 
amine 30 in 55% yield and 62% ee.
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EtOOC 
Me' 'N
X j C
COO Et 
Me
H
L-cysteine«HCI 
benzene, reflux
,Ph
29 30
55% yield 62% ee
Scheme 1-29. The earliest example of organocatalytic reduction of acyclic ¡mines.
Although the first organocatalytic asymmetric reduction of ¡mines afforded 
enantiomerically enriched amine, the transformation is of low productivity and 
enantioselectivity. Recently, Rueping and List’s groups demonstrated an excellent, 
similar organocatalytic system for the reduction of acyclic ¡mines by using different 
chiral phosphoric acids (Scheme 1-30).133,134 The chiral phosphoric acid was derived 
from the Akiyama-Terada family of binol-derivatives.135 In Rueping’s catalytic sytem, 
electron withdrawing and bulkyl 3 ,5-(CF3)-phenyl-substituted binaphthol phosphoric 
acid 82 (20%) was used for the reduction of acyclic ¡mines in a low concentration 
(0.02 M) of substrate at 60 °C.133 Thirteen enantiomerically enriched amines were 
obtained in 46-91% yield and 68-84% ee. A more bulky 
ortho-2,4,6-triisopropyl-phenyl substituted binaphthol phosphoric acid (TRIP) 83 was 
selected as the catalyst by List.134 Higher levels of isolated yields and enantioslectivites 
were obtained by using 1% of 83 for the reduction of A-aryl ketimines.
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2 E tO O C ^ /^ C O O E ti ..X.X„ . A  + M A  ' N '  Me benzene, 60 °CMr H 20 mol% Bronsted add 82 HNj Ar1'
-Ar2
Ruepling's system: 13 examples in 46-91% yield and 68-84% ee
-PMP EtOOC'•'-AAAXXCOOEt 1 mol% Bronsted acid 83p '  \  + Me N Me toluene, 35 °C
K H
,PMP
HN
A .
Lists system:! 1 examples in 80-98% yield and 80-93% ee
h n - p m p -P M P HN 'PM P H^-PMP
82: 74% ee, 
76% yield; 
83: 88% ee, 
96% yield;
82: 70% ee, 
82% yield; 
83: 84% ee, 
85% yield;
82; 84% ee, 
82% yield; 
83: 85% ee, 
95% yield;
83: 90% ee, 
80% yield
Scheme 1-30. Organocatalytic reduction of imines with Bronsted acids.
2.4.2 Reduction of Imino Esters
Following reduction of imines, enantioselective reduction of imino esters was also 
realized by using the chiral Akiyama-Terada family of Bronsted acids together with 
Hantzsch ester.136'139 Two examples of reduction of cyclic imino ester are given in 
Scheme 1-31.136 Methyl and ethyl substituted cyclic amino esters were obtained in 
97% ee (82% yield) and 79% ee (27% yield) by using 10% of chiral phosphoric acid 
84 at 40 °C in benzene. Owing to the terminal CH3 of the ethyl group shielding the 
C=N ¿’/-face which is exposed to hydride addition, lower activity and 
enantioselectivity were observed for reduction of ethyl imino ester.136
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y - ^  E tO OC 
N O
) = \  + Me'
S J
COOEt Bronsted acid
10 mol%_____,
Me 5A MS 40 °C
toluene
R = Me, 82% yield, 97%
R = Et, 27% yield, 79% ee
Scheme 1-31. Organocatalytic reduction of cyclic imino esters.
Subsequently, Antilla and You independently demonstrated a simliar 
organocatalytic reduction of a-imino ester by using chiral phosphoric acids and 
Hantzsch ester in nonpolar solvent (Scheme 1-32).137,138 In Antilla’s study, the vaulted 
biaryl phosphoric acid 85 showed high activity and enantioselectivity in transfer 
hydrogenation of a-imino esters in toluene at 50 °C. A range of aromatic and alphatic 
amino esters were obtained in 95-99% ee and 85-98% yield (Scheme 1-32). The ester 
group is found to significantly affect the activity and enantioselectivity.138 Using 86 as 
catalyst, a range of a-imino esters were reduced to a-imino esters by You et al with 
33-98% ee and 46-94% yield. However, higher levels of isolated yields and 
enantioslectivites were obtained by using 5% of 85 rather than 10% of 86 in the 
transfer hydrogenation of a-imino esters.
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5 mol% 85 
toluene, 50 °C
19 h R2"^ C 02Et
Antilla's system: 11 examples in 85-98% yield and 95-99% ee
„PM P E t O O C ^ ^ \^ C O O E t  ^p m p
N II J 1 mol% 86 t HN
R1 C 02R2 Me [¡j Me Et2° ' rt’ 48h R1 * C 02R2 
140 mol%
You's system: 15 examples in 46-94% yield and 33-98%  ee
85
Scheme 1-32. Organocatalytic reduction of acyclic imino esters.
Shortly after, a further extension into P,y-alknyl a-imino esters was explored by 
using the same acid 86 in You’s research group.139 Several trans-alkenyl a-amino 
esters were obtained in 83-96% ee and 27-64% yield by reduction of the C=C triple 
bond followed by that of the C=N double bond (Scheme 1-33).
-PMP
rj EtOOC
C0 2fBu +
Me N Me 
H
-PMP 
HN
FT ' ^ * ^ C 0 2iBu 
6 examples in 27-64% yield and 83-96% ee
COO Et 1 mol% 86
Et20, rt
220 mol%
Scheme 1-33. Organocatalytic reduction of p,y-alknyl a-imino esters.
2.5 Mechanistic Aspects of Asymmetric Hydrogenation
So far, only a few detailed studies of homogeneous hydrogenation of imines have
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been reported. Based on those studies, two types of mechanism, classical and ionic 
pathways, were postulated for the transition metal-catalyzed hydrogenation of imines. 
In James’ mechanistic investigation of Rh-catalyzed hydrogenation of imines, several 
intermediates involving imine coordination to the Rh centre via the nitrogen lone pair 
was isolated during the hydrogenation of the cyclic imine 50a.69 They suggested 
oxidative addition of hydrogen to rhodium (I) occurs after the imine is coordinated.
As described in Section 2.2.3, Osborn and Chan found that the isolated 
[Ir(diphosphine)l4]", [Ir(diphosphine)l2]2, and [Ir(diphosphine)l3]2 showed good 
activity for hydrogenation of imines 13a, 29, and 54.71 A same active monomeric Ir-H 
species was suggested to form in the catalytic cycle regardless of which precatalyst 
was used. Based on their studies, a catalytic cycle for the iridium-catalyzed imine 
hydrogenation was postulated (Scheme 1-34).
2
Scheme 1-34. Classical pathway for hydrogenation of imines with transition metal 
complex.
Firstly, the starting metal hydride (M-H) binds the imine via the lone pair in a r)1 
manner. Following the first step, a r)1 to r\ migration followed by insertion into the
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M-H bond leads to an M-amine complex. The last step is hydrogenolysis of M-N bond
to generate the chiral amine and the active catalyst. Buchwald proposed a similar 
mechanism for the Ti-catalyzed hydrogenation of imines.53 However, the ¡mine 
coordinates to the metal centre even if the first step is hydrogen activation.
On the other hand, direct hydride transfer from M-H to unsaturated O N  double 
bond without imine coordination is possible. Norton and coworkers investigated the 
reaction mechanism of stoichiometric reduction of an iminium salt with 
CpRu(diphosphine)H to generate enantiomerically enriched amine. ’ High pressure 
NMR experiments show that the hydride transfer step is rate-determining. Based on 
their studies, an ionic mechanism for imine hydrogenation was assumed. The catalytic 
cycle is depicted in Scheme 1-35 below.
R \  .R 3 
N
[CpRu(diphosphine)]H catalyst.
A similar ionic mechanism was proposed for organocatalytic reduction by several 
research groups (Scheme 1-36).133,134,136 Firstly, ketimine is activated by protonation
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with a chiral phosphoric acid to form a tight ion pair salt. Subsequently, hydride 
transfer from Hantzsch dihydropyridine to the iminium salt generates an 
enantiomerically enriched amine and pyridinium derivative.
Scheme 1-36. Proposed mechanism for organocatalytic reduction of ¡mines with chiral 
acid.
3. Direct Asymmetric Reductive Amination
3.1 Introduction
As described in previous sections, chiral amines could be accessed by asymmetric 
catalytic hydrogenation of ¡mines. However, this powerful method requires the 
isolation of unsaturated ¡mines for the sussequent reduction.140,141 Owning to the 
equilibrium existing in the formation of ¡mine, the imine may generally be obtained in 
a low isolated yield, by heating to 110 °C or by using TiCU mediated reaction at room 
temperature.74,79 In addition, the tedious purification need to be carried out quickly due 
to the limited stability of ¡mines.
The one-pot two step reductive amination could be performed under milder 
conditions because the reduction step decreases the concentration of the intermediate 
imine, thus assisting the equilibrium to favour the formation of imine. Further, the one
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pot reductive amination saves time and solvent. Therefore, the most convenient,
economical, and eco-benign synthetic pathway to chiral amines is direct asymmetric 
reductive amination (DARA) of prochiral carbonyl substrate in a one-pot fashion
(Scheme 1-37).
formation C=N double bond 
____ R3NH,
k.i
decomposition
O
, A
r3nh2
R2
NR3
A:>1 c asymmetric catalytic reductionR 1 "R* catalyst, reductant
isolated intermediate
k-i
NR3
A  2R1 R2
NHR 3
catalyst, reductant F
direct asymmetric reductive amination (DARA)
Scheme 1-37. Asymmetric reduction of imine and direct reductive amination.
R2
Although DARA is a very convenient and efficient method for the synthesis of 
chiral amino fragnments, the method is far less developed so far.136,140,141 For instance, 
AR-A2 is a new candidate drug displaying a pronounced antagonistic activity toward 
the 5-HTib receptor. The industrical process for generating the chiral amine 88 was 
nonasymmetric catalytic amination of ketone 87 with benzyl amine followed by chiral 
tartaric acid resolving the racemic enantiomers (Scheme 1-38). A more direct and 
economic synthetic route to intermediate 88 might start from compound 87 by DARA 
in one step.
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Scheme 1-38. Synthesis of pharmaceutical product AR-A2.
Owing to several reasons, the DARA has been less developed. On the one hand, 
DARA just has a history of ten years and results have not been emphasized enough in 
the past.6,54 On the other hand, comparing to reduction of ¡mines, the one-pot DARA is 
much more complicated and detailed mechanisms are not very clear to date. As is 
known, the DARA consists of two consecutive steps in one pot. The rate of reduction 
is determined by the slower step, and the enantioslectivity can be affected by the 
carbonyl compound or the partner amine. Blaser and coworkers found that the best 
productivity of catalyst in DARA remained 100 times lower than in the reduction of 
¡mine.54 Bomer and coworkers also found that the enantioselectivities in DARA were 
significantly lower than in reduction of the isolated ¡mines in transition 
metal-catalyzed hydrogenation.140 Chemoselectivity is another problem for the DARA 
process, because the existing carbonyl compound may also be reduced to the 
corresponding hydroxyl products instead of forming ¡mines.140
Only a few DARA catalysts have been developed in the past ten years. It is 
noteworthy that one has been applied to an industrical process for the production of the 
herbicide Metolachlor.54 The following sections provide a summary of the state of the 
art DARA of carbonyl compounds by hydrogenation or transfer hydrogenation.
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3.2 Transition Metal-Catalyzed DARA
The first example of transition metal-catalyzed DARA was established by Blaser 
and co-workers in 1999 (Scheme 1-39).54 A 78% ee was obtained for amine 14b by 
DARA of methoxyacetone 90 with 2-methyl-5-ethyl-aniline (MEA) 89 by using their 
Ir-16a catalyst, which has been used for the hydrogenation of isolated imines.54’56 
Various solvents, iodide salts and acids were examined for the reaction. The catalyst 
displayed higher activity and enantioselectivity in the presence of a small amount of 
trifluoroacetic acid (CF3COOH) and iodide ions in cyclohexane, leading to 99% 
conversion and 78% ee at a substrate to catalyst ratio of 10000 in 16 h. Although the 
result is quite remarkable to date, the productivity of the catalyst in DARA remained 
much lower than in the reduction of the corresponding isolated imine. The reason for 
this could either be a strong complexation of MEA, thus blocking the imine to access 
the iridium, or dimerization of Ir-16a to form an inactive species.
h2n
89 Et H? (80 bar) 50 °C t 
+ 0.01 mol% [lr(COD)CI]2
MeO
O 0.011 mol% 16a 
^ U ^ J B A I, CF3COOH
HN
Et
CICQCH,CI.CI\  J-L.
90
78% ee, 99% conv. 
14b
M e O \ / \  Et 
(S)-metolachlor 
91 16a
Scheme 1-39. Synthesis of (S)-Metolachlor by DARA of methoxyacetone.
Following the DARA of alphatic ketones,54 DARA of other ketones was realized in 
very good yield with up to 99% ee by using an air stable Pd-phosphine catalyst.142
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Selected results can be seen in Table 1-18. Several preformed chiral Pd-diphosphine
complexes, in which the structure of [(i?)-45b]PdBr2 and (5',5)-49]PdBr2 was 
characterized by X-ray, were examined for DARA of aliphatic and aromatic ketones. 
In the investigation by Rubio-Perez et al, a ligand with larger bite angle and better 
flexibility appear to be crucial for obtaining high conversion and enantioselectivity.142 
Using optimized conditions, a range of alphatic 7V-aryl amines were obtained in 
51-84% isolated yield and up to 99% ee (entries 1-3). Lower yield was obtained when 
p-methyl aniline was replaced by more electron deficient />trifluoro aniline (entries 1 
and 2). However, the catalyst displayed lower enantioselectivity in the amination of
acetophone or (£)-pent-3-en-2-one, even losing chemoselectivity in the reduction. 
Table 1-18. Pd-45b catalyzed DARA of ketones
O u L  VR3
ra r ! ♦ u
R3
n 2 üc,, /
Pd-45b (2.5 mol %)* 
5 AMS, CHCI3 
7 0 °C, 24 h
HN
R1^ R 2
^ V i p P P h .
45b
entry R 1 R2 R3 yield., % ee, % config.
1 CH3(CH2)4 c h 3 /?-Me 84 73 (-)
2 CH3(CH2)4 c h 3 w-CF3 51 95 (-)
3 Et Me p-Me 77 99 (-)
4 CH3(CH)2 c h 3 H 78 10 (-)
5 c 6h 5 c h 3 H 64 43 R
Zhang and co-workers developed a DARA system for aromatic ketones by using 
1% of Ir-f-Binaphane with 1.5 equivalent of Ti(0'Pr)4 and 10% of L (Scheme 1-40).143 
Based on their studies, Ti(0 'Pr)4 significantly promoted the formation of the imine,
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enhancing the possibility for a high conversion in DARA of ketones. An aminoalcohol 
Ti (IV) complex was supposed to form, followed by formation of imines and then 
reduction in the presence of I2. Iodine was assumed to assist Ir-17 for hydrogenation of 
the resulting imines. A range of aromatic ketones were aminated with p-anisidine in 
44-96% ee. The chiral primary amine was generated by using CAN to remove the 
protect group. However, the catalytic system did not work for reductive amination of 
alkyl ketones.
Scheme 1-40. DARA of aromatic ketones in the presence of Ti(0 'Pr)4.
In the above study, the secondary amines could be converted to primary amines by 
removing the protecting group. However, Kadyrov and coworkers realized the DARA 
of ketones with ammonium by using the catalyst [Ru((i?)-45a)Cl2], generating primary 
amines under transfer hydrogenation (Table 1-19).144 A range of combinations 
involving Ru, Rh, and Ir complexes, diphosphines and diamine ligands were examined 
for the DARA of ketones with ammonium. When the reaction was carried out with 5 to 
10 equivalents of HCOONH4 in NH3/methanol (15-25%) at 60-85 °C, 95% ee was
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observed using the catalyst [Ru((A)-45a)Cl2] (entry 1). Under optimized conditions, 
various enantiomerically enriched primary amines and TV-formyl derivatives were 
afforded in up to 24-98% ee. However, DARA of alphatic ketone only led to 24% ee 
(entry 4). Although the A-formyl derivatives can be converted to primary amines after 
hydrolysis, the limited selectivity and additional step reduce its importance.
Table 1-19. [Ru((A)-45a)Cl2] catalyzed DARA of ketones
Ar
[(ff)-45a)RuCI2l 
HCOONH4, 85 °C 
MeOH
n h 2
Jk +
A r ^ R  
up to 98% ee
+
Ar
NHCHO
45a Ar = 4-Me-C6H4
entry substrate
t
(h)
ketone
(%)
amine
(%)
formyl 
amine (%)
alcohol
(%)
yield
(%)
ee
(%)
1 acetophone 20 5 75 19 1 92 95 (R)
2 4 ’ -methy lacetophone 21 0 8 91 0 93 93 (.R)
3fl 4 ’ -nitroacetophone 48 0 45 55 0 92 95(A)
4 2 -octanone 17 0 36 64 0 44 24(5)
a 98% ee was obtained, when the reaction was carried out at 60 °C.
Clearly, DARA of keto acids is a valuable process for generating amino acids. To 
obtain an excellent catalyst for this reaction, Bomer and co-workers tested a large 
number of precatalysts by high-throughput screening.145 The catalyst was prepared in 
situ by the reaction of 96 chiral P-ligands with [Rh(COD)2]BF4 and [Rh(COD)Cl]2, 
respectively (Scheme 1-41). The ionic [Rh(COD)(A,A)-92]BF4 was found to be the
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best catalyst judging from activity and enantioselectivity in the DARA of a-ketone acid
with benzylamine. Using the Rh-92 catalyst, seven A-benzyl alphatic amino acids were 
obtained in 73-98% ee, and JV-benzylphenylglycine was also obtained, but only in 19%
ee.
1  + RnMi_| H2(60 bar)
R ^ C O O H  2 [Rh(92)]+BF4-
solvent, rt
H N 'B" _ u^ Y PPh2X  BnNvJ,,
R * COOH PPh2
19-98% ee
8 examples (R ,R )-92
Scheme 1-41. DARA of a-keto acids with benzylamine catalyzed by Rh(I) complex.
In a related study, Bunlaksananusom and Rampf demonstrated that DARA of a 
range of P-keto esters with ammonium acetate, generating P-amino esters in good yield 
and up to 99% ee by using Ru-93 at 30 bar hydrogen pressure (Scheme 1-42).146 It is 
noteworthy that cheap ammonium acetate was employed as the nitrogen source and the 
unprotected P-amino esters were formed during the reaction. Six aryl substituted 
P-amino ester salts were obtained in 96-99% ee and 79-88% yield along with some 
P-hydroxy ester. Alphatic ethyl-3-aminobutanoate was also obtained in 96% ee and 
80% yield. Furthermore, cyclic P-amino ester salts containing two chiral centres were 
obtained. Imino ester was a possible intermediate for the reduction step. Good 
enantioselectivities were observed in all cases, probably because the intermediate, 
nonprotected imino ester does not exist as a mixture of E- and Z-isomers during the 
reaction.
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AcO- NH3 0
OEt
70% yield, 58% de, 82% ee 
Scheme 1-42. DARA of p-keto esters with amonium catalyzed by Ru(I) catalyst.
PPh2
PPh2
Quiet recently, DARA of P-keto amide with ammonium salicylate to produce
unprotected p-amino amide was established by using the catalyst Ru(OAc)2(96) in
MeOH at 80 °C (Scheme 1-43). 147
H2 (30 bar)
0  0  ammonium salicylate, NH2'0
Ru(OAc)2(96)(1%) I I
Y  .  .  _  . . _ _ D
salicyclic acid
MeOH, 80 °C Y 8 examples,82-96% yield, 94.7-99.6% ee
y y r
0  HN
X AR Y
94
dimer-like by-product
(Ar = 3,5-Me2C6H3) 
96
sitagliptin 
/¡eld, 99.5'
Scheme 1-43. DARA of P-keto amides with amonium catalyzed by Ru(II) catalyst.
In the presence of 1% Ru(OAc)2(96) and 5 equiv of ammonium salicylate, 
sitagliptin 95, a potent DPP-IV inhibitor, was obtained in 91% yield and 99.5% ee in 
MeOH. Ammonium salts containing different anions, solvents, and various catalysts 
were screened; and the additional 4 equiv of ammonium salicylate was found to be 
crucial to achieve high yield because it suppressed the dimer 94 formation or broke up
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the dimer during the reaction. Under the optimized conditions, a range of p-amino 
amides were obtained in 82-96% yield and 94.7-99.6% ee.
DARA of ketones to generate cyclic amines is unusual. Wills and co-workers 
developed an efficient catalytic system to produce enantiomerically enriched 
tetraisoquinoline 51a by using (R,R)-75a under transfer hydrogenation conditions 
(Scheme 1-44).148,149 The one-pot reductive amination proceeds in two consecutive 
steps; the first step is formation of the cyclic imine 50a via deprotection of 
t-Boc-protected amino ketone 97. This is followed by reduction of 50a with (R,R)-15a 
by using the hydrogen source HCOOH-Et3N. 51a was obtained in 88% ee and 85% 
yield. Amine 98 was also obtained under similar conditions, but with almost no 
enantioselectivity. The reason for this is not entirely clear. The direction of the 
aromatic ring on the imine was considered important to achieve high enantioselectivity, 
because the aromatic ring on the side of imine lone pair could conflict with the catalyst, 
leading to loss of enantioselectivity in the reduction.
Scheme 1-44. DARA of ketones to generate tetraisoquinoline 51a.
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3.3 Organocatalytic Asymmetric Reductive Amination
The first example of one-pot organocatalytic reductive amination of ketones was 
reported by List and co-workers in 2005 (Scheme 1-45).134
Scheme 1-45. DARA of ketone and a-branched aldehydes reported by List.
The primary amine 101 was obtained in 88% ee by using CAN to remove the 
protected group 4-methoxy-/V-(l-phenylethylidene)aniline. The protect amine was 
produced by reduction of the in situ prepared imine in the presence of the phosphoric 
acid 83 prior to addition of Hantzsch ester. Subsequently, DARA of a-branched 
aldehydes to generate chiral P-branched amines was established by the same group 
(Scheme 1-45).150 A dynamic kinetic resolution was assumed, in which one of the 
imine enantiomers was reduced faster than that of the other, but they would undergo
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fast racemization via imine/enamine tautomerization in the presence of acid. Based on 
this concept, DARA of various a-branched aldehydes with p-anisidine was performed 
by using the catalyst 83, leading to chiral P-branched amines with 40-96% yield and 
40-98% ee.
Simultaneously, MacMillan and co-workers developed a highly efficient DARA of 
ketones with various primary amines, generating chiral secondary amines with good 
isolated yield and excellent enantioselectivity (Scheme 1-46). Various 
Akiyama-Terada phosphoric acids were screened in the reaction. The phosphoric acid 
84 was selected as the best catalyst for achieving good conversion and excellent 
enantioselectivity. Using optimized conditions, a range of aromatic and alphatic JV-aryl 
amines were obtained in 83-96% ee and 81-94% ee, respectively; and various 
electronically diverse amines were also obtained, in 91-93% ee.
1
V ^ R 2
r 3n h ,
N
H
84 (10 mol%)
5 A MS, 40-50 °C,
24-96 h, benzene
NHR3
R1^ R 2
27-92% yield 
79-97% ee
84
11  examples 
70-87% yield 
83-96% ee
6 examples 
49-75% yield 
81-94% ee
5 examples 
55-92% yield 
91-93% ee
Scheme 1-46. MacMillan’s catalytic system for DARA of ketone.
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As described in Section 2.4.2, Antilla and co-workers developed an excellent 
catalytic system for the reduction of a-imino esters.137 In the same paper, they also 
reported three examples of a-keto esters that were directly aminated with p-anisidine 
by using the catalyst 85 in the presence of Hantzsch ester. The a-amino esters were 
obtained in 88-90% yield and 96-99% ee (Scheme 1-47).
Scheme 1-47. Antilla’s catalytic system for DARA of a-keto esters.
4 Conclusion
In Section 1, tetrahydroquinoline and tetrahydro-p-carboline have been mentioned 
as very important pharmaceticul products or building blocks in the synthesis of natural 
product. However, apart from Buchwald’s titanocene catalyst that allows a 
tetrahydroisoquinoline to be obtained in 98% ee, all the reported hydrogenation 
catalysts afforded less than 90% ee for tetrahydroquinoline and tetrahydro-P-carboline. 
Furthermore, only a few examples of these compounds have been demonstrated with 
good to excellent enantioselectivity by using Noyori type Ru/Rh-TsDPEN catalyst 
under transfer hydrogenation. A more efficient and simpler hydrogenation of cyclic
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imines to these compounds is desired. As summarised in Sections 2 and 3, various 
catalysts have been applied to enantioselective hydrogenation of C=N functions and 
DARA of carbonyl compounds to generate chiral amines, affording good to excellent 
enantioselectivities. However, most of the transition metal catalysts show low activity, 
low enantioselectivity or narrow substrate scope. In contrast, chiral phosphoric acids 
are potentially excellent catalysts. However, the enantiomerically enriched amines 
could generally be obtained only over long reaction times. A more versatile catalyst 
will be desired for those enantioselective hydrogenation and DARA systems.
In response to those challenges, three areas of research have been carried out in the 
past three years and are presented in this thesis. Firstly, catalytic hydrogenation of 
cyclic imines to generate tetrahydroquinoline and tetrahydro-P-carboline will be 
described in Chapter 2. Secondly, an excellent cooperative catalytic system comprised 
of a chiral phosphoric acid and a transition metal will be described in Chapter 3. 
Thirdly, in Chapter 4, we will also show a metal catalytic system for DARA by using 
chiral counteranion together with a chiral Bronsted acid.
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Chapter 2. Asymmetric Hydrogenation of Cyclic Imines with 
an Ionic Cp*Rh(III)-TsDPEN Catalyst 
1 Introduction
Tetrahydroisoquinoline and tetrahydro-P-carboline rings are widely existing 
structure units in alkaloids, and their derivatives are known to display high 
bioactivities (Scheme 2-1).1 For instance, salsolidine is a naturally occurring 
alkaloid,lb while YH 1885 is of interest for the treatment of gastro-oesophageal reflux 
disease and duodenal ulcers. A further example is the tetrahydro-P-carboline 
LY23728, an antagonist for the serotonin 2B receptor. Whilst methods for the 
asymmetric synthesis of these molecules have been developed,ld’4 including chiral 
auxiliaries43,6 and organocatalysis,4b,c a straightforward, “greener” method is 
asymmetric hydrogenation of the corresponding imines, which can be readily derived 
from the Bischler-Napieralski cyclization.5
Scheme 2-1. Representive examples of tetrahydroisoquinoline and 
tetrahydro-P-carboline
Although many excellent catalysts are now available for the asymmetric 
hydrogenation of olefins and ketones,6 developing catalysts for the closely related
n
immes remains a considerable challenge. And this is the case with both acyclic and
83
cyclic imines, although the latter are devoid of the problematic syn/anti isomerisation. 
In the particular case of isoquinoline-type imines, there are only a few papers thus far, 
reporting on the formation of tetrahydroisoquinolines and tetrahydro-P-carbolines 
under either hydrogenation8 or transfer hydrogenation9 conditions. Buchwald’s 
titanium hydrogenation catalyst allows
1-methyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline to be obtained in 96% ee; but 
its application potential is rather low due to the low TOFs and difficulty in handling.7,88 
Better rates (TOF: 5 h '1) were achieved with iridium-diphosphine catalysts, although 
the ee’s were lower (<90%) and a higher H2 pressure was used (100 bar).8e Recently, a 
ruthenium-diphosphine catalyst was shown to give a 89% ee in the hydrogenation of 
1 -methyl-6,7-dimethoxy-3,4-dihydroisoquinoline.8k Still better results were obtained 
under transfer hydrogenation conditions with the Noyori-Ikariya Ru-TsDPEN 
(TsDPEN = iV-(/>toluenesulfonyl)-1,2-diphenylethylenediamine) catalyst, with ee’s of 
up to 96% being observed.98
Clearly, much remains to be done in discovering viable catalysts that use the 
desirable H2. Very recently work, Noyori, Ohkuma and coworkers discovered that 
Ru(OTf)(TsDPEN)(p-cymene) and a Cp*Ir(III) analogue are excellent catalysts for 
ketone hydrogenation in methanol.10 The alcohol was supposed to be a base that assists 
catalytic heterolytic cleavage of hydrogen to form metal-hydride and the alcohol 
synchronously accepts a proton to form oxonium by hydrogen bonding. We thought 
the alcohol could be replaced by a catalytic amount of a strong base or basic substrate. 
Based on this concept, our group have shown that a related Cp*Ir-Cl complex with
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5-10 equiv KOH enables fast hydrogenation of aldehydes in water." Because we are 
particularly interested in synthesis of chiral amines via catalytic enantioselective 
reduction of ¡mines, we presumed an efficient cooperative catalytic system in which 
the imine acts as a base assisting the heterolytic splitting of hydrogen to form 
metal-hydride and iminium salt, with the imine directly accepting a proton from the 
splitting dihydrogen (Scheme 2-2). Based on this concept, we developed an ionic 
TsDPEN-ligated Rh(III) catalyst that enables highly efficient asymmetric 
hydrogenation of cyclic ¡mines to afford tetrahydroisoquinolines and 
tetrahydro-(3-carbolines under mild conditions. To the best of our knowledge, no 
diamine ligand was successfully demonstrated in asymmetric hydrogenation of imines 
before we started this project.12
cationic catalyst 
X~ — noncoordinating anion
HN .R
R1^ R 2
Scheme 2-2. Proposed catalytic system for asymmetric hydrogenation of imines.
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2 Results and Discussion
2.1 Additive Effect
4a
NH 
5a
[Rh] =
(RR )-1 (RR)-2 (R ,R )-3
Scheme 2-3. Rhodium catalyzed asymmetric hydrogenation of the cyclic imine 4a (S = 
solvent).
The Rh-TsDPEN complex 1 is an excellent catalyst for asymmetric transfer 
hydrogenation of ketones using either isopropanol or formate salts as hydrogen source 
(Scheme 2-3). We set out by examining 1 for a model hydrogenation using the cyclic 
imine 4a as substrate. The hydrogenation was initiated by introducing 20 bar H2 into 
an autoclave charged with 4a and 1 (0.5 mol%) in dichloromethane (DCM) at room 
temperature. No reduction was observed in either 0.5 h or a prolonged time of 4 h 
under such conditions. A 2% conversion was observed when the reduction was carried 
out for 24 h. Making the reaction condition more basic by adding Et3N, KOH or 
t-BuOK did not bring about any significant changes in 0.5 h, or a prolonged time of 24 
h. In contrast, acidic conditions can bring about a 4% conversion in 0.5 h. A slightly 
improved conversion of 14% and 65% ee were observed in the presence of 5% benzoic
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acid after 24 h. The screening results are shown in Table 2-1.
Table 2- 1 : Additive effect in asymmetric hydrogenation of 4a.a
entry solvent time (h) additive conv. (%)A ee (%)c
1 DCM 0.5 No 0 n.d.
2 DCM 4 No 0 n.d.
3 DCM 24 No 2 n.d.
4 DCM 0.5 Et3N 0 n.d.
5 DCM 0.5 KOH 0 n.d.
6 DCM 0.5 t-BuOK 0 n.d.
7 DCM 0.5 Benzoic acid 4 n.d.
8 DCM 24 Et3N 3 n.d.
9 DCM 24 KOH 2 n.d.
10 DCM 24 t-BuOK 4 n.d.
11 DCM 24 Benzoic acid 14 65
° Reaction conditions: 0.5 mmol cyclic imine, 0.5 mol% 1 (2.5 nmol), 5% additive when 
added, 2 mL DCM, 20 bar H2at room temperature. b Determined by 'H NMR analysis o f  
the crude products.c Determined by GC analysis with a chiral Beta DEX-120 column; n.d. 
= not determined.
From the recent work of Noyori10b and Rauchfuss,14 one would expect that the 
corresponding cationic Rh(III) species might be more reactive towards H2 and 
particularly towards its heterolytic splitting to form the Rh-H hydride and proton. With 
this in mind, we then tested the effect of silver salts on the reduction, aiming to remove 
the chloride from the coordination sphere. As can be seen from Table 2-2, upon 
introduction of a silver salt, some reduction did take place in 0.5 h. However, the
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combination of 1 with siliver bearing a range of anions, such as noncoordinating SbFg", 
BF4\  PF6\  weakly coordinating OTf and coordinating OAc‘, PO4' and CIO4', showed 
similar activities for hydrogenation of 4a under 20 bar hydrogen pressure in dried 
CH2CI2 (entries 1-7). Much to our delight, a remarkably accelerated reduction was 
observed in the case of AgSbF6, in the wet CH2CI2; a 20% conversion was recorded, 
with 5a being produced in an excellent ee of 99% (entry 8).
Table 2-2\ Effect of anions in asymmetric hydrogenation of 4a.a
entry solvent additive conv. (%) ee (%)
1 DCM AgSbF6 6 n.d.
2 DCM AgBF4 3 n.d.
3 DCM AgPF6 3 n.d.
4 DCM AgOAc 2 n.d.
5 DCM AgOTf 3 n.d.
6 DCM Ag3P 0 4 1 n.d.
7 DCM AgC104 1 n.d.
8 DCM6 AgSbF6 20 99
“ Reaction conditions: 0.5 mmol cyclic imine, 0.5 mol% 1 (2.5 pmol), 2 mol% 
siliver salt, 2 mL DCM, 20 bar H2 at room temperature for 0.5 h. b wet DCM.
Following this observation, we started to examine the effect of water on the 
asymmetric hydrogenation of 4a in the presence of 1 (0.5 mol%) with AgSbF6 (2.0 
mol%) in distilled DCM. The results can be seen in Table 2-3. Introduction of 
increasing quantities of water into the reaction indeed increased the conversion; the 
highest conversion of 36% was recorded when the molar ratio of water to substrate
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was 3.3 in 2 mL CH2CI2, with 5a being produced in an excellent ee of 99%. Under 
such conditions, 1  is presumably converted into 2 , which bears a bulky counter anion 
SbF6-.15 Subsequently, the conversion decreased as more water was added to the 
reaction (Table 2-3). Too much water somewhat decreased the ee value of product 5a 
from 99% to 98%. As small amount of water was supposed to increase the solubility of 
AgSbF6, thus increasing the concentration of active catalyst during the reaction. 
Because water is a coordinating solvent, too much water in solution might lead to 
coordination of the ionic catalyst, thus decreasing the concentration of active catalyst.
Table 2-3. Effect of small amount of water for asymmetric hydrogenation of 4a.°
entry solvent (FbO/imine)4 conv. (%) ee (%)
1 DCM 0 6 n.d.
2 DCM 1.1 18 97
3 DCM 2.2 30 98
4 DCM 2.8 34 99
5 DCM 3.3 36 99
6 DCM 3.8 33 99
7 DCM 5.5 28 98
8 DCM 11 .1 18 98
a Reaction conditions: 0.5 mmol cyclic imine, 0.5 mol% 1 (2.5 pmol), 2 mol% 
AgSbF6, 2 mL dried DCM, 20 bar H2at room temperature for 0.5 h .4 molar ratio of 
water to substrate
To understand the role of water and anions in the catalytic system, further 
investigations have been done by examining 0.5 mol% of 1 or the analogue with no 
additive, a small amount of EtsN as additive, or a range of siliver salts in 2 mL DCM
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containing 30 pi water. The screening results are shown in Table 2-4. Consistent with 
the ionic 2 being the key for hydrogen activation, catalyst 1 also showed no activity for 
the hydrogenation of 4a under such conditions, as well as in the basic conditions by 
introducing 5% Et3N (entries 1 and 2). The catalyst derived from AgBF4, AgPF6, or 
AgOTf, which contain a noncoordinating anion BF4', PFg' or weakly coordinating 
anion OTf, led to a conversion of only 4%, 3%, 4% respectively in 0.5 h (entries 4 to 
6); and the similar catalyst which contained a coordinating anion OAc', PO4 ', or CIO4’ 
led to a conversion of only 2% in 0.5 h (entries 7, 9 and 10). A 10% conversion and 
60% ee were observed when the reaction was carried out for 10 h by using the catalyst 
bearing OAc'. Furthermore, when the 16e species 3 (Scheme 2-3) was used to replace 
2, no hydrogenation took place (entry 11) in the presence of 30 pi water. However, 
hydrogenation occurred when HSbF6 was introduced, indicating that 3 is protonated, in 
situ affording the active catalyst 2 (entry 4) .16 The preformed catalyst 2 showed a 
similar activity and enantioselectivity to the in situ catalyst in DCM containing 30 pi of 
H20  (entries 3 and 12), but 2 showed silightly higher activity in dried CH2CI2 (entry 
13). However, addition of 2 equiv. Bu4NBr (relative to rhodium) completely stopped 
the hydrogenation with 2 (entry 14). The analogue of 2, i.e. in situ generated ionic 
ruthenium and iridium catalyst, only afforded a conversion of 2% and 14% (92% ee) 
for hydrogenation of 4a in 0.5 h, and 63% conversion (83% ee) by the ruthenium 
catalyst in 10 h (entries 15-17). Still further, somewhat lower conversions were 
observed when the solvent was neat water, isopropanol (IPA), methanol (MeOH) or 
toluene (entries 18-21).
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Table 2-4: Effect of anion on asymmetric hydrogenation of 4a in the 
presence of water.“
entry solvent time (h) additive conv. (%) ee (%)
1 DCM 0.5 No 0 n.d.
2 DCM 0.5 Et3N * 0 n.d.
3 DCM 0.5 AgSbF6 36 99
4 DCM 0.5 AgBF4 4 n.d.
5 DCM 0.5 AgPF6 3 n.d.
6 DCM 0.5 AgOTf 4 n.d.
7 DCM 0.5 AgOAc 2 n.d.
8 DCM 10 AgOAc 10 60
9 DCM 0.5 Ag3P 0 4 2 n.d.
10 DCM 0.5 AgC104 2 n.d.
i r DCM 0.5 No 0 n.d.
\ 2 d DCM 0.5 No 33 99
13e DCM 0.5 No 37 99
I4 d DCM 0.5 Bu4NBr 0 n.d.
15f DCM 0.5 AgSbF6 2 n.d.
I t / DCM 10 AgSbF6 63 83
17g DCM 0.5 AgSbF6 14 92
18 H20 0.5 AgSbF6 1 n.d.
19 IPA 0.5 AgSbF6 18 98
20 MeOH 0.5 AgSbF6 20 99
2 1 Toluene 0.5 AgSbFs 30 99
“ Reaction conditions: 0.5 mmol o f cyclic imine, 0.5 mol% of 1 (2.5 pmol), 2 mol% o f siliver 
salt when added, 2 mL o f DCM, 30 pi o f H20 , 20 bar of H2 at room temperature. b 2.5 mol% 
of Et3N c 0.5 mol% of 3 as a catalyst d 0.5 mol% of 2 as a catalyst. e 0.5 mol% of 2 as 
catalyst in the absence o f water/  The analogous [RuCl(TsDPEN-H)(p-cymene)] as catalyst (1 
mol% of catalyst, 4 mol% of silver salt). g0.5 mol% of [Cp*IrCl(TsDPEN-H)] as catalyst.
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This dramatic anion effect is further demonstrated by the kinetic profiles shown in 
Figure 2-1. Whilst 1 showed no reduction, the conversions effected by the 
corresponding OTf and PF6~ salt were less than 20% in 4 h reaction time. By way of 
contrast, the in situ-generated 2 afforded a conversion of 93% (99% ee), and its initial 
rate was more than 5 times that of the OTf catalyst. This is surprising, as the related, 
weakly-coordinating OTf salt of Ru(II) and Ir(III) are active for ketone 
hydrogenation.10 We note, however, that a similar effect of anions has previously been 
revealed by Pfaltz and coworkers in olefin hydrogenation with iridium catalysts 
containing PAN ligands.17
Figure 2-1. Effect o f anions (A  Cl', ♦ PF6', ■ OTf, □ SbF6') on the rate o f hydrogenation 
of 4a in DCM at room temperature. The catalysts were either 1 or in situ derived from 1 in 
the presence of a silver salt; see Table 2-4 (entries 6-13) for conditions.
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2.2 Hydrogen Pressure Effect
The effect of hydrogen pressure has also have been investigated for the reduction. 
The hydrogenation rate, but not the enantioselectivity, varied with hydrogen pressure, 
as shown in Figure 2. As can be seen, the reaction rate increases almost linearly when 
the hydrogen pressure increased from 5 bar to 20 bar, and then the reaction rate 
gradually slows down when the hydrogen pressure exceeds 20 bar. It suggests that the 
hydrogenation rate is affected by the rate of formation of hydride and hydride transfer. 
Owing to the low concentration of hydrogen in solution at low pressure, the 
pressure-dependent step of hydride formation is rate-determining step in the whole 
reduction. As the hydrogen pressure increases, both the rate of hydride formation and 
the rate of hydride transfer affect the overall reaction rate.
Figure 2-2. Effect o f hydrogen pressure on the conversion (■) and 
enantioselectivity (A )  o f hydrogenation o f 4a catalyzed by 2 (generated in situ 
from 1 and AgSbF6) in DCM at room temperature for 0.5 h.
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This observation supports a Michaelis-Menten type sequence as shown in Eq. 2-1.
Evidently, the presence of coordinating anions such as Br' will decrease the 
concentration of 2  and hence the hydrogenation rate.
2.3 Asymmetric Hydrogenation of Cyclic Imines 4
Using the optimized conditions, viz. with 2 being generated in situ from 1 (1 mol%) 
and AgSbF6 in the presence of 30 pi water at 20 bar hydrogen pressure, a range of 
cyclic imines 4 were hydrogenated to tetrahydroisoquinolones 5. The results on
3.4- dihydroisoquinolines and 3,4-dihydro-6,7-dimethoxyisoquinolines are given in 
Table 2-5. As can be seen, 4a was completely reduced, affording 5a in 99% ee and 
94% isolated yield in 1 h at room temperature (entry 1). However, replacing the methyl 
with the bulkier Et, 'Pr, Cy and Ph substituents necessitated longer reaction times, and 
the enantioselectivity decreased significantly in the case of 4c, 4d and 4e (entries 3-5). 
Surprisingly but delightfully, excellent yields and ee’s were observed for
3.4- dihydro-6,7-dimethoxyisoquinolines. Thus, the compounds 4f-4i and 4n were all 
fully reduced in 4-5 h, with ee’s up to 99% being obtained. These results suggest that 
the poor behaviour of 4c and 4d cannot simply be ascribed to steric effects. Since the 
enantioselectivity of the hydrogenation may be determined by weak C-H n interactions
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between the Cp* methyl group and the imine aromatic ring,18 the more electron-rich 
4h and 4i might be expected to give rise to stronger interactions and so higher ee’s. 
However, the catalytic system showed less efficiency with the much bulkier i-Bu, Ph,
4-MeO-Ph and 4-CF3-Ph substituted substrates in either activities or 
enantioselectivities (entries 10-13) under such conditions.
Table 2-5: Asymmetric hydrogenation of cyclic imines 4 to give amines 5.a
Entry 4 substrate time (h) solvent yield (% )b ee (% )c
1 4a
4b
4c CO
1 DCM 94 99d
8 DCM 95 97
DCM 90 40
4 DCM 90 65
24 DCM 30 8
4 DCM 95 96
4 DCM 90 93
4 DCM 95 93
4 DCM 94 95
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Entry 4 substrate
10 4j
11 4k
12 41
OMe
time (h) solvent yield (% )b ee (% )c
24 DCM 8 e n.d.
24 DCM 25 5
24 DCM 30 8
20 bar H2 at room temperature. b Isolated yields, after flash chromatography. c S product, 
determined by HPLC analysis with a chiralpak OD-H column. d Determined by GC; see 
Table 1 .e conversion, determined by 1 H NMR analysis o f the crude product.
In contrast to 5e and 5j-5m where both low conversion and low ee’s were obtained, 
5c and 5d were obtained in good conversion but medium ee’s under those conditions. 
For 5c and 5d, we focused on increasing their ee’s by optimization of reaction 
conditions. Various silver salts and solvents with or without water were examined for 
hydrogenation of 4c and 4d. The screening results are seen in Table 2-6. Consistent 
with the former observation on hydrogenation of 4a, the ionic catalyst 2, in situ from 1
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and AgSbF6, showed higher activities and enantioselectivities for hydrogenation of 4c 
than the catalyst formed from 1 and AgBF4 (entries 1-4).
Table 2-6: Optimization of conditions for the hydrogenation of 4c and 4d.a
entry 4 additive
time
(h)
solvent
conv.
(%)*
ee
( % r
1 4c AgBF4 4 DCM 30 30
2 4c AgSbF6 4 DCM 67 38
3 4c AgBF4 + H2O 4 DCM 25 32
4 4c AgSbF6 + H20 4 DCM 95 40
5 4c AgSbF6 4 CH3CN 2 n.d.
6 4c AgSbF6 + H20 4 CH3CN 2 n.d.
7 4c AgSbF6 4 MeOH 38 78
8 4c AgSbF6+ H 20 4 MeOH 45 80
9 4c AgSbF6 + H20 4 TFE 40 63
10 4c AgSbF6 + H20 4 IPA 43 83
11 4c AgSbF6 + H20 24 IPA 85 83
\2d 4c AgSbF6+ H 20 24 IPA 97 83
13 4d AgSbF6+ H 20 4 DCM 95 65
14 4d AgSbF6+ H 20 4 MeOH 50 88
15 4d AgSbF6 + H20 4 IPA 45 91
16 4d AgSbF6 + H20 24 IPA 88 91
\ l d 4d AgSbF6 + H20 24 IPA 99 91
a Reaction conditions: 0.5 mmol 4, 1 mol% 1, 4 mol% siliver salt when added, 2 mL 
solvent, 30 pL water when added, 20 bar H2 at room temperature. b Determined by 'H NMR 
analysis o f the crude products. CS product, determined by HPLC analysis with a chiralpak 
OD-H column. d 50 bar hydrogen pressure.
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Furthermore, the ionic 2 was found to almost completely lose activity in strongly
coordinating solvents such as CH3CN with or without water (entries 5 and 6). When 
the solvent was changed to isopropanol (IPA), the ee’s were improved to 83% and 
91% for 5c and 5d respectively (entries 10 and 15). However, compared to the reaction 
in DCM, the ionic 2 showed lower activities in methanol, IPA and TFE; and the 
hydrogenation of 4c and 4d could not completely be finished after 24 h. Finally, 5c 
and 5d were obtained in 83% ee (97% conversion) and 91% ee (99% conversion) 
respectively, by increasing the hydrogen pressure to 50 bar in 24 h.
The observations showed that hydrogen pressure affects the reaction rate and solvent 
affects the ee of product. In order to improve the conversion and ee’s of 5e and 5j-5m, 
4e was selected as a model for the optimization of conditions by using ionic 2 under 
various hydrogen pressures in DCM or MeOH with or without water (Table 2-7). A 
24% and 18% conversion of 4e was obtained, respectively, in DCM with or without 30 
pL water in 5 h, and the conversion increased to ca 30% in 20 h (entries 1-4); the 
conversion was improved to 45% by increasing the hydrogen pressure to 55 bar in 20 h 
(entries 5-8). Furthermore, in contrast with the observation on hydrogenation of 4c and 
4d, 5e was obtained in 8% ee in both DCM and methanol. Catalyst 2 showed less 
efficiency for hydrogenation of 4e, probably because the chiral diamine ligand was 
replaced by the substrate imine or product amine during the reaction, particularly as 
phenyl substituted imine can easily form cyclometallation complexs.19
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Table 2-7: Optimization of conditions for the hydrogenation of 4e.a
entry additive
time
(h)
pressure
(bar)
solvent
conversion
(% )A
ee
( % r
1 AgSbF6 5 20 DCM 18 8
2 AgSbF6 + H20 5 20 DCM 24 8
3 AgSbF6 20 20 DCM 28 8
4 AgSbF6+ H 20 20 20 DCM 30 8
5 AgSbF6 20 40 DCM 43 8
6 AgSbF6 + H20 20 40 DCM 45 8
7 AgSbF6 20 55 DCM 44 8
8 AgSbF6+ H 20 20 55 DCM 45 8
9 AgSbF6 20 20 MeOH 22 8
10 AgSbF6 + H20 20 20 MeOH 30 8
0 Reaction conditions: 0.5 mmol 4e, 1 mol% 1, 4 mol% AgSbF6, 2 mL solvent, 30 p.L water 
when added, room temperature. b Determined by 'H NMR analysis o f the crude products. CS 
product, determined by HPLC analysis with a chiralpak OD-H column.
2.4 Asymmetric Hydrogenation of Cyclic Imines 6
The applicability of 2 was also demonstrated in the hydrogenation of imine 
precursors to tetrahydro-P-carbolines. The results are summarized in Table 2-8. Unlike 
the reduction of 4, these reactions were performed in methanol. This is because all the 
substrates 6 have low solubility in DCM but are soluble in methanol. In contrast to the 
less electron-rich 4a-4d, all the alkyl substituted imines 6 gave rise to excellent 
isolated yields and ee’s, including those having cyclohexyl and lBu groups, although 
6e necessitated a longer time of 12  h.
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Table 2-8: Asymmetric hydrogenation of cyclic imines 6 to give amines l . a
Entry 6 substrate time (h) yield (%) ee (%) b 
3 95 99
3 96 99
3 94 98
3 95 98
24 91 98
12 97 >99
4 94 99
3 96 20
5 95 96
5 95 99
0 The conditions were the same as those in Table 2-7 except with MeOH being used as 
solvent. b S product. e 0.1 mol% 1 and 0.4 mol% AgSbF6 at 50 bar H2. d The ee was 
determined using a Chiralpak AD column.
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Remarkably, the electronic properties of the aryl substituents impact significantly on 
the enantioselectivity. Thus, in contrast to the p-trifluoromethyl substituted 6h, which 
led to a 95% ee, the p-methoxyl analogue 6g afforded an ee of only 20%, showing the 
importance of electronic effects on the process of C=N bond facial discrimination. In 
line with this trend, when the electronic effect is mitigated with a spacer, a high ee of 
99% was obtained (entry 10). Like 6i, the product 7i is highly bioactive.1,3
Table 2-9 Optimization of conditions for the hydrogenation of 6g.a
entry additive
time
(h)
pressure 
H2 (bar)
solvent
conversion
(%)*
ee
(%)
1 AgBF4 4 20 MeOH 99 11
2 AgOTf 4 20 MeOH 99 9
3 Ag3P 0 4 4 20 MeOH 95 8
4 AgSbF6 4 20 MeOH 99 20
5 AgSbF6 4 20 CH3CN 5 n.d.
6 AgSbF6 4 20 MeOH/DCM c 99 12
7 AgSbF6 4 30 MeOH 99 16
8 AgSbF6 1 20 MeOH 99 20
9 d AgSbFe 4 20 MeOH 99 4
1 0 e AgSbF6 4 20 MeOH 99 1
1 1 ' AgSbF6 4 20 MeOH 99 10
12  8 AgSbF6 4 20 MeOH 99 97
a Reaction conditions: 0.5 mmol 6g, 1 mol% 1 (5 prnol), 4 mol% silver salt, 2 mL solvent, 30 pi H20 ,  
room temperature. b Determined by 'H NMR analysis o f the crude products. c 1 ml MeOH and 1 ml 
DCM. d The analogous [Cp*RhCl(CF3TsCYDN-H)] as catalyst (1 mol% catalyst). e The analogous 
[Cp*RhCl(TsCYDN-H)] as catalyst (1 mol% catalyst).f  The analogous [Cp*RhCl(CsDPEN-H)] as 
catalyst (1 mol% catalyst). g 1.0 mol% [Cp*IrCl(TsDPEN-H)] as catalyst.
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In order to obtain a better ee of 7g, a range of conditions were explored by 
optimization of conditions. The screening results are shown in Table 2-9. Although the 
catalyst 2 afforded only 20% ee of 7g, it still afforded the best enantioselectivity for 
hydrogenation of 6g in comparsion with those catalysts derived from AgBF4, AgOTf 
or Ag3P04, which led to 11% , 9% and 8% ee, respectively (entries 1-4). Catalyst 2 
almost lost activity in the strongly coordinating solvent CH3CN, which led to only 5% 
conversion of 7g in 4 h (entry 5). These solvent and anion effects are consistent with 
the previous observations. Further more, making the reaction solvent less polar by 
adding CH2CI2 or increasing the hydrogen pressure somewhat decreased the ee’s of 7g 
(entries 6 and 7). Further optimizations by changing ionic 2 to the more 
electron-deficient or rich diamine-ligated analogue [Cp*RhCl(CF3TsCYDN-H)] or 
[Cp*RhCl(TsCYDN-H)] have not improved the ee’s of 7g (entries 9 and 10); 
[Cp*RhCl(CsDPEN-H)] was also inefficient in enantioselectivity for the 
hydrogenation of 6g (entry 11). However, a high ee of 97% was obtained by using 
[Cp*IrCl(TsDPEN-H)] together with AgSbF6 (entry 12).
2.5 Asymmetric Hydrogenation of Acylic Imines
To expand the application of the ionic catalyst, 2 and analogues have also been 
tested for asymmetric hydrogenation of acyclic imine 8; the results can be seen in 
Table 2-10.
102
Table 2-10: Optimization of conditions for the hydrogenation of 8.a
entry additive
time
(h)
solvent
conversion 
(% )6
ee
(% )e
1 AgBF4 12 DCM 18 2
2 AgOTf 12 DCM 20 1
3 Ag3P 0 4 12 DCM 10 0
4 AgSbFe 12 DCM 35 3
5 AgN03 12 DCM 20 0
6 AgSbF6 + acid d 12 DCM 20 2
7 AgBF4 + H20 12 DCM 22 1
8 AgSbF6+ H20 12 DCM 40 2
9 AgSbF6 + H20 24 MeOH 65 3
10 AgSbF6 + H20 24 toluene 50 3
0 Reaction conditions: 0.5 mmol 8, 1 mol% 1 (5 pmol), 4 mol% silver salt, 2 mL 
solvent, 30 pi H20  when added, room temperature. b Determined by 'H NMR analysis 
of the crude products. c Determined by HPLC analysis. d 5% benzoic acid was 
added.
Probably owning to the equilibrium of syn/anti isomerisation existing during the 
reaction, 0-3% ee’s were obtained by using 2 or analogues bearing various anions in 
DCM with or without water. Beside the low ee’s obtained, the catalytic system also 
showed low activities for reduction of the acyclic imine 8. A 10-35% conversion were 
recorded by using 1 with AgBF4, AgOTf, Ag3PC>4, AgSbF6 or AgNC>3 in dried DCM 
(entries 1-5). Furthermore, addition of 5% benzoic acid also could not promote the 
reduction in the presence of catalyst 2 (entry 6). A slightly improved conversion of 
40% was made by using 1 with AgSbF6 in the presence of a small amount of water in
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12 h; the maximum conversion reached was 65% by a prolonged time of 24 h. Some of
the acyclic imine decomposed to actophenone and p-anisidine during the reaction in 
the presence of water (entries 8 and 9), partly explaining the low yield obtained. 
However, a lower conversion was observed when the solvent was toluene (entry 10).
3. Conclusion
In conclusion, we have developed a diamine-ligated, ionic Rh(III) catalyst 2 for 
asymmetric hydrogenation of cyclic imines. The catalyst displayed high activity and 
excellent enantioselectivity in the reduction of a range of cyclic imines to give 
bioactive tetrahydroisoquinolines and tetrahydro-p-carbolines. The cationic nature and 
the bulky non-coordinating counter anion are believed to be the key to the success of 2 .
4. Experimental Section 
General Infromation
Unless otherwise specified, the chemicals were obtained commercially and used 
without further purification. The compounds (R,R)-1 and (R,R)-3 were prepared 
according to the literature.20’103 All the cyclic imines were prepared according to the 
following procedure, and were characterized by 'H NMR. Dichloromethane (DCM) 
was dried over CaH2 and distilled prior to use. Methanol was dried over Mg and 
distilled prior to use. ’H NMR and 13C NMR spectra were recorded on a DRX-400 
spectrometer at 400 (]H) and 100 MHz (13C) in ppm with TMS as the internal standard 
in CDCI3. The mass spectra were obtained by chemical ionization (Cl). Gas
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chromatographic analysis was carried out on a Varian 3800 GC equipped with a Beta 
DEX-120 column and an FID detector. HPLC analysis was performed on Gilson 
UV/VIS-151 equipped with a Chiralpak AD or Chiralcel OD-H column purchased 
from Daicel Chemical Industries. Chromatographic purification was performed on 
silica gel (mesh 300-400) by the flash techinique. All the products were satisfactorily 
characterized by 'H and 13C NMR, HRMS and element analysis. When possible, 
comparison of their NMR spectra has been made with available literature data. The 
configuration of the products 5f, 5g, 5h, 5i, 5n, 7a, 7b, 7c, 7d, and I f  was assigned by 
comparison of their HPLC retention times with the literature,2 and that of the other 
product was based on analogy with the assignment for other compounds without 
further verification.
General Procedure for the Preparation of Substrates 4 and 6 5,21
4a to 4e 4f to 4n 6a to 6i
Preparation of 12 To a stirred solution of 10 (0.15 mol) in anhydrous CH2CI2 (200 mL) 
under N2 was added Et3N (27.8 mL, 0.20 mol). Freshly distilled 11 (0.16 mol) was 
added dropwise with stirring. A white precipitate formed immediately, and the reaction 
mixture was stirred at room temperature overnight. Aqueous NaCl (5%, 200 mL) was
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added and following stirring for 0.5 h, CH2Cl2(50 mL) was added. After separation of 
the CH2CI2 phase, the aqueous layer was extracted with CH2CI2 (100 mL), and the 
combined organic layer was washed with aqueous NaCl (5%, 2 X 200 mL), dried 
(Na2SC>4) and evaporated in vacuo to afford the crude product that was used for next 
step without any further purification.
Preparation of 4 or 6. To a three-neck, round-bottom flask under N2 containing about 
0.15 mol of 12 in 500 mL of dry toluene was added P2O5 (39.5 g, 0.25 mol) in portions 
followed by dropwise addition of 41.2 mL (0.44 mol) of freshly of distilled POCI3. 
The mixture was stirred at reflux under N2 for 6 h followed by cooling to room 
temperature, and the toulene were decanted. The solid residue was cooled with an ice 
bath and cautiously triturated with sufficient 10% NaOH to afford a suspension (pH 
8-9). The suspension was extracted with CH2CI2, and the organic extracts dried 
(Na2S04) and evaporated in vacuo to afford the crude product which was purified by 
column chromatography. Cyclic ¡mines 4a to 4n and 6a to 6i were obtained in 45-85% 
yield.
Complex 2
The compound [Cp*Rh(TsDPEN-H)(H20 )][SbFe] 2 was synthesized from 3 and 
HSbF6.6H20  in DCM (TsDPEN-H refers to
iV-(p-toluenesulfonyl)-1 ,2 -diphenylethylenediamine with the hydrogen on the 
sulfonylated nitrogen being removed). The isolated complex showed similar activity 
and selectivity in preliminary studies. Complex 2: 'H NMR (CDCI3, 400 MHz) 8 
(ppm): 1.79 (s, 15H,), 2.16 (br, 2H, H20), 2.20 (s, 3H), 3.91 (br, 1H), 4.13 (br, 1H),
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4.28 (b r, 1 H), 4.50 (b r, 1H), 6.65-6.69 (m, 2H), 6.79-6.81 (m, 2H), 6.97-7.03 (m, 3H), 
7.09 (m, 2H), 7.17-7.23 (m, 5H); MS (ES) fo r  [C3iH36N20 2SRh]+: m/z c a lc d  603.1553; 
fo u n d  603.1564; A n a l.  C a lc d  fo r C 3i H 36 R h N 20 2S -H 20 - S b F 6: C ,  43.43; H, 4.47; N , 
3.27. F o u n d : C ,  43.73; H, 4.41; N , 3.31.
General Procedure for Preparation of Racemic Amines 5 and 7
To a reaction tube charged with a cyclic imine (0.5 mmol) and NaBFE (1.0 mmol, 38 
mg) were added MeOH (2 mL). The readuction was stirred at room temperature for 
overnight. The solution was transferred to a flask and concentrated to afford the 
crude product. Flash chromatography purification with a column of silica gel eluted 
with DCM/MeOH (8/1 to 4/1) yielded the pure product.
General Procedure for Asymmetric Hydrogenation 
To a reaction tube charged with (R,R)-1 (3 mg, 5 pmol), AgSbF6 (7 mg, 20 prnol) and a 
cyclic imine (0.5 mmol) were added DCM (2 mL) and distilled FLO (30 pL). The 
reaction tube was put into an autoclave, which was then pressurized with H2 (20 bar). 
Following degassing with H2 three times, the hydrogenation was performed at 20 bar 
H2 with stirring at room temperature for a certain period of time. The hydrogen gas 
was then carefully released, and the solution was transferred to a flask and 
concentrated to afford the crude product. Flash chromatography purification with a 
column of silica gel eluted with DCM/MeOH (8/1 to 4/1) yielded the pure product. 
Analytic Data of Products
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l-Methyl-l,2,3,4-tetrahydroisoquinoline (5a).22,23 69 mg obtained (eluent:
DCM/MeOH = 6/1-3/1), 94% yield; !H NMR (CDCI3, 400 MHz) 5 (ppm): 1.46 (d, J  =
6.6 Hz, 3H), 1.71 (br, 1H), 2.78 (dt, J  = 4.4 Hz, 16.0 Hz, 1H), 2.84-2.93 (m, 1H), 
3.00-3.09 (m, 1H), 3.30 (dt, J  = 5.2 Hz, 12.4 Hz, 1H), 4.11 (q, J  = 6.4 Hz, 1H),
7.06-7.08 (m, 1H), 7.10-7.16 (m, 3H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 23.1,
30.5, 42.2, 52.0, 126.2, 126.3(2C), 129.6, 135.20, 141.0; HRMS for C 10H 14N [M+H]+: 
m/z calcd 148.1126, found 148.1127; Elemental analysis calcd (%) for C10H13N: C, 
81.59; H, 8.90; N, 9.51; Found: C, 81.89; H, 9.12; N, 9.13; GC (Beta DEX-120 
column, 110 °C): tR= 84.0 min (minor), ts = 85.7 min (major); 99% ee.
l-Ethyl-l,2,3,4-tetrahydroisoquinoline (5b).24 76 mg obtained (eluent: DCM/MeOH 
= 6/1- 4/1), 95% yield; 'H NMR (CDC13, 400 MHz) 5 (ppm): 1.01 (t, J  = 7.6 Hz, 3H), 
1.69-1.80 (m, 1H), 1.88-1.98 (m, 1H), 2.63 (br, 1H), 2.75 (dt, J=  5.2 Hz, 16.4 Hz, 1H), 
2.80-2.88 (m, 1H), 2.96-3.02 (m, 1H), 3.25 (dt, J=  5.2 Hz, 12.4 Hz, 1H), 3.92 (dd, J  =
3.6 Hz, 8.4 Hz, 1H), 7.06-7.08 (m, 1H), 7.10-7.015 (m, 3H); 13C NMR (CDC13, 100 
MHz) 5 (ppm): 10.9, 29.3, 30.3, 41.4, 57.4, 126.2, 126.3, 126.6, 129.6, 135.5, 139.7; 
HRMS for C 11H 16N [M+H]+: m/z calcd 162.1283, found 162.1286; Elemental analysis 
calcd (%) for CnHi5N: C, 81.94; H, 9.38; N, 8.69; Found: C, 81.59; H, 9.25; N, 9.03; 
HPLC (Chiralcel OD-H, hexane:isopropanol:diethylamine = 99:1:0.1, flow rate 0.5 
mL/min, 254 nm): ts = 18.7 min (major), tR = 22.8 min (minor); 97% ee.
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l-Isopropyl-l,2,3,4-tetrahydroisoquinoline (5c).25 74 mg obtained (eluent:
DCM/MeOH = 6/1- 4/1), 85% yield; *H NMR (CDC13, 400 MHz) 6 (ppm): 0.74 (d, J  
= 7.2 Hz, 3H), 1.11 (d, J =  1 2  Hz, 3H), 1.78 (br, 1H), 2.30-2.38 (m, 1H), 2.66 (dt, J  =
3.2 Hz, 14.8 Hz, 1H), 2.81-2.89 (m, 1H), 2.90-2.96 (m, 1H), 3.27-3.32 (m, 1H), 3.94 
(d, J =  3.6 Hz, 1H), 7.06-7.11 (m, 4H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 16.1,
20.7, 30.9, 32.5, 42.9, 61.4, 126.0, 126.3, 126.4, 129.6, 136.7, 139.2; HRMS for 
CnHigN [M+H]+: m/z calcd 176.1439, found 176.1441; Elemental analysis calcd (%) 
for C 12H 17N: C, 82.23; H, 9.78; N, 7.99; Found: C, 82.69; H, 10.10; N, 7.63; HPLC 
(Chiralcel OD-H, hexane:isopropanol: diethylamine = 99:1:0.1, flow rate 0.5 mL/min, 
254 nm): ts = 11.2 min (major), tR = 12.1 min (minor); 83% ee.
l-Cyclohexyl-l,2,3,4-tetrahydroisoquinoline (5d).24 97 mg obtained (eluent: 
DCM/MeOH = 6/1- 4/1), 90% yield; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.06-1.19 
(m, 3H), 1.28-1.42 (m, 3H), 1.65-1.73 (m, 3H), 1.80-1.84 (m, 1H), 1.88-1.92 (m, 1H), 
2.15 (br, 1H), 2.65 (dt, J=  4.0 Hz, 15.6 Hz, 1H), 2.78-2.86 (m, 1H), 2.88-2.95 (m, 1H), 
3.23-3.30 (m, 1H), 3.91 (d, 4.4 Hz, 1H), 7.04-7.14 (m, 4H); 13C NMR (CDC13, 100
MHz) 5 (ppm): 26.8, 27.0, 27.1, 27.5, 30.7, 31.4, 42.8, 43.4, 61.2, 125.9, 126.0, 126.5,
129.6, 136.7, 138.9; HRMS for C 15H22N [M+H]+: m/z calcd 216.1752, found 216.1754; 
Elemental analysis calcd (%) for CisH2iN: C, 83.67; H, 9.83; N, 6.50; Found: C, 83.69;
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H, 10.10; N, 6.63; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine =
90:10:0.1, flow rate 0.5 mL/min, 254 nm): ts =9.4 min (major), tR = 10.3 min (minor); 
91% ee.
6,7-Dimethoxy-l-methyl-l,2,3,4-tetrahydroisoquinoline (5f).10a 98 mg obtained 
(eluent: DCM/MeOH = 4/1- 1/1), 95% yield; 'H NMR (CDC13, 400 MHz) 5 (ppm):
1.43 (d, J =  6.8 Hz, 3H), 1.74 (br, 1H), 2.64 (dt, J =  4.8 Hz, 16.0 Hz, 1H), 2.75-2.83 
(m, 1H), 2.96-3.02 (m, 1H), 3.25 (dt, J =  4.8 Hz, 12.4 Hz, 1H), 3.84 (s, 3H), 3.85 (s, 
3H), 4.04 (q, J =  6.8 Hz, 1 H), 6.57 (s, 1H), 6.63 (s, 1H); 13C NMR (CDCI3, 100 MHz) 
5 (ppm): 23.3, 30.0, 42.3, 51.6, 56.2, 56.4, 109.4, 112.1, 127.2, 132.9, 147.6; 147.7; 
HRMS for C i2H i8N 0 2 [M+H]+: m/z calcd 208.1338, found 208.1342; Elemental 
analysis calcd (%) for C,2H i7N0 2: C, 69.54; H, 8.27; N, 6.76; Found: C, 69.69; H, 
8.10; N, 6.63; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 80:20:0.1, 
flow rate 0.5 mL/min, 280 nm): ts = 18.0 min (major), tR = 23.9 min (minor); 96% ee.
6,7-Dimethoxy-l-ethyl-l,2,3,4-tetrahydroisoquinoline (5g).l0a 104 mg obtained 
(eluent: DCM/MeOH = 4/1- 1/1), 94% yield; ]H NMR (CDCI3, 400 MHz) 5 (ppm): 
1.01 (t, J=  7.6 Hz, 3H), 1.64-1.76 (m, 1H), 1.78 (br, 1H ), 1.85-1.95 (m, 1H), 2.65 (dt, 
J =  5.6 Hz, 16.0 Hz, 1H), 2.71-2.78 (m, 1H), 2.93-2.99 (m, 1H), 3.22 (dt, J  = 5.6 Hz,
12.0 Hz, 1H), 3.82 (d, J = 2.8 Hz, 1 H), 3.84 (s, 6H), 6.57 (s, 1H), 6.62 (s, 1H); 13C
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NMR(CDC13, 100 MHz) 5 (ppm): 10.9, 29.5,30.0,41.6, 56.2,56.4,57.1, 109.7, 1 1 2 .2 ,
127.7, 131.9, 147.5, 147.6; HRMS for C 13H20NO2 [M+H]+: m/z calcd 222.1494, found 
222.1496; Elemental analysis calcd (%) for C13H 19NO2: C, 70.56; H, 8.65; N, 6.33; 
Found: C, 70.69; H, 8.76; N, 6.66; HPLC (Chiralcel OD-H, hexane:isopropanol: 
diethylamine = 80:20:0.1, flow rate 0.5 mL/min, 290 nm): ts = 15.7 min (major), tR =
20.8 min (minor); 93% ee.
6,7-Dimethoxy-l-isopropyl -1,2,3,4-tetrahydroisoquinoline (5h).10a 112 mg obtained 
(eluent: DCM/MeOH = 6/1- 4/1), 95% yield; [H NMR (CDC13, 400 MHz) 5 (ppm): 
0.74 (d, J  = 6.8 Hz, 3H), 1.12 (d, J =  6.8 Hz, 3H), 1.89 (br, 1H ), 2.26-2.34 (m, 1H), 
2.58 (dt, J=  3.6 Hz, 15.6 Hz, 1H), 2.74-2.82 (m, 1H), 2.87-2.94 (m, 1H), 3.26-3.31 (m, 
1H), 3.84 (s, 3H), 3.85 (s, 3H), 3.89 (d, J=  4.0 Hz, 1 H), 6.57 (s, 1H), 6.65 (s, 1H); 13C 
NMR (CDCI3, 100 MHz) 5 (ppm): 16.0, 20.6, 30.3, 32.8, 43.1, 56.2, 56.4, 61.0, 109.4,
112.1, 128.8, 131.0, 147.4, 147.6; HRMS for C14H22N0 2 [M+H]+: m/z calcd 236.1651, 
found 236.1643; Elemental analysis calcd (%) for Ci4H2iN0 2: C, 71.46; H, 8.99; N, 
5.95; Found: C, 71.88; H, 9.16; N, 5.76; HPLC (Chiralcel OD-H, hexane:isopropanol: 
diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 280 nm): ts = 17.0 min (major), tR =
21.0 min (minor); 93% ee.
6,7-Dimethoxy-l-cyclohexyl-l,2,3,4-tetrahydroisoquinoIine (5i).9b 129 mg obtained
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(eluent: DCM/MeOH = 6/1-4/1), 94% yield; *H NMR (CDC13, 400 MHz) 5 (ppm):
1.05-1.18 (m, 3H), 1.30-1.43 (m, 3H), 1.66-1.72 (m, 3H), 1.81-1.88 (m, 2H), 2.57 (dt, 
J =  4.0 Hz, 15.6 Hz, 1H), 2.71-2.79 (m, 1H), 2.86-2.93 (m, 1H), 3.26 (dt, J  = 3.6 Hz,
12.0 Hz, 1H), 3.84 (s, 4H, overlapped with NCH), 3.85 (s, 3H), 6.56 (s, 1H), 6.64 (s, 
1H); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 26.8, 27.0, 27.1, 27.4, 30.2, 31.3, 42.8,
43.6, 56.2, 56.5, 60.7, 109.7, 112.1, 128.8, 130.7, 147.4, 147.5; HRMS for C 17H26NO2 
[M+H]+: m/z calcd 276.1964, found 276.1957; Elemental analysis calcd (%) for 
C 17H25NO2: C, 74.14; H, 9.15; N, 5.09; Found: C, 74.46; H, 9.23; N, 4.88; HPLC 
(Chiralcel OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 
274 nm): ts = 17.1 min (major), tR = 21.1 min (minor); 95% ee.
l-(3,4-Dimethoxyphenethyl)-6,7-dimethoxy-l,2,3,4-tetrahydroisoquinoline (5n).22 
170 mg obtained (eluent: DCM/MeOH = 4/1- 1/1), 95% yield; *H NMR (CDC13, 400 
MHz) 5 (ppm): 1.90-2.09 (m, 2H), 2.15 (br, 1H ), 2.56-2.75 (m, 4H), 2.89-2.95 (m, 
1H), 3.17 (dt, J=  5.6 Hz, 12.8 Hz, 1H), 3.75 (s, 3H), 3.77 (s, 3H), 3.78 (s, 3H), 3.79 (s, 
3H), 3.90 (dd, J =  3.6 Hz, 8.8 Hz 1H), 6.49 (s, 1H), 6.50 (s, 1H), 6.68-6.74 (m, 3H); 
13C NMR (CDCb, 100 MHz) 5 (ppm): 29.8, 32.5, 38.8, 41.5, 55.5(2C), 56.2, 56.3,
56.5, 109.6, 111.7, 112.2, 112.2, 120.6, 127.7, 131.6, 135.4, 147.6, 147.7, 147.8, 149.3; 
HRMS for C21H28NO4 [M+H]+: m/z calcd 358.2018, found 358.2011; Elemental
112
analysis calcd (%) for C21H27NO4: C, 70.56; H, 7.61; N, 3.92; Found: C, 70.44; H, 
7.77; N, 3.87; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 60:40:0.1, 
flow rate 0.5 mL/min, 274 nm): ts = 27.5 min (major), tR = 46.3 min (minor); 99% ee.
H
1-Methyl-1,2,3,4-tetrahydro-l/f-pyrido[3,4-b] indole (7a).10a 88 mg obtained (eluent: 
DCM/MeOH = 4/1- 1/1), 95% yield; 'H NMR (CDCI3, 400 MHz) 6 (ppm): 1.44 (d, J  
= 6.8 Hz, 3H), 1.96 (br, 1H), 2.67-2.81 (m, 2H), 3.01-3.08 (m, 1H), 3.36 (dt, J =  4.4,
12.8 Hz, 1H), 4.17 (q, J =  6.8 Hz, 1H), 7.07-7.16 (m, 2H), 7.29 (d, J =  7.6 Hz, 1H),
7.48 (d, J =  7.6 Hz, 1H), 7.97 (br, 1H); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 21.1,
23.1, 43.1, 48.7, 108.9, 111.2, 118.5, 119.8, 122.0, 127.9, 136.1, 137.4; HRMS for 
C12H 15N2 [M+H]+: m/z calcd 187.1235, found 187.1242; Elemental analysis calcd (%) 
for C 12H 14N2: C, 77.38; H, 7.58; N, 15.04; Found: C, 77.46; H, 7.88; N, 14.83; HPLC 
(Chiralcel OD-H, hexane:isopropanol: diethylamine = 80:20:0.1, flow rate 0.5 mL/min, 
280 nm): tR = 25.3 min (minor), ts = 35.7 min (major); 99% ee.
1-Ethyl-1,2,3,4-tetrahydro-li/-pyrido[3,4-b] indole (7b).10a 100 mg obtained (eluent: 
DCM/MeOH = 6/1- 4/1), 96% yield; 'H NMR (CDC13, 400 MHz) 5 (ppm): 1.02 (t, J  =
7.6 Hz, 3H), 1.62-1.70 (m, 1H), 1.79 (br, 1H ), 1.83-1.93 (m, 1H), 2.68-2.79 (m, 2H), 
2.97-3.04 (m, 1H), 3.35 (dt, J =  4.4, 12.8 Hz, 1H), 3.95-3.98 (m, 1H), 7.06-7.15 (m, 
2H), 7.24 (d, J  = 8.0 Hz, 1H), 7.47 (d, J  = 8.0 Hz, 1H), 8.07 (br, 1H); 13C NMR
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(CDC13, 100 MHz) 5 (ppm): 10.7, 23.2, 28.1, 43.1, 54.3, 109.5, 111.2, 118.5, 119.7, 
121.9, 128.0, 136.1, 136.7; HRMS for Ci3H i7N2 [M+H]+: m/z calcd 201.1392, found 
201.1396; Elemental analysis calcd (%) for Ci3Hi6N2: C, 77.96; H, 8.05; N, 13.99; 
Found: C, 77.84; H, 8.24; N, 13.88; HPLC (Chiralcel OD-H, hexane:isopropanol: 
diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 280 nm): ts = 35.8 min (major), tR =
50.5 min (minor); 99% ee.
1-Isopropyl-1,2,3,4-tetrahydro-l/f-pyrido[3,4-b]indole (7c).10a 101 mg obtained 
(eluent: DCM/MeOH = 6/1- 4/1), 94% yield; 'H NMR (CDC13, 400 MHz) 6 (ppm): 
0.86 (d, J=  6.80 Hz, 3H), 1.13 (d, J=  6.80 Hz, 3H), 1.62 (br, 1H ), 2.13-2.21 (m, 1H), 
2.68-2.79 (m, 2H), 2.94-3.01 (m, 1H), 3.39 (dt, J=  4.0 Hz, 12.4 Hz, 1H), 3.99 (dd, J  =
2.0 Hz, 4.0 Hz, 1H), 7.07-7.16 (m, 2H), 7.29 (d, J =  7.6 Hz, 1H), 7.49 (d, J=  7.6 Hz, 
1H), 7.89 (br, 1H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 17.3, 20.0, 23.2, 32.1, 43.7,
58.6, 110.6, 111.1, 118.4, 119.7, 121.8, 128.0, 136.0, 136.1; HRMS for Ci4H i9N2 
[M+H]+: m/z calcd 215.1548, found 215.1547; Elemental analysis calcd (%) for 
C)4H i8N2: C, 78.46; H, 8.47; N, 13.07; Found: C, 78.78; H, 8.49; N, 12.77; HPLC 
(Chiralcel OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 
290 nm): ts = 24.7 min (major), tR = 41.9 min (minor); 98% ee.
l-Cyclohexyl-l,2,3,4-tetrahydro-l/7-pyrido[3,4-b]indole (7d).10a 121 mg obtained
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(eluent: DCM/MeOH = 6/1- 4/1), 95% yield; 'H NMR (CDC13, 400 MHz) 5 (ppm):
1.08-1.50 (m, 6H), 1.66-1.83 (m, 6H, overlapped with //NCH2 ), 2.69-2.73 (m, 2H), 
2.93-3.00 (m, 1H), 3.36 (dt, J  = 4.2 Hz, 12.4 Hz, 1H), 3.94 (t, J  = 1.6 Hz, 1H),
7.06-7.15 (m, 2H), 7.27 (d, J=  8.0 Hz, 1H), 7.47 (d, J=  8.0 Hz, 1H), 7.99 (br, 1H); 13C 
NMR (CDCI3, 100 MHz) 5 (ppm): 23.2, 26.9, 27.1, 27.3, 27.9, 30.7, 42.7, 43.6, 58.3,
110.4, 111.1, 118.4, 119.7, 121.8, 128.0, 135.8, 136.1; HRMS for C 17H23N2 [M+H]+: 
m/z calcd 255.1861, found 255.1860; Elemental analysis calcd (%) for C 17H22N2: C, 
80.27; H, 8.72; N, 11.01; Found: C, 79.98; H, 8.86; N, 11.23; HPLC (Chiralcel 
OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 280 nm): 
ts = 21.4 min (major), tR = 41.4 min (minor); 98% ee.
l-ter/-Butyl-l,2,3,4-tetrahydro-l/f-pyrido[3,4-b]indole (7e). I l l  mg obtained 
(eluent: DCM/MeOH = 6/1- 4/1), 97% yield; *H NMR (CDCI3, 400 MHz) 8 (ppm):
1.07 (s, 9H), 1.62 (br, 1H ), 2.67-2.70 (m, 2H), 2.86 (dt, J=  6.8 Hz, 12.4 Hz, 1H), 3.34 
(dt, J=  4.0 Hz, 12.4 Hz, 1H), 3.80 (s, 1H), 7.06-7.15 (m, 2H), 7.28 (d, J=  7.6 Hz, 1H),
7.48 (d, J  = 8.0 Hz 1H), 7.80 (br, 1H); 13C NMR (CDC13, 100 MHz) 8 (ppm): 23.6, 
27.9, 36.3, 44.0, 62.9, 111.1, 112.3, 118.4, 119.7, 122.0, 127.7, 135.1, 136.1; HRMS 
for C15H21N2 [M+H]+: m/z calcd 229.1705, found 229.1708; Elemental analysis calcd 
(%) for C 15H20N2: C, 78.90; H, 8.83; N, 12.27; Found: C, 79.00; H, 8.86; N, 11.99; 
HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 0.5 
mL/min, 280 nm): ts = 21.4 min (major), tR = 38.8 min (minor); >99% ee.
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1-Phenyl-1,2,3,4-tetrahydro-l/f-pyrido[3,4-b] indole (7f).10a 117 mg obtained (eluent: 
DCM/MeOH = 6/1- 4/1), 94% yield; 'H NMR (CDC13, 400 MHz) 5 (ppm): 1.78 (br, 
1H ), 2.73-2.79 (m, 1H), 2.82-2.90 (m, 1H), 2.99-3.06 (m, 1H), 3.24 (dt, J =  4.8 Hz,
12.8 Hz, 1H), 5.01 (s, 1H), 7.06-7.09 (m, 3H), 7.18-7.22 (m, 2H), 7.26-7.30 (m, 3H), 
7.49-7.52 (m, 1H), 8.00 (br, 1H); 13C NMR (CDC13, 100 MHz) 8 (ppm): 22.9, 43.2,
58.5, 110.6, 111.3, 118.7, 119.8, 122.1, 127.8, 128.6, 129.0, 129.2, 134.9, 136.3, 142.3; 
HRMS for C17H 17N2 [M+H]+: m/z calcd 249.1392, found 249.1398; Elemental analysis 
calcd (%) for Ci7H i6N2: C, 82.22; H, 6.49; N, 11.28; Found: C, 82.00; H, 6.88; N,
11.02; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 80:20:0.1, flow 
rate 0.5 mL/min, 280 nm): ts = 25.6 min (major), tR = 40.4 min (minor); 99% ee.
l-(4-Methoxyphenyl)-l,2,3,4-tetrahydro-l//-pyrido[3,4-b]indole (7g). 133 mg
obtained (eluent: DCM/MeOH = 6/1- 4/1), 96% yield; *H NMR (CDC13, 400 MHz) 5 
(ppm): 1.77 (br, 1H), 2.72-2.79 (m, 1H), 2.82-2.90 (m, 1H), 2.99-3.06 (m, 1H), 3.26 
(dt, J =  4.4 Hz, 12.4 Hz, 1H), 3.74 (s, 3H ), 4.99 (s, 1H ), 6.80 (d, J =  8.4 Hz, 2H), 
7.05-7.14 (m, 5H), 7.49-7.52 (m, 1H), 8.03 (br, 1H); 13C NMR (CDC13, 100 MHz) 5 
(ppm): 22.9, 43.1, 55.8, 57.8, 110.5, 111.3, 114.5, 118.6, 119.7, 122.0, 127.8, 130.1,
134.4, 135.3, 136.3, 159.9; HRMS for CigHi9N20  [M+H]+: m/z calcd 279.1497, found
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279.1497; Elemental analysis calcd (%) for C 18H 18N2O: C, 77.67; H, 6.52; N, 10.06; 
Found: C, 77.93; H, 6.73; N, 10.00; HPLC (Chiralcel OD-H, hexane:isopropanol: 
diethylamine = 80:20:0.1, flow rate 0.5 mL/min, 280 nm): ts = 33.2 min (major), tR =
48.6 min (minor); 97% ee.
l-(4-Trifluorophenyl)-l,2,3,4-tetrahydro-l^f-pyrido[3,4-b]indole (7h). 150 mg
obtained (eluent: DCM/MeOH = 6/1- 4/1), 95% yield; *H NMR (CDCI3, 400 MHz) 5 
(ppm): 1.95 (br, 1H ), 2.84-2.90 (m, 1H), 2.92-3.00 (m, 1H), 3.13-3.19 (m, 1H), 3.33 
(dt, J=  4.8 Hz, 12.4 Hz, 1H), 5.17 (s, 1H), 7.15-7.23 (m, 3H), 7.42 (d, J=  8.0 Hz, 2H), 
7.59-7.64 (m, 3H), 7.83 (br, 1H); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 22.9, 42.9, 
57.90, 111.0, 111.3, 118.7, 120.0, 122.5, 124.5 (q, J CF = 270.6 Hz), 126.2 (q ,JCF = 3.8 
Hz), 127.7, 129.4, 130.9 (q, Jcf = 32.4 Hz), 133.7, 136.4, 146.3; HRMS for 
C 18H 16F3N2 [M+H]+: m/z calcd 317.1266, found 317.1265; Elemental analysis calcd 
(%) for Ci8H 15F3N2: C, 68.35; H, 4.78; N, 8.86; Found: C, 68.74; H, 4.70; N, 8.58; 
HPLC (Chirapak AD, hexane:isopropanol: diethylamine = 80:20:0.1, flow rate 0.5 
mL/min, 280 nm): tR = 14.2 min (minor), ts = 19.8 min (major); 96% ee.
l-(3,4-Dimethoxyphenethyl)-l,2,3,4-tetrahydro-l//-pyrido[3,4-b]indole (7i). 160
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mg obtained (eluent: DCM/MeOH = 4/1- 1/1), 95% yield; 'H  NMR (CDCI3, 400 MHz) 
5 (ppm): 1.74 (br, 1H ), 1.95-2.03 (m, 1H), 2.11-2.19 (m, 1H), 2.70-2.87 (m, 4H), 
3.02-3.09 (m, 1H), 3.34-3.39 (m, 1H), 3.84 (s, 3H), 3.85 (s, 3H), 4.10-4.13 (m, 1H), 
6.74-6.8l(m, 3H), 7.07-7.16 (m, 2H), 7.25-7.28 (m, 1H), 7.48 (d, J =  7.6 Hz, 1H), 7.73 
(br, 1H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 23.2, 32.2, 37.4, 42.9, 52.6, 56.3, 56.4,
109.6, 111.1, 111.8, 112.2, 118.5, 119.8, 120.6, 122.0, 127.9, 134.9, 136.1, 136.4,
147.8, 149.4; HRMS for C21H25N2O2 [M+H]+: m/z calcd 337.1916, found 337.1908; 
Elemental analysis calcd (%) for C21H24N2O2: C, 74.97; H, 7.19; N, 8.33; Found: C, 
75.23; H, 7.31; N, 8.11; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 
60:40:0.1, flow rate 1.0 mL/min, 280 nm): tR = 17.5 min (minor), ts = 44.2 min (major); 
99% ee.
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Chapter 3. Chiral Counter Anion-Aided Asymmetric 
Hydrogenation of Acyclic Imines 
1. Introduction
Asymmetric hydrogenation of imines provides direct access to chiral amines, one of 
the most important functionalities in fine chemical, agrochemical and pharmaceutical 
products.1,2 However, in terms of both enantioselectivity and substrate scope, this 
transformation remains challenging, particularly in the case of acyclic imines.lb,c The 
vast majority of the transition metal catalysts reported thus far employ 
phosphorus-containing ligands, and it is generally believed that the reduction proceeds 
via imine nitrogen coordination to the metal center.lc However, Norton recently 
showed that imines can be reduced through an ionic pathway, where a Ru(II)-H2 
complex is deprotonated by an amine and the resulting Ru(II)-H reduces preformed 
iminium salts (Scheme 3-la).3 In more recent studies in organocatalysis,4 the groups of 
Rueping, List, and MacMillan reported highly enantioselective transfer hydrogenation 
with Hantzsch ester of imines4b,c or imines in situ generated from ketones and 
amines;4d the reduction is catalyzed by chiral phosphoric acids, which protonate the 
imines while the anion of which directs the facial attack of the hydride (Scheme 3-la). 
Inspired by these discoveries, we envisioned that if a heterolitically 
hydrogen-activating catalyst5 is associated with a chiral counter anion, the latter may 
be exploited to influence the enantiodiscrimination of the chiral ligands by ion-paring 
with the resulting iminium cation (Scheme 3-lb ).6 In this chapter, we show that when 
combined with a chiral phosphate anion, chiral diamine-ligated Ir(III) catalysts indeed
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enable highly enantioselective asymmetric hydrogenation of acyclic ¡mines, affording 
up to 99% ee. To broaden the concept of counter anion-aided catalysis, the 
combination of various achiral (chiral) acids with different chiral (achiral) transition 
metal catalysts have also been investigated for enantioselective hydrogenation of the 
model imine 4-methoxy-/V-(l-phenylethylidene)benzenamine la , affording the amine 
with up to 73% ee.
a) reaction pathway
,R 2 ,R 2 .R 2 H .+ ,R 2
INI - t classical pathway
1j
A  3 
A R3
H-M-H R1^
A  3
R3
3
R1 R3 R1 R3
imine iminium
+ HX • LUMO activation
• easier to be reducedX’ ,
ionic pathway h ' n ' r HX:
M-H JL • protonate imine
R1 R3 * X' induce chirality
b) proposed catalytic system
ion pair
Scheme 3-1. Reduction of ¡mines via ionic pathway.
2 Results and Discussion
2.1 Chiral Diamine-ligated Ir(lII) and Chiral Anion System
We have found that the complex [Cp*Rh(TSDPEN-HXH2O)] [SbFg] acts as an 
excellent catalyst for asymmetric hydrogenation of cyclic imines; that is described in 
Chapter 2 .7'9 However, disappointing results were obtained with acyclic imines. Thus,
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in the reduction of the model imine la  at 20 bar H2 in toluene, an ee of only 3% was
observed at 20 °C (Table 3-1, entry 1). In contrast, the analogous Ir(III) complex or (S, 
S)-3a with 6% HSbF6 led to encouraging results, affording a 22%-26% ee (entries 2 
and 3). This prompted us to search for Cp*Ir(III) catalysts containing chiral anions, 
such as chiral carbonate sulfate and phosphate anion. A quick way for accessing such 
catalysts is to protonate the 16e complex 3 with the corresponding commercially 
available chiral acids, e.g. L-proline, (R) or (S)-camphor-10-sulfonic acids (CSA), or 
easily prepared phosphoric acid 5,10 which are expected to in situ generate the catalyst 
4 or analogues.11 As can be seen from Table 3-1, 3a was inactive in hydrogenating la  
(entry 4). To our surprise, the combination of 3a and L-proline also was inactive for 
the hydrogenation of la  (entry 5); and the combination of 3a with R-CSA or S-CSA 
afforded the amine with the same configuration in 7% ee and 91% conversion or 12% 
ee and 94% conversion (entries 6-7). The results indicate that L-proline, containing 
both an acid and amine functional group, may not protonate the 16e 3a to form the 
analogue of 4 and the less bulky R-CSA or S-CSA could not aid 4 to induce chirality in 
the hydrogenation. Changing the anion to the phosphate 5, the combination of 3a and 
5a-e delightfully led to good conversions and enantioselectivities, which vary with the 
phosphoric acid used, with 5e promoting an excellent ee of 97% (entry 12). The 3b-5e 
and 3c-5e couples were less enantioselective, however (entries 13 and 14). Remarkably, 
the phosphoric acids 5a,b afforded the amine with configuration opposite to that 
observed with 5c-e (entries 8-9 vs 10-12), revealing the directing effect of phosphates 
on enantioselection. Still further, on changing the chirality of the diamine ligand, i.e.
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from (5,S)-3a,c to (R,R)-3a,c, a dramatic decrease in ee’s (entries 12, 14 vs 15, 16) was
recorded, showing the chirality of the catalyst needs to match that of its counter anion.
a: Ar = 2,4I6-(2-C3H7)3C6H2 a: Ar = 2,4,6-(2-C3H7)3C6H2 a:R = H;b:R = Ph 
b: Ar = 2,3,4,5,6-(CH3)5C6 X = 5e-H c: R = 3,5-(CF3)2C6H3
c: Ar = 4-CH3C6H4 b: Ar = 2,3,4,5,6-(CH3)5C6 d: R = 1-naphthyl
X = 5e-H e: R =2,4,6-(2-C3H7)3C6H2
Table 3-1: Optimization of Conditions for the Hydrogenation of la a
entry solvent catalyst additive
conv.
(%)*
ee
(%)c
1 toluene ca td none 43 3(5)
2 toluene ca te none 36 26(5)
3 toluene (5,5)-3a HSbF6(6%) 37 22(5)
4 toluene (5,5)-3a none 0 -
5 toluene (5,5)-3a L-proline (6%) 0 -
6 toluene (5,5)-3 a 7?-CSA 91 7(5)
7 toluene (5,5)-3a 5-CSA 94 12(5)
8 toluene (5,5)-3a 5a (6%) 53 17(7?)
9 toluene (5,5)-3a 5b (6%) 57 26(7?)
10 toluene (5,5)-3a 5c (6%) 40 20(5)
11 toluene (5,5)-3a 5d (6%) 43 38(5)
12 toluene (5,5)-3a 5e (6%) 60 97(5)
13 toluene (5,5)-3b 5e (6%) 76 92(5)
129
14 toluene (5,5)-3c 5e (6%) 30 81(5)
15 toluene (R,R)-3a 5e (6%) 47 38(7?)
16 toluene (R,R)-3c 5e (6%) 27 3(7?)
17 toluene (5,5)-4a none 76 97(5)
18 toluene (5,5)-4a 5e 0.5%) 90 97(5)
19 toluene (5,5)-4a 5e (1%) 92 97(5)
20 toluene (S,S)-4a 5e (3%) 84 97(5)
21 toluene (5,5)-4a 5e (7%) 69 96(5)
22 toluene (5,5)-4a 5e (10%) 60 96(5)
23 DCM (5,5)-4a 5e (1%) 88 94(5)
24 Benzene (5,5)-4a 5e (1%) 93 97(5)
25 CH3CN (S,S)-4a 5e (1%) 9 10(5)
26 THF (5,5)-4a 5e (1%) 60 92(5)
27 methanol (S,S)-4a 5e (1%) 18 8(5)
28r toluene (5,5)-4a 5e (5%) 83 99(5)
"Reaction conditions: 0.5 mmol la , 1 mol% catalyst, 2 mL solvent, 20 bar H2, 20 °C, 12 
h. b Determined by *H NMR analysis o f the crude product. c Determined by HPLC 
analysis; configuration assigned by comparison with the literature.2,4 d 1 mol% 
[Cp*Rh(TsDPEN-H)(H20)][SbF6] .£ l mol% [Cp*Ir(TsDPEN-H)(H20)][SbF6]. f  10°C, 
18 h.
Having identified the bulky 5e to be the best promoter for enantioselectivity amongst 
5a-e, we prepared the complex 4a, which has the conjugate base of 5e as the counter 
anion. Using 4a as catalyst with no additional phosphoric acid, the hydrogenation of 
la  afforded the same ee as when the catalyst was in situ prepared from 3a and 5e 
(entries 12 vs. 17). Introduction of more acid 5e was found to increase the reaction rate 
probably by increasing the concentration of iminium salt (entries 17-19). However, 
additional 5e was found to decrease the catalytic activity, with the highest conversion
130
being observed at ca 1 mol% 5e (entries 18-22), probably because the additional 5e
might destroy the active catalyst thus decreasing the concentration of the catalyst in 
solution. A higher ee of 99% was obtained when the hydrogenation was performed at a 
lower temperature of 10 °C (entry 28). As with reactions that involve ion-pairing 
intermediates,6 the hydrogenation is solvent sensitive. Thus, lower ee’s and conversion 
were observed in more polar solvents such as THF (92% ee, 60% conversion), MeCN 
(10% ee, 9% conversion) and methanol (8% ee, 18% conversion) (entries 25-27).
Using the optimized conditions, i.e. 1 mol% 4a or the analogous 4b in the presence 
of 1 mol% 5e, a range of acyclic imines were hydrogenated. The results are given in 
Table 3-2.
Table 3-2. Asymmetric Hydrogenation of Imines 1 to Amines 2a
entry 1 substrate product time(h)
yield
( % ) 6
ee
(%)c
1 la NO~0Me HN0°Me 15 94 97
2 lb
X f '
QMe
X f '
15 93 97
3 lc ifC^oMe
x ^
°Me
X T
15 95 96
4 Id
vO om°
. i X f " a j C i 15 94 98
5 le ii^ G^ oMe HN^>0Me
j r *
15 93 97
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16 lp
96
97
97
93
92
84
98
94
95
97
95
132
90
“Reaction conditions: 0.5 mmol la , 1 mol% 4a, 1 mol% 5e, 2 mL toluene, 20 bar H2, 20 °C, 
15-20 h. b Isolated yields. c Determined by HPLC analysis; S configuration, assigned by 
comparison with the literature.2,4 rf(S,S)-4b as catalyst. With 4a, the ee’s were ca 6% lower. e 
Configuration was assigned by analogy with entry 20. / (5,S)-4a with 1 mol%, 3 mol%, 5 mol% 
and 10 mol% 5e were used for hydrogenation at 20 °C or 50 °C; similar results were obtained 
or with (S,S)-4b.
As can be seen, a wide spectrum of imines are hydrogenated with 4, affording 
excellent yields and ee’s with almost all the N-aryl imines. Notably, the catalyst 
tolerates functional groups of diverse electronic properties (-OMe, -Br, -Cl, -CN, -NO2,
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alkenyl, and cyclopropyl). Furthermore, it allows //-aryl ketimines with aryl ethyl
groups (entries 17, 18) and with dialkyl substituents (entries 20-23) to be reduced with 
90-97% ee’s. In both metal- and organo-catalysis,1,2,4 such substrates have rarely 
proved to be viable. MacMillan,4d List4c and coworkers recently reported ee’s of 
81-94% for dialkyl-substituted /V-aryl ketimines in organocatalytic reduction; but for 
related aryl alkyl ketimines with high enantioselectivities, the alkyl group appears to be 
restricted to a methyl.4d Much lower enantioselectivities were reported for the dialkyl 
ketimines with homogeneous metal catalysts; in fact, none seems to give ee’s higher 
than 80%.12,13 Moving to //-alky imines, however, both the catalyst 4a and 4b showed 
very low activities in the presence of 1% 5e, or under more acidic conditions by 
introduction of 3%-10% of 5e at 20 °C (entries 24-26). A higher temperature did not 
help either. We speculate that a possible reason for the lost activities is the strong 
basicity of /V-alkyl imines, which can coordinate to the metal of active catalyst, 
rendering the catalyst inactive. The hydrogenation of //-alkyl imines is being studied 
by another Ph.D student in the Xiao group.
2.2 Chiral Diamine-ligated Ir(III) and Achiral Anion System
Although the combination of chiral diamine-ligated Ir(III) and chiral phosphoric 
acid has demonstrated excellent enantioselectivity and good activity for a range of 
acyclic imines, a combination containing one chiral and one achiral entity would be 
even cheaper and simpler to use for catalytic hydrogenation. To realize the idea, the 
combination of the chiral diamine-ligated Ir(III) (S,S)-3a with a range of achiral acids
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have been investigated for enantioselective hydrogenation of la . The screening results
are seen in Table 3-3.
Table 3-3. Optimization of Conditions for the Hydrogenation of la a
entry catalyst additive conv. (%) ee (%)
1 ca tb none 43 3(5)
2 ca tc none 36 26(5)
3 (S,S)-3a HSbF6(6%) 37 26(5)
4 (5,5)-3a TsOH.H20  (6%) 98 17(7?)
5 (5,5)-3a Benzoic acid (6%) 45 29(5)
6 (5,5)-3a Toluic acid (6%) 49 27(5)
7 (S,S)-3a PhB(OH)2 (6%) 50 66(5)
8 (5,5)-3a l-NpB(OH)2 (6%) 25 15(5)
9 (S,S)-3a 2-Me-l-NpB(OH)2 (6%) 21 12(5)
10 (5,5)-3a 2-Me-PhB(OH)2 (6%) 30 38(5)
11 {S,S)-3a 2-Br-PhB(OH)2 (6%) 36 39(5)
12 (5,5)-3a 2-MeO-PhB(OH)2 (6%) 5 -
“Reaction conditions: 0.5 mmol la, 1 mol% catalyst, 2 mL toluene, 20 bar H2, 
20 °C, 12 h. * 1 mol% [Cp*Rh(TsDPEN-H)(H20)][SbF6]. C1 mol%
[Cp*Ir(TsDPEN-H)(H20)][SbF6].
As can be seen, the ionic rhodium or iridium catalyst bearing SbF6_ afforded 3-26% 
ee (entries 1-3). Furthemore, the combination of 3a and achiral p-toluenesulfonic acid 
monohydrate afforded the amine in 98% conversion and 17% ee but with opposite 
configuration in comparison with other combinations (entry 4). Changing the acid to 
benzoic acid or toluic acid, the combination led to 29% ee (45% conversion) or 27% ee
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(49% conversion) (entries 5 and 6). To our delight, the combination of 3a and 
phenylboronic acid significantly improved the ee value to 66% with 50% conversion 
(entry 7). However, replacing the phenylboronic acid with bulky boronic acids, such as
1- NpB(OH)2, 2-Me-l-NpB(OH)2, 2-Me-PhB(OH)2, 2-Br-PhB(OH)2, or
2- MeO-PhB(OH)2, all led to lower ee’s and conversions (entries 8-12). The results 
point to that the combination of a chiral transition metal catalyst and achiral acid could 
afford good ee’s for enantioselective hydrogenation of acyclic imines. However, more 
investigations will be needed in order to find catalysts of practical use.
2.3 Achiral Organometallic Complex and Chiral Anion System
In Section 2.1 on the combination of chiral transition metal with chiral Brpnsted 
acid, the chiral acid was considered to give a major contribution to chirality induction 
for enantioselective hydrogenation of acyclic imines. The design of a combination of 
achiral transition metal with a chiral Brpnsted acid offers another potential approach to 
achieve good ee’s for the hydrogenation. Toward this end, a range of combinations 
have been investigated; the results can be seen in the Table 3-4. The achiral in situ 
catalyst Ir-DPPP, Ir-[Ph3P, Ph2P(0)H] and 5a afforded 10-20% conversion and 0% ee 
in 12 h (entries 1 and 2). Changing the Brpnsted acid to the bulky 5e, the combination 
of acid and Ir-DPPP or Ir-DPPE also led to 0% ee and low conversion (entries 3 and 
4). Introduction of 10% iodine, the combination afforded 99% conversion in 12 h, but 
again no ee (entries 5 and 6). Furthermore, the combination of Pd/C and 5e led to 99% 
conversion and 0% ee (entry 7). Replacing the Ir-diphosphine with ionic
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Rh-diphosphine complexes, the in situ catalyst, Rh-DPPM, Rh-DPPE, Rh-DPPP, or 
Rh-BIPHEP and 5e, led to 20-35% conversion and 0% ee (entries 8-11). The above 
results show that chiral Brpnsted acid could not induce chirality in such the transitin 
metal-catalyzed hydrogenation, which may involve imine coordination to the metal for 
hydrogenation to take place. 14
R = H
6a, M = Rh. 6b, M = Ir; 
R = OMe
6c, M = Rh, 6d, M = Ir;
A r  =  4 - C H 3C 6 H 4 A r  =  2 ,4 ,6 - ( 2 - C 3 H 7 )3 C 6 H2 9a, M  =  Rh, 9b, M  =  Ir;
7a, M  =  Rh, 7b, M  =  Ir; 8a, M  =  Rh, 8b, M  =  Ir;
Ar= 1-naphthyl 
7c, M  = Rh, 7d, M  = Ir;
Ar = 2,4,6-(2-C3H7)3C6H2 
7e, M  = Rh, 7f, M  = Ir;
Table 3-4: Optimization of Conditions for the Hydrogenation of la a
entry solvent catalyst additive
conv.
(%)
ee
(%)
1 A DCM Ir-DPPPe 5a (6%) 10 0
2 b DCM Ir-[Ph3P,Ph2P(0)H] b 5a (6%) 20 0
3 b DCM Ir-D PPPe 5e (6%) 15 0
4 b DCM Ir-DPPEe 5e (6%) 30 0
5 b DCM Ir-DPPPe 5e (6%) + 12 99 0
6 b DCM Ir-DPPEe 5e (6%) + 12 99 0
7 b DCM Pd/C 5e (6%) 99 0
8 C DCM Rh-DPPM7 5e (6%) 20 0
9 C DCM Rh-DPPE7 5e (6%) 30 0
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1 0 c DCM Rh- DPPP7 5e (6%) 20 0
i r DCM Rh-BIPHEP7 5e (6%) 35 0
1 2 c benzene [Cp*Rh(DPPP)]Clg 5e (6%)+AgSbF6 2 -
13c benzene [Cp*Ir(DPPP)]Cl * 5e (6%)+AgSbF6 6 -
14c DCM 6a 5e (6%) 0 -
15c DCM 6b 5e (6%) 0 -
16c DCM 6a 5e (6%)+AgSbF6 1 -
1 l c DCM 6b 5e (6%)+AgSbF6 1 -
18c DCM 6c 5e (6%)+AgSbF6 2 0
19c DCM 6d 5e (6%)+AgSbF6 2 0
20 toluene 7a 5e (6%) 44 0
2 1  d toluene 7c 5e (6%) 40 45(5)
22d toluene 7d 5e (6%) 50 46(5)
23 d toluene 7e 5e (6%) 40 45(5)
24 d toluene 7f 5e (6%) 60 73(5)
25d toluene 8a 5e (6%) 20 42(5)
26d toluene 9a 5e (6%) 10 30(5)
27 d toluene 9b 5e (6%) 15 35(5)
2Sd toluene [Cp*RhCl2]2 5e (6%) 1 -
29 d toluene [Cp*IrCl2]2 5e (6%) 1 -
30d DCM 7f 5e (6%) 70 65(5)
3 l d benzene 7f 5e (6%) 60 73(5)
32d xylene 7f 5e (6%) 40 70(5)
"Reaction conditions: 0.5 mmol la, 1 mol% catalyst, 2 mL solvent, 20 °C, 12 h. *40 bar 
H2; c30 bar H2;d 20 bar H2; e The in situ catalyst was prepared from [Ir(COD)2Cl]2 and 
phosphine in DCM. /  The in situ catalyst prepared from [Rh(COD)2]BF4 and phosphine in 
DCM. 8 The in situ catalyst prepared from [Cp*RhCl2]2 and phosphine in toluene. h The in 
situ catalyst prepared from [Cp*IrCl2]2 and phosphine in toluene.
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Following the previous direction, we searched for a catalyst which could be used
for reduction via an ionic pathway. However, the combination of the in situ catalyst 
Cp*Rh(DPPP)Cl or Cp*Ir(DPPP)Cl and 5e showed almost no activities for la  
hydrogenation in the presence of 4% of AgSbFg (entries 12 and 13). Furthermore, 
6a-6d in combination with 5e were inactive for la  hydrogenation, even in the presence 
of 4% of AgSbFe (entries 14-19). Changing to diamine-ligated catalyst, 7a and 5e 
afforded 44% conversion but no ee. Delightfully, the bulky 7c-5e, 7d-5e and 7e-5e 
combinations led to 45% and 46% ee (entries 21-23); and the couple 7f-5e afforded the 
highest ee value of 73% with 60% conversion (entry 24). However, the couples 8a-5e, 
9a-5e, and 9b-5e were less enantioselective (entries 25-27). Still further, [Cp*RhCl2]2 
and [Cp*IrCl2]2 in combination with 5e were examined, but they showed no activity 
for la  hydrogenation (entries 28 and 29). Slightly lower ee’s were observed with 7f-5e 
in DCM (65%), benzene (73%) and xylene (70%) (entries 30-32). Clearly, more 
investigations will be needed in order to find catalysts of practical use.
3 Mechanistic Aspects
For Rh and Ir diphosphine-based catalytic systems, a general catalytic cycle for 
imine hydrogenation has been postulated by several groups (Scheme 3-2).14 The 
starting metal hydride (M-H) binds the imine via the lone pair in a r|' manner. 
Following the first step, a t) 1 to r| 2 migration followed by insertion into the M-H bond 
leads to an M-amine complex. The last step is hydrogenolysis of the resulting M-N 
bond to generate chiral amine and the active catalyst. It needs to be pointed out that the
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transition metal needs an empty site for ¡mine coordination in this classical catalytic
cycle.
Scheme 3-2. Classical pathway for asymmetric hydrogenation (AH) of ¡mines with the 
Rh or Ir-diphosphine catalyst.
According to the our results presented above, a more likely ionic pathway is 
postulated for the diamine-ligated Rh/Ir catalyzed AH of ¡mines (Scheme 3-3). 
Different to catalysts in the classical pathway, the metal in Cp*(N-N)M-H (M = Rh, Ir) 
is coordinatively saturated; the reduction could not go through a catalytic cycle in 
which the metal is coordinated by the ¡mine. Furthermore, the observation in achiral 
Rh/Ir diphosphine and chiral Brpnsted acid system suggests that chiral acids are 
involved in the catalytic cycle. A bifunctional pathway was proposed for asymmetric 
transfer hydrogenation of ketone with the similar catalyst. 15 Assuming a bifunctional 
pathway for the AH of ¡mine, the reduction could take place via a six-membered 
pericyclic transition state involving NH hydrogen bonding with the imine rather than 
ion pair interaction. However, our observations suggest that the reduction is notably 
affected by anion on both activity and enantioselectivity, which are consistent with the
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proposed ionic mechanism shown in Scheme 3-3. More detailed theoretical
investigations will be carried out in the Xiao’s group using NMR study and theoretical
calculations.
Ar A r
less likely
bifunctional pathway
Scheme 3-3. Proposed ionic pathway for AH of imines with Cp*Rh/Ir catalysts.
4. Conclusion
In conclusion, we have developed an efficient chiral diamine-ligated Ir(III) and chiral 
Bronsted acid catalytic system for asymmetric hydrogenation of the often-problematic 
acyclic imines. The catalyst is viable for a wide variety of imines and appears to 
operate via cooperative catalysis between the chiral metal catalyst and its chiral 
counter anion. We also explored the combination of chiral (achiral) transition metals
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and achiral (chiral) Bronsted acids for imine hydrogenation. Preliminary investigations
indicate that the simpler and cheaper catalytic systems could be realized by further 
exploration.
5. Experimental Section 
General information
Unless otherwise specified, the chemicals were obtained commercially and used 
without further purification. Toluene, THF, benzene and xylene were dried over 
sodium and distilled prior to use. Dichloromethane (DCM) was dried over Cafb and 
distilled prior to use. Methanol was dried over Mg and distilled prior to use. 'H NMR 
and 13C NMR spectra were recorded on a DRX-400 spectrometer at 400 ('H) and 100 
MHz (13C) in ppm with TMS as the internal standard in CDCI3. The mass spectra were 
obtained by chemical ionization (Cl). Chromatographic purification was performed on 
silica gel (mesh 300-400) by the flash techinique. All the products were satisfactorily 
characterized by H and C NMR, HRMS and elemental analysis. When possible, 
comparison of their NMR spectra has been made with available literature data. HPLC 
analysis was performed on Gilson UV/VIS-151 equipped with an OD-H or OB-H 
column purchased from Daicel Chemical Industries. The configuration of the products 
2 a, 2 b, 2 g, 2 i, 21, 2 m, 2o, 2 p and 2 t was assigned by comparison with the literature, 
and that of the rest was based on analogy with the assignment for other compounds 
without verification. The compounds 3a-c were prepared according to the literature 
procedures.1516
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General procedure for the preparation of acyclic imines 1
J +  r 3m m  4 A MS, tolulene  ^ N ' R 
r i ^ r2  2 NaHC03, reflux r i ^ r2
A 250 mL round-bottomed flask was charged with a ketone (10.0 mmol), NaHCCb
(50 mmol), an amine (12.0 mmol) and activated molecular sieves (4 A, 8 g) in
anhydrous toluene (60 mL). The reaction mixture was refluxed until full conversion
was reached (conversion was monitored by TLC and 'H  NMR) under nitrogen
atmosphere. The reaction mixture was filtered through celite, solvent was evaporated
and the crude product was was subjected to distillation or recrystallization to give pure
imine. Acyclic imines la  to lz  were obtained in 30% to 80% isolated yield.
17
Preparation of chiral phosphoric acids 5 4d’18
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5b: Ar = Ph;
5c: Ar = 3,5-(CF3)2C6H3;
5d: Ar = 1-naphthyl
5e: Ar = 2,4,6-(2-C3H7)3C6H2;
Synthesis of (R ) -2 , 2’-bis(methoxymethoxy)-l,r-binaphthyl ((l?)-ll)18b
To a suspension of NaH (16.0 g, 400 mmol, 60% dispersion in mineral oil, prewashed 
using hexane) in a mixture of dry THF (350 mL) and dry DMF (80 mL), a dry THF 
solution (150 mL) of (i?)-l,l’-bi-2-naphthol (28.6 g, 100 mmol) was added dropwise 
under a nitrogen atmosphere at 0 °C over 30 minutes. After FL evolution ceased (about 
2 h), chloromethyl methyl ether ( 30.0 g, 19.6 mL, 240 mmol) was added dropwise to 
the mixture, and the resulting mixture stirred overnight at room temperature. The 
reaction mixture was quenched with ice-water, and then THF was evaporated. The 
residual aqueous layer was extracted with diethyl ether (3 X 100 mL). The combined 
organic phase was washed twice with water, brine, and then dried over Na2SC>4. The 
mixture was filtered through silica gel and dried under high vacuo for 30 min to give 
(i?)-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl (35.9 g, 96%). ’H NMR (400MHz, 
CDC13) 6 (ppm): 3.14 (s, 6H), 4.97 (d, J=  6.4 Hz, 2H), 5.08 (d, J=  6.8 Hz, 2H), 7.15 
(d, J=  8.0 Hz, 2H), 7.20-7.24 (m, 2H), 7.32-7.36 (m, 2H), 7.57 (d, J  = 9.2, 2H), 7.86 
(d, J  = 8.0 Hz, 2H), 7.94 (d, J  = 9.2 Hz, 2H); 13C NMR (CDC13, 100 MHz) 6 (ppm):
56.2, 95.6, 117.7, 121.7, 124.5, 126.0, 126.7, 128.3, 129.8, 130.3, 133.4, 153.1. MS Cl
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m/z (%): 392.1 [M + NH4]+; Elemental analysis calcd (%) for C24H22O4: C, 76.99; H,
5.92; Found: C, 77.02; H, 5.92.
Synthesis of (/?)-3, 3’-dibromo-2,
2’-bis(methoxymethoxy)-l,l’-binaphthyl ((/?)-12)18b
The MOM protected (J?)-ll (33.7 g, 90 mmol) was dissolved in anhydrous THF (200 
mL) under N2 at -78 °C. To this solution, n-BuLi (84 mL, 2.5 M in hexanes, 210 mmol) 
was added dropwise over 30 minutes, and the solution colour changed from dark 
brown to yellow brown. The mixture was allowed to warm to 0 °C, and stirred for 2 h, 
and then cooled to -78 °C again. To the mixture was added a solution of bromine (43.2 
g, 13.8 mL, 270 mmol) dropwise over 40 min and then let it warm to room 
temperature. After stirring over night at room temperature, the resulting mixture was 
poured into saturated Na2SC>3. The organic layer was separated and aqueous phase was 
extracted with ethyl acetate. The combined organic extracts were washed with brine 
and dried over Na2S0 4. The mixture was filtered and evaporated, the resulting crude 
product was purified by column chromatography on silica gel (ethyl acetate / hexane =
1 : 10) to give the product (R)-12, (38.2 g, 80%). ’H NMR (400MHz, CDC13) 5 (ppm): 
2.55 (6H, s), 4.81 (s, 4H), 7.17 (d,J=  8.4 Hz, 2H), 7.24-7.32 (dd, J =  6.8, 8.4 Hz, 2H), 
7.41 (t, J =  6.8 Hz, 2H), 7.79 (d, J =  8.0 Hz, 2H), 8.26 (s, 2H); 13C NMR (CDC13, 100 
MHz) 6 (ppm): 55.5, 98.3, 116.5, 125.3, 125.7, 126.5, 126.6, 127.1, 130.8, 132.2, 
132.3, 149.3; ES+ for C24H2o79Br223N a04 [M + Na]+ m/z calcd 552.9626, found 
552.9710; Elemental analysis calcd (%) for C24H2oBr204: C, 54.16; H, 3.79; Found: C,
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54.28; H, 3.68.
Synthesis of (/?)-3,3’-dibromo-l,l’-bi-2-naphthol ((/?)-13)18b
A mixture of (i?)-12 (36 g, 67.9 mmol) and concentrated HC1 (4.6 mL, 150 mmol) in 1, 
4-dioxane (100 mL) was heated to 50 °C and stirred overnight. The resulting mixture 
was poured into water (100 mL) and extracted with diethyl ether. The organic extracts 
were washed with brine and dried over Na^CL, and evaporated in vacuo to afford 30 g 
crude product i?-13 that was used for next step without any further purification. 
Synthesis of ( / f ^ ^ ’-dibromo-l^’-dimethoxy-l^’-dinaphthyl 
((/?)-14)18c
A suspension of crude (R)-13 (30 g) was heated in acetone (300 mL) to give a 
homogeneous solution. To this solution were added potassium carbonate (27.6 g, 200 
mmol) and methyl iodide (28.4 g, 200 mmol), and the mixture was heated at reflux for 
24 h. Additional methyl iodide (3.6 g, 25 mmol) was added, and heating was continued 
for 4 h. The solvent was evaporated to leave a volume of 100 mL, which was cooled to 
room temperature and treated with 250 mL of water. The mixture was stirred for 4 h, 
and the resulting solid was washed with water and evaporated, and the resulting crude 
product was purified by column chromatography on silica gel (ethyl acetate / hexane = 
1:10)  to give the product (K)-14, (29.4 g, 92% two step yield ) as a white powder. 'H 
NMR (400 MHz, CDC13) 5 (ppm): 3.50 (s, 6H), 7.07 (d, J =  8.4 Hz, 2H), 7.26 (t, J  =
7.6 Hz, 2H), 7.41 (dd, J=  7.2, 8.0 Hz, 2H), 7.81 (d, J  = 8.4 Hz, 2H), 8.26 (s, 2H); 13C 
NMR (CDCI3, 100 MHz) 5 (ppm): 61.5, 117.9, 126.2, 126.3, 127.0, 127.3, 127.6,
131.9, 133.4, 133.5, 152.9; ES+ for C22Hi679Br223N a02 [M + N a f  m/z calcd 492.9415,
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found 492.9396; Elemental analysis calcd (%) for C22Hi6Br202: C, 55.96; H, 3.42;
Found: C, 55.88; H, 3.40.
Preparation of Grignard reagent18a
A three-neck round-bottom flask containing Mg (0.60 g, 25 mmol) was equipped 
with a condenser and an addition funnel. A 10.0 mL portion of a 1.0 M solution of 
ArBr (20 mmol in 20 mL of Et20 ) was added to the flask through the addition funnel. 
After 5 min, 0.10 mL (0.001 mmol) of 1,2-dibromoethane was added to the mixture. 
Once the solution began to reflux, the remaining ArBr solution was slowly added over 
30 minutes. After the addition was complete, the reaction was allowed to reflux for 
2-16 h.
Synthesis of (R)-1518a
(Z?)-3,3’-Dibromo-2,2’-dimethoxy-l,r-dinaphthyl (2.35 g, 5 mmol) and 
Ni(PPh3)2Cl2 (0.33 g, 10 mol %, 0.50 mmol) were suspended in 60 mL of Et2 0 . To this 
suspension was added prepared Grignard reagent slowly at rt. The mixture was 
allowed to stir at rt for 10 min; at this point, the resulting dark green solution was 
refluxed for 24 h. The reaction was then allowed to cool to 0 °C and quenched slowly 
by the addition of 30 mL of a 1.0 M solution of HC1. The resulting aqueous layer was 
separated from the Et20  layer and washed three times with excess Et20  (30 mL). The 
resulting organic layers were then dried over MgS04; volatile solvents were removed 
in vacuo to afford the crude product as white solid that was used for next step without 
further purification.
Synthesis of (/?)-1618c
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To a solution of crude i?-15 (about 4.5-5.0 mmol) in 30 mL of CH2CI2 was added 
BBr3 (4.96 g, 20.0 mmol in 20.0 mL CH2CI2) slowly at 0 °C. The resulting mixture was 
allowed to warm to room temperature and stirred for 24 h. The mixture was then 
cooled to 0 °C, and the reaction was quenched by the slow addition of 40 mL water. 
Aqueous extraction with CH2CI2 (3 X 40 mL), followed by drying of the organic layers 
over MgS04 and removal of the solvents in vacuo, afforded an off-white solid, which 
was washed with hexanes, filtered, and dried in vacuo to afford crude product. Flash 
chromatography purification with a column of silica gel eluted with hexane/EtOAc 
(10/1 to 8/1) yielded the pure product in 90-95% yield (two steps).
General procedure for synthesis of (2?)-54d,18c’e 
(i?)-16 (4 mmol) was suspended in pyridine (11.0 mL). Phosphorous oxychloride 
(1.2 g, 0.76 mL, 8.1 mmol) was added dropwise at room temperature with rapid 
stirring and the resulting suspension was heated to 80 °C. Upon reaching 80 °C all 
material had dissolved to provide a pale yellow clear solution The reaction mixture 
was stirred for 24 hours at 80 °C until all starting material was deemed consumed by 
TLC. The reaction mixture was cooled to 0 °C and water (10 mL) was added very 
slowly. The resulting biphasic suspension was heated to 80 °C for an additional 4 h. 
The reaction mixture was diluted with CH2CI2 and the pyridine was removed via 
washing with IN  HC1. The combined organic phase was dried over Na2SC>4, filtered 
and concentrated to give crude product as a pale yellow solid. Purification by flash
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column chromatography (gradient from 1% to 4% MeOH in CH2CI2) yielded acids 5
as a white solid.
(i?)-3,3'-Diphenyl-l,l'-binaphyl phosphoric acid (5b)l8c 
5b was prepared from (i?)-3,3'-diphenyl-l,l'-binaphthol. *H NMR (400MHz, CDCI3) 
5 (ppm): 6.94-7.01 (m, 2H), 7.01-7.12 (m, 4H), 7.17-7.24 (m, 2H), 7.31 (d,J =  8.4 Hz, 
2H), 7.35-7.43 (m, 2H), 7.56 (d, J -  7.6 Hz, 4H), 7.50 (brs, 1H), 7.80-7.88 (m, 4H); 
13C NMR (CDCI3, 100 MHz) 5 (ppm): 122.6, 125.9, 126.5, 127.1, 127.7, 128.4, 128.5,
129.9, 131.4, 132.1, 134.3, 136.9, 144.8, 144.9; 31P NMR (CDC13, 162 MHz) 5 (ppm): 
2.03; HRMS for C32H20O4P [M-H]+: m/z calcd 499.1099, found 499.1085.
(R)-3,3'-Bis[3,5-bis(trifIuoromethyI)phenyl]-l,r-binaphthyl phosphoric acid
(5c)18d
5c was prepared from (R)-3,3'-6/s[3,5-bis(trifluorornethyl)phenyl]-l,r-binaphthol. 
'H NMR (400 MHz, CDC13) 6 (ppm): 7.31 (d, J  = 3.6 Hz, 4H), 7.47-7.51 (m, 2H), 
7.76 (s, 2H), 7.95 (t, J  = 4.0 Hz, 4H), 8.21 (s, 4H). 13C NMR (CDC13, 100 MHz) 5 
(ppm): 121.3, 122.4, 123.1 (q, JC-f =272.8 Hz), 126.4, 127.4, 127.6, 128.9, 130.3,
130.6, 131.2 (d, Jp-c = 3.2 Hz), 131.4, 131.5 (q, JC-f =33.2 Hz), 133.2, 140.5, 145.7(d, 
Jp-C = 14.9 Hz); 31P NMR (CDC13, 162 MHz) 5 (ppm): 5.86; HRMS for C36H 16O4F 12P 
[M-H]+: m/z calcd 771.0595, found 771.0557.
(i?)-3,3'-Bw(l-naphthyi)-l,l'-binaphthyl phosphoric acid (5d)
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5d was prepared from (i?)-3,3'-bis(l-naphthyl)-l,r- binaphthol. 'H NMR (400MHz, 
CDC13) 6 (ppm): 6.76-7.32 (m, 12H), 7.43-7.72 (m, 10H), 7.91 (s, 2H); 13C NMR 
(CDCI3, 100 MHz) 5 (ppm): 123.0, 124.9, 125.8, 126.3, 126.5, 126.8, 127.6, 127.8,
128.5, 128.6, 129.4, 131.0, 131.4, 132.5, 133.0, 133.1, 133.5, 135.7, 147.1, 147.2; 31P 
NMR (C D C I3, 162 MHz) 5 (ppm): 3.08; HRMS for C40H24O4P [M-H]+: m/z calcd 
599.1412, found 599.1418.
(J?)-3,3’-Bis(2,4,6-triisopropylphenyl)-l,l’-dinaphthyl phosphoric acid (5e)18e 
5e was prepared from3,3’-bis(2,4,6-triisopropylphenyl)-l,r- binaphthol. 'H NMR 
(400MHz, CDCI3) 5 (ppm): 0.84 (brs, 6H), 0.9l(d, J =  6.8 Hz, 6H), 1.04 (d, J=  6.8 Hz, 
6H), 1.09 (d, J=  6.8 Hz, 6H), 1.20 (d, J=  6.8 Hz, 12H), 2.46 (brs, 1H), 2.66 (brs, 3H), 
2.80-2.87 (m, 2H), 6.97 (s, 4H), 7.22-7.27 (m, 4H), 7.39-7.43 (m, 2H), 7.77 (s, 2H), 
7.83 (d, J =  8.4 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 23.7, 23.8, 24.4, 24.7,
25.5, 26.8, 31.2, 31.4, 34.7, 120.6, 121.5, 122.6, 122.7, 125.7, 126.4, 127.8, 128.6,
131.2, 132.7, 132.8, 132.9, 133.1, 147.1, 148.1, 148.6, 148.7; 3IP NMR (CDC13, 162 
MHz) 5 (ppm): 4.81; HRMS for C50H56O4P [M-H]+: m/z calcd 751.3916, found 
751.3885.
Procedure for preparation of ligand 17 to 2219
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(1R, 2/?)-(+)-l,2-Diphenylethylenediamine (424 mg, 2.0 mmol) was added in dried 
DCM (20 mL) and cooled down to 0 °C with an ice bath. Et3N (0.42 mL, 3.0 mmol) 
was added in the solution and stirred at 0 °C for a few minutes. Then a solution of
2,4,6-triisopropylbenzenesulfonyl chloride (636 mg, 2.1 mmol) in dried DCM (15 mL) 
was added dropwise during 1 h period. The reaction mixture was stirred for 2 h at 0 °C, 
and then it was let to warm up to room temperature and stirred at room temperature 
overnight. The reaction mixture was washed with water (3 x 20 mL), dried over 
Na2SC>4 and concentrated in vacuum to afford the crude product. Flash 
chromatography purification with a column of silica gel eluted with DCM/MeOH 
(10/1) yielded the pure product as a white solid (765 mg, 80% yield). (S,S)-11, (SV^-IS, 
19, 20, 21, and 22was synthesized in a similar method.
(lf?,2/?)/(15',25')-./V-(2,4,6-TriisopropylbenzenesuIfonyl)-l,2-diphenylethylenediami
___ 19ane
((R,R)-17/(S,S)-17): ’H NMR (CDC13, 400 MHz) 6 (ppm): 1.01 (d,J =  6.4 Hz, 6H),
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1.08 (d, J=  6.8 Hz, 6H), 1.12 (d, J=  6.8 Hz, 6H), 1.75 (brs, 2H), 2.75 (sept, J=  6.8 Hz, 
1H), 3.89 (sept, J =  6.8 Hz, 2H), 3.90 (d, J =  8.0 Hz, 1H ), 4.39 (d, J =  8.0 Hz, 1H ), 
6.20 (brs, 1H), 6.71-6.74 (m, 2H), 6.83-6.96 (m, 7H), 7.04-7.10 (m, 3H); 13C NMR 
(CDCh, 100 MHz) 8 (ppm): 24.0, 24.1, 25.0, 25.2, 25.3, 30.2, 30.4, 34.6, 123.7, 127.3,
127.7, 127.8, 127.9, 128.2, 128.8, 134.4, 139.1, 142.4, 150.1, 152.8; ES+ for 
C29H39N2O2S [M + H]+ m/z calcd 479.2732, found 479.2745; Elemental analysis calcd 
(%) for C29H38N2O2S: C, 72.76; H, 8.00; N, 5.86; Found: C, 72.84; H, 8.04; N, 5.92. 
(15',25)-Ar-(2,3,4,5,6-Pentamethylbenzenesulfonyl)-l,2-diphenylethylenediamine 
((S,S)-18): 'H NMR (CDC13, 400 MHz) 5 (ppm): 1.81 (brs, 1H), 2.06 (s, 6H), 2.17 
(s, 3H), 2.36 (s, 6H), 4.07 (d, J=  7.6 Hz, 1H ), 4.36 (d, J = 7.6 Hz, 1H ), 6.15 (brs, 1H), 
6.86-6.89 (m, 2H), 6.96-7.07 (m, 5H), 7.08-7.14 (m, 3H); ,3C NMR (CDCI3, 100 MHz) 
8 (ppm): 17.3, 18.0, 19.2, 61.0, 64.2, 127.1, 127.5, 127.6, 127.7, 128.1, 128.6, 134.4,
134.6, 136.6, 139.1, 139.3, 142.1; ES+ for C25H31N2O2S [M + H]+ m/z calcd 423.2106, 
found 423.2098; Elemental analysis calcd (%) for C25H30N2O2S: C, 71.06; H, 7.16; N, 
6.63; Found: C, 71.13; H, 7.14; N, 6.66.
7V-(4-Methylbenzenesulfonyl)-ethylenediamine (19):19a 'H NMR (CDCI3, 400 MHz) 
8 (ppm): 2.30 (brs, 2H), 2.43 (s, 3H), 2.79 (t, J=  5.6 Hz, 2H ), 2.96 (t, J = 5.6 Hz, 2H ), 
7.30 (d, J=  8.0 Hz, 2H ), 7.75 (dd, 7 =  1.6, 6.4 Hz, 2H ); 13C NMR (CDC13, 100 MHz) 
8 (ppm): 21.7, 41.3, 45.8, 127.5, 130.1, 137.5, 143.7; MS Cl m/z (%): 215 [M + H]+; 
Elemental analysis calcd (%) for C9H 14N2O2S: C, 50.45; H, 6.59; N, 13.07; Found: C, 
49.98; H, 6.48; N, 12.73.
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/V-(l-Naphthalenesulfonyl)-ethylenediamine (20): *H NMR (CDCI3, 400 MHz) 5 
(ppm): 2.71 (t, J =  5.6 Hz, 2H ), 2.92 (t, J =  5.6 Hz, 2H ), 2.94 (brs, 2H), 7.53 (t, J  =
7.2 Hz, 1H ), 7.59 (t, J  = 7.6 Hz, 1H ), 7.66 (t, J =  6.8 Hz, 1H ), 7.94 (d, J =  8.0 Hz, 
1H ), 8.06 (d, J =  8.4 Hz, 1H ), 8.27 (dd, J =  1.2, 7.6 Hz, 1H ), 8.67 (d, J =  8.4 Hz, 
1H ); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 41.2, 45.7, 124.6, 124.8, 127.3, 128.5,
128.8, 129.5, 130.0, 134.6, 134.7, 135.0; MS CI m/z (%): 251 [M + H]+; Elemental 
analysis caled (%) for C 12H 14N2O2S: C, 57.58; H, 5.64; N, 11.19; Found: C, 57.61; H, 
5.64; N, 11.35.
/V-(2,4,6-Trüsopropylbenzenesulfonyl)-ethylenediamine (21): ’H NMR (CDCI3, 400 
MHz) 5 (ppm): 1.25 (d, J =  6.4 Hz, 6H ), 1.27 (t, J =  6.8 Hz, 12H ), 2.84-2.87 (m, 2H), 
2.90 (sept, J =  6.8 Hz, 1H ), 2.98-3.01 (m, 2H), 4.17 (sept, J =  6.8 Hz, 2H ), 7.16 (s, 
2H ); 13C NMR (CDC13, 100 MHz) 5 (ppm): 24.0, 25.3, 30.0, 34.5, 41.2, 45.2, 124.2,
132.6, 150.7, 153.0; MS CI m/z (%): 327 [M + H]+; Elemental analysis caled (%) for 
C 17H30N2O2S: C, 62.54; H, 9.26; N, 8.58; Found: C, 62.40; H, 9.22; N, 8.52.
/V-(2,4,6-TriisopropylbenzenesuIfonyl)-propylenediamine (22): *H NMR (CDCI3, 
400 MHz) 5 (ppm): 1.26 (d, J =  7.2 Hz, 6H ), 1.27 (d, J =  6.8 Hz, 12H ), 1.63-1.69 (m, 
2H), 2.83-2.86 (m, 2H), 2.90 (sept, J =  6.8 Hz, 1H ), 3.08-3.11 (m, 2H), 4.17 (sept, J  =
6.8 Hz, 2H ), 7.16 (s, 2H ); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 24.0, 25.3, 30.0,
31.4, 34.5, 41.5, 42.9, 124.1, 132.8, 150.5, 150.7, 152.8; MS CI m/z (%): 341.2 [M +
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H]+; Elemental analysis calcd (%) for C18H32N2O2S: C, 63.49; H, 9.47; N, 8.23; Found: 
C, 63.39; H, 9.48; N, 8.25.
Procedure for the preparation of complexes (S , <S)-4a and (S , S)-4b
A solution of 5e (113 mg, 0.15 mmol) in DCM (5 mL) was added dropwise into a 
solution of (S , S )-3a (121 mg, 0.15 mmol) in DCM (5 mL) under a nitrogen 
atmosphere at room temperature over a period of 30 min. After the solution was stirred 
for another 30 min, the solvent was removed under reduced pressure. The resulting red 
solid (S , S)-4a (230 mg) was used for hydrogenation without further purification. (S, 
S)-4b was synthesized in a similar method. The following analytic data have been 
obtained.
(.S, S)-4a: ’H NMR (CDCI3, 400 MHz) 5 (ppm): 0.92 (d, J  = 6.8 Hz, 12H), 1.11 (d, J  =
6.8 Hz, 12H), 1.16 (d, J =  7.2 Hz, 12H), 1.18 (d, J - 7.2 Hz, 6H), 1.24 (d ,J= 7 .2 H z , 
12H), 2.02 (s, 15H), 2.54-2.62 (m, 2H), 2.68-2.79 (m, 3H), 2.85-2.91 (m, 2H), 2.94 (br, 
1H), 3.73-3.80 (m, 2H), 3.93-3.95 (m, 1H), 4.02 (s, 1H), 5.36 (br, 1 H), 6.83 (s, 2H), 
6.99 (s, 2H), 7.03 (s, 2H), 7.09-7.17 (m, 8H), 7.21-7.30 (m, 6H), 7.40 (t, J =  6.8 Hz, 
2H), 7.77 (s, 2H), 7.85 (d, J =  8.0 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 10.8,
23.8, 24.1, 24.5, 24.7, 25.5, 26.9, 29.7, 31.1, 31.2, 34.4, 34.7, 73.2, 81.7, 85.7, 120.3,
121.0, 123.0, 124.9, 125.8, 126.7, 127.0, 127.3, 127.8, 128.3, 128.4, 130.7, 132.0,
133.2, 133.3, 133.4, 133.7, 134.5, 146.5, 147.4, 148.0, 148.6, 150.8, 151.0; 31PNM R 
(CDCI3, 162 MHz) 5 (ppm): 7.0; MS (ES) for [C39H52N20 2S193Ir]+: m/z calcd 805.3379; 
found 805.3391.
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(S, S)-4b: 'H NMR (CDC13, 400 MHz) 5 (ppm): 0.94 (d, J =  6.8 Hz, 12H), 1.12 (d,
6.8 Hz, 6H), 1.20 (d, J =  12  Hz, 6H), 1.26 (d, J =  6.8 Hz, 12H), 1.99 (s, 6H), 2.00 (s, 
6H), 2.06 (s, 15H), 2.16 (s, 3H), 2.58-2.64 (m, 2H), 2.70-2.79 (m, 2H), 2.86-2.93 (m, 
2H), 2.99 (br, 1H), 3.95 (s, 1H), 4.00 (s, 1H), 5.17 (br, 1H), 7.00 (s, 2H), 7.04 (s, 2H), 
7.13-7.31 (m, 12H), 7.40-7.44 (m, 4H), 7.99 (s, 2H), 7.86 (d, J  = 8.0 Hz, 2H); 13C 
NMR (CDC13, 100 MHz) 5 (ppm): 9.3, 15.7, 16.4, 17.7, 22.3, 22.9, 23.2, 23.9, 25.3,
29.6, 33.1, 77.9, 78.8, 84.1, 119.2, 121.3, 123.0, 124.0, 124.8, 124.9, 125.8, 126.0,
126.1, 126.5, 128.9, 130.2, 131.4, 131.6, 131.9, 132.0, 133.9, 135.8, 143.7, 145.9,
146.1, 146.8; 31P NMR (CDCI3, 162 MHz) 8 (ppm): 6.9; MS (ES) for 
[C35H44N2O2S 193Ir]+: m/z calcd 749.2753; found 749.2733.
General Procedure for Preparation of Racemic Amines 2 
To a reaction tube charged with an acyclic ¡mine (0.5 mmol) and NaBFfi (1.0 mmol, 
38 mg) were added MeOH (2 mL). The readuction was stirred at room temperature for 
overnight. The solution was transferred to a flask and concentrated to afford the 
crude product. Flash chromatography purification with a column of silica gel eluted 
with petroleum ether/ethyl acetate ( 10/1 to 8/ 1) yielded the desired amine product. 
General procedure for asymmetric hydrogenation
To a glass liner charged with 5e (4 mg, 5 pmol) and an imine (0.5 mmol) was added 
toluene (2 mL). After stirring for half minute, the catalyst 4a (8 mg, 5 pmol) was 
introduced. The glass liner was then placed into an autoclave followed by degassing 
with H2 three times. The hydrogenation was carried out at 20 bar H2 with stirring at 20 
°C for 15-20 h. The hydrogen gas was then carefully released, and the solution was
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transferred to a flask and concentrated to afford the crude product. Flash
chromatography purification with a column of silica gel eluted with petroleum 
ether/ethyl acetate ( 10/1 to 8/ 1 ) yielded the desired amine product.
Analytic data of products
HN
4-Methoxy-/V-(l-phenylethyl)aniline (2a)4c,d’20
2a (106 mg, 94% yield, 97% ee) was obtained according to the general procedure from 
the ¡mine la  (113 mg, 0.5 mmol) in 15 h; *H NMR (CDC13, 400 MHz) 5 (ppm): 1.48 
(d, J  = 6.8 Hz, 3H), 3.68 (s, 3H), 4.40 (q, J  = 6.8 Hz, 1H ), 6.45-6.47 (m, 2H), 
6.67-6.70 (m, 2H), 7.19-7.23 (m, 1H), 7.29-7.36 (m, 4H); 13C NMR (CDC13, 100 MHz) 
5 (ppm): 25.6, 54.7, 56.2, 115.0, 115.2, 126.3, 127.3, 129.1, 142.0, 145.9, 152.3; 
HRMS for C15H 18NO [M+H]+: m/z calcd 228.1388, found 228.1384; Elemental 
analysis calcd (%) for Ci5H,7NO: C, 79.26; H, 7.54; N, 6.16; Found: C, 79.19; H, 7.55; 
N, 6.13; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, 
X = 254 nm): tR = 24.3 min (minor), tR - 27.1 min (major).
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2b (112 mg, 93% yield, 97% ee) was obtained according to the general procedure from 
the imine lb  (120 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.35 
(d, J  = 6.6 Hz, 3H), 2.20 (s, 3H), 3.58 (s, 3H ), 4.27 (q, J  = 6.6 Hz, 1H), 6.34-6.38 (m, 
2H), 6.56-6.59 (m, 2H), 7.00 (d, J =  8.0 Hz, 2H), 7.13 (d, J =  8.0 Hz, 2H); 13C NMR 
(CDCb, 100 MHz) 5 (ppm): 21.6, 25.7, 54.4, 56.2, 115.0, 115.6, 126.3, 129.8, 136.8,
142.2, 143.0, 152.3; HRMS for C i6H20NO [M+H]+: m/z calcd 242.1545, found 
242.1550; Elemental analysis calcd (%) for C 16H 19NO: C, 79.63; H, 7.94; N, 5.80; 
Found: C, 79.55; H, 7.98; N, 5.75; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, 
flow rate 0.5 mL/min, X = 254 nm): tR = 19.6 min (minor), tR = 22.4 min (major).
4-Methoxy-iV-(l-/M-tolylethyl)aniline (2c)
2c (114 mg, 95% yield, 96% ee) was obtained according to the general procedure from 
the imine lc  (120 mg, 0.5 mmol) in 15 h; *H NMR (CDCI3, 400 MHz) 5 (ppm): 1.48 
(d, J =  6.7 Hz, 3H), 2.33 (s, 3H), 3.70 (s, 3H ), 4.36 (q, J  = 6.7 Hz, 1H), 6.47-6.50 (m, 
2H), 6.67-6.71 (m, 2H), 7.03 (d, J =  6.8 Hz, 1H), 7.14-7.25 (m, 3H); 13C NMR (CDC13, 
100 MHz) 5 (ppm): 21.9, 25.5, 54.8, 56.2, 115.1, 115.3, 123.4, 127.1, 128.1, 128.9,
138.6, 141.9, 145.8, 152.4; HRMS for C 16H20NO [M+H]+: m/z calcd 242.1545, found 
242.1545; Elemental analysis calcd (%) for C16H 19NO: C, 79.63; H, 7.94; N, 5.80; 
Found: C, 80.01; H, 8.02; N, 5.74; HPLC (Chiralcel OD-H, hexane:isopropanol = 
98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 21.6 min (minor), tR = 25.3 min (major).
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7V-[l-(4-Isobutylphenyl)ethyl]-4-methoxyaniline (2d)
2d (133 mg, 94% yield, 98% ee) was obtained according to the general procedure from 
the imine Id (141 mg, 0.5 mmol) in 15 h; 'H NMR (CDC13, 400 MHz) 5 (ppm): 0.88 
(d, J =  6.6 Hz, 6H), 1.47 (d, J =  6.7 Hz, 3H), 1.80-1.87 (m, 1H ), 2.43 (d, J =  7.2 Hz, 
2H), 3.68 (s, 3H), 4.38 (q, J =  6.7 Hz, 1H), 6.46-6.50 (m, 2H), 6.68-6.71 (m, 2H), 7.08 
(d, J =  8.0 Hz, 2H), 7.25 (d, J =  8.0 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm):
22.9, 25.4, 30.6, 45.5, 54.4, 56.2, 115.0, 115.5, 126.1, 130.0, 140.6, 142.2, 143.1, 152.3; 
HRMS for C,9H26NO [M+H]+: m/z calcd 284.2014, found 284.2021; Elemental 
analysis calcd (%) for Ci9H25NO: C, 80.52; H, 8.89; N, 4.94; Found: C, 80.44; H, 9.00; 
N, 4.90; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X, 
= 254 nm): tR = 16.7 min (minor), tR = 19.2 min (major).
7V-[l-(4-Bromophenyl)ethyl]-4-methoxyaniline (2e)22
2e (141 mg, 93% yield, 97% ee) was obtained according to the general procedure from 
the imine le  (152 mg, 0.5 mmol) in 15 h; 'H NMR (CDC13, 400 MHz) 8 (ppm): 1.44 
(d, J  = 6.7 Hz, 3H), 3.67 (s, 3H), 4.34 (q, J  = 6.7 Hz, 1H), 6.40-6.44 (m, 2H), 
6.66-6.70 (m, 2H), 7.21-7.23 (m, 2H), 7.39-7.43 (m, 2H); 13C NMR (CDC13, 100 MHz) 
5 (ppm): 25.5, 54.3, 56.2, 115.0, 115.3, 120.9, 128.2, 132.1, 141.6, 145.1, 152.5;
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HRMS for Ci5Hi7BrNO [M+H]+: m/z calcd 306.0494, found 306.0482; Elemental
analysis calcd (%) for CisHieBrNO: C, 58.84; H, 5.27; N, 4.57; Found: C, 58.90; H,
5.30; N, 4.55; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1 mL/min,
A = 254 nm): tR = 16.0 min (minor), tR = 19.9 min (major).
OMe
a
jV-[l-(4-Chlorophenyl)ethyl]-4-methoxyaniline (2f)4d’21’23
2f (122 mg, 94% yield, 96% ee) was obtained according to the general procedure from 
the ¡mine If (130 mg, 0.5 mmol) in 15 h; ’H NMR (CDCI3, 400 MHz) 5 (ppm): 1.45 (d, 
J =  6.7 Hz, 3H), 3.68 (s, 3H), 4.36 (q, ./ = 6.7 Hz, 1H), 6.41-6.45 (m, 2H), 6.67-6.69 
(m, 2H), 7.22-7.30 (m, 4H); 13C NMR (CDCI3, 100 MHz) 6 (ppm): 25.6, 54.2, 56.2,
115.1, 115.2, 127.8, 129.2, 132.8, 141.6, 144.5, 152.5; HRMS for C i5H 17C1NO 
[M+H]+: m/z calcd 262.0999, found 262.0998; Elemental analysis calcd (%) for 
C i5H 16C1NO: C, 68.83; H, 6.16; N, 5.35; Found: C, 69.30; H, 6.35; N, 5.73; HPLC 
(Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, A = 254 nm): tR 
= 31.6 min (minor), tR = 38.3 min (major).
4-Methoxy-/V-[l-(4-methoxyphenyl)ethyI]aniline (2g)4b,d’23,24
2g (119 mg, 93% yield, 97% ee) was obtained according to the general procedure from
the imine lg  (128 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.44
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(d, J  = 6.7 Hz, 3H), 3.65 (s, 3H), 3.73 (s, 3H), 4.34 (q, J =  6.7 Hz, 1H), 6.44-6.47 (m, 
2H), 6.66-6.69 (m, 2H), 6.82-6.85 (m, 2H), 7.24-7.26 (m, 2H); 13C NMR (CDC13, 100 
MHz) 5 (ppm): 25.6, 54.1, 55.7, 56.2, 114.5, 115.1, 115.2, 127.4, 138.0, 142.2, 152.3, 
158.9; HRMS for C16H20NO2 [M+H]+: m/z calcd 258.1494, found 258.1485; Elemental 
analysis calcd (%) for C 16H 19NO2: C, 74.68; H, 7.44; N, 5.44; Found: C, 74.74; H, 
7.47; N, 5.45; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 
mL/min, X = 254 nm): tR = 30.0 min (minor), tR = 34.9 min (major).
7V-[l-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyaniline (2h)4c
2h (132 mg, 92% yield, 97% ee) was obtained according to the general procedure from 
the imine lh (143 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.48 
(d, J =  6.6 Hz, 3H), 3.70 (s, 3H), 3.85 (s, 3H), 3.87 (s, 3H), 4.34 (q, J =  6.6 Hz, 1H), 
6.47-6.50 (m, 2H), 6.68-6.72 (m, 2H), 6.80-6.82 (m, 1H), 6.89-6.92 (m, 2H); ,3C NMR 
(CDCI3, 100 MHz) 5 (ppm): 25.6, 54.6, 56.1, 56.2, 56.3, 109.5, 111.6, 115.0, 115.1,
118.2, 138.6, 142.1, 148.2, 149.5, 152.4; HRMS for C 17H22NO3 [M+H]+: m/z calcd 
288.1600, found 288.1606; Elemental analysis calcd (%) for C17H21NO3: C, 71.06; H, 
7.37; N, 4.87; Found: C, 71.05; H, 7.40; N, 4.85; HPLC (Chiralcel OD-H, 
hexane:isopropanol:diethylamine = 90:10:0.1, flow rate 0.5 mL/min, X = 254 nm): tR 
= 25.3 min (minor), tR = 29.0 min (major).
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NC
2i (118 mg, 94% yield, 93% ee) was obtained according to the general procedure from 
the imine l i  (125 mg, 0.5 mmol) in 20 h; !H NMR (CDCI3, 400 MHz) 5 (ppm): 1.47 (d, 
J =  6.8 Hz, 3H), 3.67 (s, 3H), 3.86 (brs, 1H), 4.43 (q, J =  6.7 Hz, 1H), 6.38-6.41 (m, 
2H), 6.67-6.70 (m, 2H), 7.45-7.48 (m, 2H), 7.56-7.58 (m, 2H); 13C NMR (CDCI3, 100 
MHz) 6 (ppm): 25.4, 54.6, 56.1, 111.0, 114.9, 115.3, 119.5, 127.2, 133.0, 141.3, 151.9, 
152.6; HRMS for C 16H 17N2O [M+H]+: m/z calcd 253.1341, found 253.1347; Elemental 
analysis calcd (%) for C 16H 16N2O: C, 76.16; H, 6.39; N, 11.10; Found: C, 76.60; H, 
6.60; N, 10.88; HPLC (Chiralcel OD-H, hexane:isopropanol: diethylamine = 
90:10:0.1, flow rate 1 mL/min, X = 254 nm): tR = 18.4 min (minor), tR = 21.8 min 
(major).
4-Methoxy-Ar-[l-(4-nitrophenyl)ethyl]aniline (2j)4c,d
2j (126 mg, 93% yield, 92% ee) was obtained according to the general procedure from 
the imine lj (135 mg, 0.5 mmol) in 20 h; 'H NMR (CDCI3, 400 MHz) 8 (ppm): 1.51 (d, 
J =  6.8 Hz, 3H), 3.68 (s, 3H), 3.87 (brs, 1H), 4.49 (q, J =  6.8 Hz, 1H), 6.39-6.42 (m, 
2H), 6.67-6.70 (m, 2H), 7.52-7.54 (m, 2H), 8.15-8.17 (m, 2H); 13C NMR (CDCI3, 100 
MHz) 5 (ppm): 25.4, 54.4, 56.1, 115.0, 115.3, 124.5, 127.2, 141.2, 147.4, 152.7, 154.0;
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HRMS for C 15H17N2O3 [M+H]+: m/z calcd 273.1239, found 273.1236; Elemental 
analysis calcd (%) for Ci5H 16N20 3 : C, 66.16; H, 5.92; N, 10.29; Found: C, 66.26; H, 
5.97; N, 10.34; HPLC (Chiralcel OD-H, hexanerisopropanol: diethylamine = 90:10:0.1, 
flow rate 1 mL/min, X = 254 nm): tR = 20.4 min (minor), tR = 22.7 min (major).
4-Methoxy-jV-[l-(3-nitrophenyl)ethyl]aniline (2k)
2k (126 mg, 93% yield, 84% ee) was obtained according to the general procedure from 
the imine lk  (135 mg, 0.5 mmol) in 20 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.52 
(d, J =  6.8 Hz, 3H), 3.68 (s, 3H), 3.89 (brs, 1H), 4.50 (q, J =  6.8 Hz, 1H), 6.42-6.45 (m, 
2H), 6.68-6.71 (m, 2H), 7.46 (t, J = 8.0 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 8.05-8.08 (m, 
1H), 8.24 (t, J =  2.0 Hz, 1H); 13C NMR (CDCI3, 100 MHz) 6 (ppm): 25.5, 54.3, 56.1,
115.0, 115.3, 121.4, 122.5, 130.1, 132.7, 141.2, 148.6, 149.1, 152.7; HRMS for 
C 15H 17N2O3 [M+H]+: m/z calcd 273.1239, found 273.1240; Elemental analysis calcd 
(%) for C 15H 16N2O3: C, 66.16; H, 5.92; N, 10.29; Found: C, 65.98; H, 5.95; N, 10.24; 
HPLC (Chiralcel OD-H, hexane:isopropanol:diethylamine = 90:10:0.1, flow rate 1 
mL/min, X 254 nm): tR = 15.2 min (minor), tR 19.0 min (major).
4-Methoxy-7V-[l-(naphthalen-2-yl)ethyI]aniline (21)4b,c133’152
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21 (132 mg, 96% yield, 98% ee) was obtained according to the general procedure from 
the ¡mine 11 (138 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 6 (ppm): 1.56 (d, 
J =  6.7 Hz, 3H), 3.66 (s, 3H), 4.56 (q, J =  6.7 Hz, 1H), 6.49-6.53 (m, 2H), 6.65-6.69 
(m, 2H), 7.40-7.50 (m, 3H), 7.77-7.81 (m, 4H); 13C NMR (CDCI3, 100 MHz) 5 (ppm):
25.5, 55.1, 56.1, 115.2, 115.3, 124.8, 124.9, 125.9, 126.4, 128.1, 128.3, 128.9, 133.2,
134.0, 141.8, 143.3, 152.5; HRMS for C i9H20NO [M+H]+: m/z calcd 278.1545, found 
278.1544; Elemental analysis calcd (%) for C19H 19NO: C, 82.28; H, 6.90; N, 5.05; 
Found: C, 82.23; H, 6.94; N, 4.99; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, 
flow rate 0.5 mL/min, X = 254 nm): tR = 33.8 min (minor), tR = 40.4 min (major).
4-Bromo-Ar-(l-phenylethyl)aniline (2m)25153
2m (127 mg, 93% yield, 94% ee) was obtained according to the general procedure 
from the ¡mine lm  (137 mg, 0.5 mmol)in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm):
1.48 (d, J  = 6.8 Hz, 3H), 4.05 (brs, 1H), 4.40 (q, J =  6.8 Hz, 1H), 6.34-6.37 (m, 2H), 
7.12-7.15 (m, 2H), 7.20-7.23 (m, 1H), 7.29-7.32 (m, 4H); 13C NMR (CDC13, 100 MHz) 
8 (ppm): 25.4, 53.9, 109.3, 115.4, 126.2, 127.5, 129.2, 132.2, 145.1, 146.6; HRMS for 
CnHisBrN [M+H]+: m/z calcd 276.0388, found 276.0389; Elemental analysis calcd (%) 
for Ci4H 14BrN: C, 60.89; H, 5.11; N, 5.07; Found: C, 61.27; H, 5.27; N, 4.96; HPLC 
(Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 nm): tR =
25.6 min (minor), tR = 30.4 min (major).
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iV-(l-Phenylethyl)aniline (2n)
2n (92 mg, 94% yield, 95% ee) was obtained according to the general procedure from 
the imine In (98 mg, 0.5 mmol) in 15 h; 'HNM R (CDCI3, 400 MHz) 5 (ppm): 1.51 (d, 
J =  6.8 Hz, 3H), 4.02 (brs, 1H), 4.48 (q, J =  6.8 Hz, 1H), 6.49-6.52 (m, 2H), 6.62-6.66 
(m, 1H), 7.06-7.11 (m, 2H), 7.20-7.38 (m, 5H); 13C NMR (CDC13, 100 MHz) 6 (ppm):
25.5, 53.9, 113.7, 117.6, 126.3, 127.3, 129.1, 129.5, 145.7, 147.7; HRMS for
C 14H 16N [M+H]+: m/z calcd 198.1283, found 198.1282; Elemental analysis calcd (%) 
for C 14H 15N: C, 85.24; H, 7.66; N, 7.10; Found: C, 85.38; H, 7.71; N, 7.05; HPLC 
(Chiralcel OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 
X = 254 nm): tR = 12.7 min (major), tR 15.2 min (minor).
MeO
iV-[l-(4-Methoxyphenyl)ethyl]aniline (2o)2c
2o (105 mg, 93% yield, 97% ee) was obtained according to the general procedure from 
the imine lo  (113 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.48 
(d, J =  6.6 Hz, 3H), 3.77 (s, 3H), 3.98 (brs, 1H), 4.44 (q, J  = 6.6 Hz, 1H), 6.49 (d, J  =
8.0 Hz, 2H), 6.63 (t, J=  8.0 Hz, 1H), 6.85 (d, J=  8.0 Hz, 2H), 7.09 (t, J = 8.0 Hz, 1H), 
7.27 (d, J =  8.0 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 25.4, 53.3, 55.7, 113.7,
114.4, 117.6, 127.3, 129.5, 137.7, 147.8, 158.9; HRMS for Ci5H 18NO [M+H]+: m/z 
calcd 228.1388, found 228.1380; Elemental analysis calcd (%) for C15H 17NO: C, 79.26;
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H, 7.54; N, 6.16; Found: C, 78.90; H, 7.59; N, 5.99; HPLC (Chiralcel OD-H,
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 nm): ír = 26.8 min (major), 
tR = 30.2 min (minor).
2p (116 mg, 94% yield, 95% ee) was obtained according to the general procedure from 
the ¡mine lp  (123 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 8 (ppm): 1.54 
(d, J  = 6.7 Hz, 3H), 4.05 (brs, 1H), 4.60 (q, J  = 6.7 Hz, 1H), 6.52-6.66 (m, 3H), 
7.04-7.08 (m, 2H), 7.38-7.48 (m, 3H), 7.75-7.79 (m, 4H); 13C NMR (CDCI3, 100 MHz) 
5 (ppm): 25.5, 54.2, 113.9, 117.8, 124.8, 124.9, 126.0, 126.5, 128.2, 128.3, 129.0,
129.6, 133.3, 134.1, 143.3, 147.8; HRMS for C i8H i8N [M+H]+: m/z caled 248.1439, 
found 248.1439; Elemental analysis caled (%) for CisH^N: C, 87.41; H, 6.93; N, 5.66; 
Found: C, 87.60; H, 6.95; N, 5.58; HPLC (Chiralcel OD-H, hexane:isopropanol: 
diethylamine = 90:10:0.1, flow rate 0.5 mL/min, X = 254 nm): tR = 16.5 min (major), tR 
= 18.7 min (minor).
4-Methoxy-7V-(l-phenylpropyl)aniline (2q)28
2q (110 mg, 92% yield, 90% ee) was obtained according to the general procedure from 
the imine lq  (120 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 8 (ppm): 0.93 (t, 
J =  7.6 Hz, 3H), 1.77-1.82 (m, 2H), 3.66 (s, 3H), 4.14 (t, J = 6.7 Hz, 1H), 6.45-6.47 (m,
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2H), 6.66-6.68 (m, 2H), 7.18-7.23 (m, 1H), 7.27-7.33 (m, 4H); 13C NMR (CDC13, 100 
MHz) 8 (ppm): 11.3, 32.1, 56.2, 61.0, 115.0, 115.2, 127.0, 127.3, 129.0, 142.2, 144.6, 
152.3; HRMS for Ci6H20NO [M+H]+: m/z calcd 242.1545, found 242.1544; Elemental 
analysis calcd (%) for Ci6H i9NO: C, 79.63; H, 7.94; N, 5.80; Found: C, 79.49; H, 7.97; 
N, 5.78; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, A. 
= 254 nm): tR = 18.0 min (minor), tR = 19.8 min (major).
4-Methoxy-/V-(l-p-tolylpropyl)aniline (2r)
2r (118 mg, 93% yield, 91% ee) was obtained according to the general procedure from 
the ¡mine lr  (127 mg, 0.5 mmol) in 15 h; 'H NMR (CDC13, 400 MHz) 5 (ppm): 0.93 (t, 
J  = 7.4 Hz, 3H), 1.75-1.81 (m, 2H), 2.31 (s, 3H), 3.68 (s, 3H), 4.11 (t, J =  6.7 Hz, 
1H), 6.45-6.48 (m, 2H), 6.66-6.69 (m, 2H), 7.11 (d, J =  8.0 Hz, 2H), 7.21 (d, J =  8.0 
Hz, 2H); 13C NMR (CDCI3, 100 MHz) 8 (ppm): 11.3, 21.5, 32.1, 56.2, 60.7, 114.8,
115.2, 126.9, 129.6, 136.7, 141.5, 142.3, 152.2; HRMS for C i7H22NO [M+H]+: m/z 
calcd 256.1701, found 256.1702; Elemental analysis calcd (%) for Ci7H2iNO: C, 79.96; 
H, 8.29; N, 5.49; Found: C, 79.93; H, 8.35; N, 5.44; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 14.8 min (minor), 
tR = 16.4 min (major).
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7V-[CyclopropyI(phenyl)methyl]-4-methoxyaniline (2s)
2s (116 mg, 92% yield, 97% ee) was obtained according to the general procedure from 
the imine Is (126 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 
0.27-0.52 (m, 4H), 1.05-1.09 (m, 1H), 3.47 (d, J  = 8.4 Hz, 1H), 3.57 (s, 3H), 4.02 
(brs, 1H), 6.32-6.56 (m, 2H), 6.56-6.59 (m, 2H), 7.11-7.16 (m, 1H), 7.20-7.24 (m, 2H), 
7.29-7.32 (m, 2H); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 3.9, 4.7, 20.3, 56.2, 64.3,
115.1, 115.2, 127.0, 127.5, 129.0, 142.4, 144.1, 152.4; HRMS for C i7H20NO [M+H]+: 
m/z caled 254.1545, found 254.1543; Elemental analysis caled (%) for C17H 19NO: C, 
80.60; H, 7.56; N, 5.53; Found: C, 80.55; H, 7.60; N, 5.48; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X, = 254 nm): tR = 19.6 min (minor), 
tR = 23.7 min (major).
./V-(Hex-5-en-2-yl)-4-methoxyaniline (2t)4d
2t (90 mg, 88% yield, 95% ee) was obtained according to the general procedure from 
the imine It (102 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 1.15 (d, 
J  -  6.3 Hz, 3H), 1.45-1.54 (m, 1H), 1.61-1.70 (m, 1H), 2.13-2.19 (m, 2H), 3.10 (brs, 
1H), 3.40 (q, J =  6.3 Hz, 1H), 3.74 (s, 3H), 4.95-5.05 (m, 2H), 5.79-5.86 (m, 1H), 
6.54-6.57 (m, 2H), 6.76-6.78 (m, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm): 21.2,
30.9, 36.7, 49.4, 56.2, 115.1, 115.2, 115.4, 138.9, 142.3, 152.3; HRMS for C,3H2oNO 
[M+H]+: m/z ealed 206.1545, found 206.1547; Elemental analysis ealed (%) for 
C 13H 19NO: C, 76.06; H, 9.33; N, 6.82; Found: C, 76.50; H, 9.64; N, 7.02; HPLC
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(Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 254 nm): tR = 
13.4 min (major), tR = 15.8 min (minor).
o c h 3
4-Methoxy-/V-(4-methylpentan-2-yl)aniline (2u)
2u (93 mg, 90% yield, 92% ee) was obtained according to the general procedure from 
the imine lu (103 mg, 0.5 mmol) in 15 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 0.90 
(d, J  = 6.4 Hz, 3H), 0.93 (d, J =  6.4 Hz, 3H), 1.13 (d, J =  6.4 Hz, 3H), 1.19-1.26 (m, 
1H), 1.42-1.49 (m, 1H), 1.73-1.77 (m, 1H), 3.09 (brs, 1H), 3.39-3.47 (m, 1H), 3.74 (s,
3H), 6.54-6.57 (m, 2H), 6.76-6.78 (m, 2H); 13C NMR (CDC13, 100 MHz) 5 (ppm):
21.5, 23.0, 23.4, 25.5, 47.4, 47.9, 56.3, 115.0, 115.4, 142.4, 152.2; HRMS for 
C 13H22NO [M+H]+: m/z calcd 208.1701, found 208.1706; Elemental analysis calcd (%) 
for C13H21NO: C, 75.32; H, 10.21; N, 6.76; Found: C, 75.59; H, 10.42; N, 6.55; HPLC 
(Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 254 nm): tR =
7.0 min (minor), tR = 7.5 min (major).
7V-(Heptan-2-yl)-4-methoxyaniline (2v)
2v (100 mg, 91% yield, 94% ee) was obtained according to the general procedure from 
the imine lv  (110 mg, 0.5 mmol) in 15 h; *H NMR (CDCI3, 400 MHz) 5 (ppm): 0.89 (t, 
J =  6.8 Hz, 3H), 1.14 (d, J =  6.3 Hz, 3H), 1.24-1.32 (m, 4H), 1.34-1.43 (m, 3H), 
1.50-1.59 (m, 1H), 3.12 (brs, 1H), 3.32-3.39 (m, 1H), 3.74 (s, 3H), 6.53-6.57 (m, 2H),
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6.75-6.79 (m, 2H); 13C NMR (CDCI3, 100 MHz) 5 (ppm): 14.5, 21.2, 23.1, 26.3, 32.3,
37.6, 49.9, 56.2, 115.1, 115.4, 142.4, 152.2; HRMS for C 14H24NO [M+H]+: m/z calcd 
222.1858, found 222.1854; Elemental analysis calcd (%) for C i4H23NO: C, 75.97; H, 
10.47; N, 6.33; Found: C, 76.38; H, 10.71; N, 6.28; HPLC (Chiralcel OB-H, 
hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 254 nm): tR = 9.3 min (major), 
tR = 10.6 min (minor).
s A
7V-.sec-butyl-(4-methoxyphenyI)amine (2w)
2w (79 mg, 88% yield, 91% ee) was obtained according to the general procedure from 
the ¡mine lw  (110 mg, 0.5 mmol) in 15 h; *H NMR (CDCI3, 400 MHz) 5 (ppm): 
0.93(dd, 3H, J=  7.5, 7.5 Hz), 1.13 (d, 3H, J =  6.0 Hz), 1.35-1.68 (m, 2H), 3.30 (sextet, 
1H, J =  6.4 Hz), 3.72 (s, 3H), 6.55-6.58 (m, 2H), 6.76-6.79 (m, 2H); 13C NMR (CDCI3, 
100 MHz) 5 (ppm): 10.40, 20.27, 29.64, 50.80, 55.80, 114.70, 114.94, 141.99, 151.78; 
HRMS for CiiH,8NO [M+H]+: m/z calcd 180.1388, found 180.1384.; Elemental 
analysis calcd (%) for CnHnNO: C, 73.70; H, 9.56; N, 7.81; Found: C, 73.73; H, 9.58; 
N, 7.84; HPLC (Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X 
= 254 nm): tR = 7.4 min (minor), tR = 8.7 min (major).
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Chapter 4. Metal-Brensted Acid Cooperative Catalysis for 
Asymmetric Reductive Amination
1 Introduction
Chiral amines are one of the ubiquitous functional groups in fine chemical, 
agrochemical and pharmaceutical products.1 They can be accessed by asymmetric 
hydrogenation of ¡mines.1,2 A shortfall of this powerful method is the need for isolated 
¡mines as substrates, which are not always easy to synthesize due to their limited 
stability. The most convenient, economical, and eco-benign synthetic pathway to chiral 
amines is direct asymmetric reductive amination (DARA) of prochiral ketones in a 
one-pot fashion.18,3 It is surprising, however, that “few laboratory methods are known 
for enantioselective reductive amination”4 and DARA remains a key green chemistry 
research area.5 As described in Section 1.3, there are thus far only a few efficient 
homogeneous metal catalysts reported for DARA, displaying varying 
enantioselectivities for a limited range of ketones and amines.6 A major progress has 
recently been made with organocatalysts by the groups of List, MacMillan and Antilla, 
who showed that DARA with Hantzsch esters can be catalyzed by chiral phosphoric 
acids, which activate the imines via protonation and induce chirality via ion pairing 
between the resulting phosphate anion and iminium cation.4,7
Inspired by the work on organocatalysis and our work in Chapter 3 on imine 
asymmetric hydrogenation,8 we have carried out studies, which show that efficient 
DARA of ketones can be effected by cooperative catalysis of a metal catalyst and a 
chiral Brpnsted acid, with the former reducing an in-situ generated iminium cation via
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ionic hydrogenation,9 while the latter aiding enantioselective hydride transfer via 
ion-pairing of its conjugate base X' with the iminium ion (Scheme 4-1).10 A further 
extension of DARA into keto esters has also been explored, but not very successful. 
One example of a P-amino ester was obtained in 80% ee and 99% conversion.
Scheme 4-1. Proposed cooperative catalysis for asymmetric reductive amination.
2 Results and Discussion
2.1 Reductive Amination of Ketones
Ar = 2,4,6-(2-C3H7)3C6H2 
a: X = Cl; b: X = 7-H 
c: Ar = 4-CH3C6H4, X = 7-H 
d:Ar=2,3,4,5,6-(CH3)5C6tX
Ph
Me
0 = S = 0
'rS lr i«
Ph N 
H
(S,S)-6 
X = 7-H
7-H
Ar = 2,4,6-(2-C3H7)3C6H2
In  Chapters 2 and 3, we have shown that the half-sandwich Cp*M(III)-diamine 
(M = Rh, Ir) catalysts enables highly enantioselective hydrogenation of cyclic and
Q  11
acyclic imines. ’ In particular, the complex 5b, which bears a chiral phosphate
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counteranion derived from the phosphoric acid R-7,12 showed superior performance in 
the hydrogenation of acyclic imines, key intermediates in DARA.8b With these results 
in hand, we set out to examine the feasibility of 5 in DARA of a model ketone, 
acetophenone 1, with p-anisidine 2 in toluene. As can be seen from Table 4-1, no 
reduction was observed when using 5a or its SbFe’ derivative at 5 bar H2 and 35 °C 
(entries 1 and 2). Switching to the phosphate catalyst 5b, a 5% conversion of 2 into the 
chiral amine 3 was observed (entry 3). However, under the same conditions but with 
no ketone present, the reduction of ketimines was much faster, affording a 94% 
conversion and 97% ee when using the ketimine isolated from the condensation of 1 
with 2.
Speculating that formation of the ketimine might be rate-limiting in the DARA13 
and a Brpnsted acid might assist both this step and the subsequent hydrogenation9 
(Scheme 4-1), we examined the effect of 7 on the DARA. Delightfully, introduction of 
increasing quantities of 7 into the reaction indeed afforded a higher conversion, a 
higher ratio of 3/4 and a higher ee (entries 3-8). Thus, when 10% of 7 was added, an 
81% conversion, 4/1 of 3/4 and an excellent ee of 97% were recorded (entry 8). 
Further studies revealed that the DARA went still faster in the presence of 4 A 
molecular sieves (4 A MS) (entries 2-8 vs 9-19). The combination of 5a and 2% of 
AgSbFe also led to higher conversion of 5% in the presence of 4 A MS (entry 2 vs 9). 
The molecular sieves are expected to facilitate the ketimine formation; however, they 
were less effective when added alone (entry 10). Introduction of additional amounts of 
7 led to an enhanced conversion and ratio of 3/4 when the quantity of 7 was less than
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5%; but only a slightly improved conversion was observed when the quantity of 7 was 
increased from 5% to 15% (entries 10-16). Thus, a 92% conversion, 10/1 of 3/4 and 
97% ee were obtained when catalyst 5b, 5% of 7 and 200 mg 4 A MS were combined 
to effect the reaction. Further increase in the quantity of 4 A MS does not appear to 
have any significant effect (entries 16-19). Furthermore, a lower pressure of 1 bar 
hydrogen led to 99/1 of 3/4 and 97% ee, but only 30% conversion (entry 20). 
Increasing the pressure to 10 bar or 20 bar, the reduction afforded 92% conversion 
(97% ee, 6/1 of 3/4) and 90% conversion (97% ee, 5/1 of 3/4), respectively (entries 21 
and 22).
Following the optimization, the quantity of 1 also was examined for the DARA. 
The conversions were increased from 87% to 99% but the ratios of 3/4 were decreased 
form 16/1 to 3/1, when the quantities of 1 increased from 0.5 mmol to 1.5 mmol 
(enties 13 and 23-25). Still further, changing the reaction temperature from 35 °C to 20 
°C, the reduction led to a higher enantioselectivity of 98% ee but a lower conversion of 
35%. Conversely, when the temperature was set at 50 °C, the conversion was higher 
(95%) but the ee was lower (84%). On the other hand, the reduction afforded a near 
full conversion at a 5% loading of 7 in a longer time of 15 h at 35 °C (entry 28).
Table 4-1. Optimization of Conditions for the DARA of 1"
N H
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entry catalyst
Pm
(bar)
additive
conv.
(%)*
3/4c
ee
(%)"
1 5a 5 none NR - -
2 5a 5 AgSbF6(2%) NR - -
3 5b 5 None 5 1/3 -
4 5b 5 7 (1%) 10 1/2 86
5 5b 5 7 (3%) 44 3/1 92
6 5b 5 7 (5%) 62 3/1 97
7 5b 5 7 (8%) 75 3/1 97
8 5b 5 7 (10%) 81 4/1 97
9 5a 5 4Â Ms (200 mg) + AgSbF6 (2%) 5 1/1 -
10 5b 5 4Â Ms (200 mg) 10 1/2 90
11 5b 5 7 (1%), 4Â MS (200 mg) 58 3/1 97
12 5b 5 7 (3%), 4Â MS (200 mg) 82 6/1 97
13 5b 5 7 (5%), 4Â MS (200 mg) 92 10/1 97
14 5b 5 7 (8%), 4Â MS (200 mg) 94 10/1 97
15 5b 5 7 (10%), 4Á MS (200 mg) 94 10/1 97
16 5b 5 7(15%), 4Â MS (200 mg) 94 10/1 97
17 5b 5 7 (5%), 4Â MS (100 mg) 86 9/1 97
18 5b 5 7 (5%), 4Â MS (400 mg) 93 10/1 97
19 5b 5 7 (5%), 4À MS (800 mg) 92 10/1 97
20 5b 1 7 (5%), 4Â MS (200 mg) 30 99/1 97
21 5b 10 7 (5%), 4Á MS (200 mg) 92 6/1 97
22 5b 20 7 (5%), 4À MS (200 mg) 90 5/1 97
23 e 5b 5 7 (5%), 4Â MS (200 mg) 87 16/1 97
24 7 5b 5 7 (5%), 4Â MS (200 mg) 94 5/1 97
25* 5b 5 7 (5%), 4Â MS (200 mg) 99 3/1 97
26 h 5b 5 7 (5%), 4Â MS (200 mg) 95 5/1 84
27 '' 5b 5 7 (5%), 4Â MS (200 mg) 35 6/1 98
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287 5b 5 7 (5%), 4Â MS (200 mg) >99 10/1 97
a Conditions: 0.6 mmol of 1, 0.5 mmol of 2, 1 mol% of 5, 2 mL of toluene, 35 °C, 12 h. b 
Conversion of 2, determined by ’H NMR analysis of crude product.c Molar ratio of 3/4. d 5-3, 
determined by HPLC; configuration assigned by comparison with the literature [see the 
experiment section]/ 0.5 mmol of l / 1.0 mmol of 1. s 1.5 mmol of 1. h 50 °C.' 20 °C. j 15 h.
The effect of 7 on both the DARA rate and enantioselectivity is herein graphically 
illustrated in Figure 4-1, demonstrating that the DARA is co-catalyzed by the 
hydrogen-activating 5b and the Bronsted acid 7. The curve denoting conversion show 
that 7 enhance the rate of reductive amination, but its effect becomes insignificant 
when more than 5% is added. Note various amounts of alcohol 4 were also produced 
and importantly, its formation can be significantly suppressed by 7 (entries 3 and 4 vs 
4-8 and 10-16).
Figure 4-1. Effect of added 7 (mmol%) on the 5b-catalyzed conversion 
(■) of 2 into and the enantioselectivity (A) of 3 in the DARA of 1 in 
toluene in the presence of 4 Â MS at 35 °C (1 mol% of 5b, 200 mg of 
MS).
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Using the conditions established above, i.e. 1 mol% 5b in the presence of 5 mol% 
7 and molecular sieves, a wide range of para and meta-substituted aromatic ketones 
were readily aminated with 2 under 5 bar H2 at 35 °C (Table 4-2).
182
toluene, 200 mg of 4 Â MS, 5 bar of H2, 35 °C, 15-24 h.A Isolated yields.c Determined by 
HPLC; configuration assigned by comparison with the literature (see the experimental 
section). d0.1 mmol of ketone, 8 mmol% of 7. With 5 mmol% of 7, the ee was ca. 3% lower.
As can be seen, the amines 3 were obtained with excellent yields and ee’s in 
almost all the cases. 4-Methoxy-jY-(l-phenylethyl)aniline was obtained from the 
corresponding acetophenone in 94% yield and 97% ee (entry 1). Replacing the
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acetophenone with 4’-methylacetophenone or 3’-methylacetophenone, the
corresponding enantiomerically enriched amines were obtained in 97% ee (93% yield) 
and 94% ee (93% yield), respectively (entries 2 and 11). Changing to 
isobutylacetophenone, the chiral amine was also obtained in excellent ee (entry 3). 
Notably, the catalyst tolerates functional groups of diverse electronic properties on the 
ketones (-OMe, -Br, -Cl, -CN, -NO2, -CF3, -F); but the enantioselectivities suffered 
with the strongly electron-withdrawing -NO 2 and -CN  groups (<rp = 0.78, 0.70 
respectively) (entries 9, 10 and 15). The results indicate that the enantioselectivity in 
DARA of para or meta- substituted ketones is more sensitive to the electron effect than 
steric effect. Further, enantiomerically enriched amines of 2’-acetonaphthone, 
4-benzodioxan-6-yl methyl ketone, and 3’,4’-dimethoxyacetophenone were also 
obtained in high ee’s (entries 16-18). In comparison with the results of Chapter 3 on 
ketimine hydrogenation using 5b at 20 °C,8b the DARA afforded the amines with 
slightly decreased enantioselectivities, but with the advantage of not isolating 
problematic imines.
We next investigated the DARA of aniline and its electron-deficient analogous. As 
shown in Table 4-3, a range of amines 3 were obtained in good yields and decent ee’s. 
Comparing the results in Tables 4-2 (entry 1) and 4-3, it is clear that electron 
deficiency on the anilines reduces both the DARA yield and enantioselectivity. This is 
reminiscent of the observations above and, to some degree, those in organocatalysis.4,73 
Further, the more strongly electron-withdrawing 4-aminobenzonitrile could not 
aminate acetophenone under the standard conditions (entry 7). In this case, we
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Table 4-3. DARA with other Aniline Derivatives“
entry substrate product yield (%) ee (%)
and 24 h reaction time. ABoth (S,S)-5b and (S ^ -S d  with 1-10 mol% 7 were tested 
for the reductive amination.
speculate that the formation of imine is a rate-limiting step because the weak 
nucleophile 4-aminobenzonitrile would be difficult to couple with acetophenone to 
form the corresponding imine, even in harsh conditions. Replacing with an 
electron-rich benzylamine, however, no reduction was observed either (entry 8). In
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Chapter 3, we showed that catalysts 5 is inefficient for reduction of acetophenone 
iV-benzylimine. This suggests that it is the reduction step that stops the DARA of 
ketones with benzylamine.
We encountered problems when attempting the DARA of sterically more 
demanding ketones. Thus, using 5b as above, the reaction of 2 ’-methylacetophenone 
with 2 led to only a 49% ee. However, much improved enantioselectivities became 
accessible when less bulky metal catalysts were selected. Thus, ee’s of 69%, 85% and 
91% were observed with the catalysts 5d, 5c, and 6, respectively. Table 4-4 
summarizes the results obtained with a series of ketones. Using catalyst 5d, a-methyl 
substituted chiral amines were obtained from propiophenone, 4’-methylpropiophenone 
and 4’-methoxypropiophenone in 91% and 92% ee’s (entries 1-3). With a bulkier a 
position, however, isobutyrophenone showed almost no activity in this amination 
reaction (entry 4); A-[Cyclopropyl(phenyl)methyl]-4-methoxyaniline was obtained in 
97% ee but only 20% yield (entry 6). Further, no reduction was observed in the DARA 
of 2 ’-bromoacetophenone (entry 13). Clearly, by replacing 5b with the analogous 5c, 
5d or 6 while keeping 7, a and ortho substituted ketones can be aminated, affording 
amines in excellent enantioselectivities. We note that few metal catalysts are capable of 
DARA of these substrates. The results highlight one advantage of the current method, 
i.e. the metal and Bronsted acid catalysts can be independently varied to tackle a 
particular set of substrates.
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Table 4-4. DARA of Bulkier Aromatic Ketones with 2a
substrate catal
entry product
yield
ee (%)
(%)
93 92
91 91
91 92
6 -
50 75
35 * 77 *
25° 76c
2 0 97
93 91
92 * 87*
92 c 87c
90 d 81 d
90 87
91d 46
9 2 e 69e
92 91
90 * 85*
92c 49c
92 e 69e
93 8 6
92 d 49 ¿
92 96
92c 9 3  c
91 d 85 d
92 e 94e
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d 5b as catalyst.e 5d as catalyst.
With the success in aromatic ketones, aliphatic ketones were next explored, bearing 
in mind in particular that there appear to be no metal catalysts capable of DARA of 
both aryl and aliphatic ketones. The DARA was shown to be feasible. Due to time 
restriction, however, the work was carried out by Barbara Villa-Marcos of the Xiao 
group. The results are included here simply to show the scope of the catalysis 
established to date. Barbara’s screening established that 5d outperformed 5b in both 
enantioselectivity and conversion, and in the presence of molecular sieves, the effect of 
7 on the DARA was, surprisingly somehow, less significant than in the case of 
aromatic ketones (Table 4-5, entries 4-7 ). Unlike aromatic ketones, aliphatic ketones 
were not reduced under the DARA conditions and so are less likely to compete with 
DARA. This may have partly contributed to the diminished role of 7. However, the 
phosphate counteranion remains critical. Replacing 7-H with SbF6 in 5d only led to a 
42% conversion and 15% ee in the DARA shown in entry 7, Table 4-5, in 17 h. Aiming 
to reduce the chiral acid loading, we chose to use 5d with no extra 7 added. As shown 
in Table 4-5, various aliphatic ketones were aminated with 2 and aniline, furnishing 
good amine yields with enantioselectivities up to 95%. Notably, the catalyst system
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tolerates other reducible groups in the ketone substrates (entries 8-10, 15, 16). The 
easy access to these chiral amines via DARA is particularly pleasing, as the 
corresponding ketimines are prone to decomposition and so are difficult to isolate.
Table 4-5. DARA of Aliphatic Ketones a
Entry substrate product yield (%) ee (%)b
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15 91 92
16 
17
18 .oJL
a Conditions: 0.55 mmol of ketone, 0.5 mmol of 2, 1 mol% of 5d, 2 mL of toluene, 150 
mg of 4 A MS, 5 bar of H2, 35 °C, 12-20 h. b Determined by HPLC; configuration 
assigned by comparison with the literature (see the experimental section). c 5 h. d 
Conversion of 2, determined by 'H NMR analysis of the crude product. e 5 h, 5 mol% of 
7. { 5 h, 8 mol% of 7. g 5b as catalyst.
2.2 Reductive Amination of Keto Esters
To further explore the potential of the metal-Bronsted acid cooperative catalysis, 
DARA of a-keto esters and P-keto esters was examined. The screening results are seen 
in Table 4-6.
91 91
95 91
88
88
18
49 (55)'*
Table 4-6. DARA of Keto Esters with 2 a
5 bar H2 f ^ X ^ O M e
HN - \ J  +
^ ^ V fC O O R 2 
R n
OH O
[lr] (1%) '  
toluene 
35 °C, 12 h
r 1^ ^ O R 2
9 10
a a 0CHs^ ^ O C H 3 C' ^ j^ / ^ o c 2h 5
8c 8d 8e
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entry substrate catalyst additive
conv.
( % f
9/10 c
ee
(%)d
1 8a 5b none NR - -
2 8a 5b 7(1%) NR - -
3 8a 5b 7 (5%) 2 1/15 -
4 8a 5b 7 (8%) 5 1/6 -
5 8a 5b 7 (10%) 5 1/6 -
6 e 8a 5b 7 (8%) 5 1/9 -
1 f 8a 5b 7 (8%) 5 1/8 -
8 8a 5c 7 (8%) 6 1/6 -
9 8a 5d 7 (8%) 6 1/6 -
10 8a 6 7 (8%) 6 1/6 -
11 8b 5d 7 (8%) 10 1/2 -
12 8c 5b 7 (8%) 70 10/1 65
13 8c 5d 7 (8%) 99 15/1 80
14 8d 5b 7 (8%) 6 1/3 -
15 8(1 5c 7 (8%) 7 1/3 -
16 8d 5d 7 (8%) 9 1/2 -
17 8d 6 7 (8%) 8 1/2 -
18 8e 5b 7 (8%) 3 9/1 -
19 8e 5c 7 (8%) 5 5/1 -
20 8e 5d 7 (8%) 5 5/1 -
21 8e 6 7 (8%) 5 4/1 -
22  e 8e 5d 7 (8%) 5 7/1 -
23 f 8e 5d 7 (8%) 5 6/1 -
“Conditions: 0.6 mmol o f 8, 0.5 mmol o f 2, 1 mol% of 5, 2 mL o f toluene, 35 °C, 24 h.* 
Conversion of 2, determined by ‘H NMR analysis o f crude product.e Molar ratio of 9/10. 
d Determined by HPLC analysis with a chiralpak OD-H column.e 50 °C. ^20 bar H2.
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No reduction was observed when using 5b at 5 bar H2 and 35 °C (entry 1). 
Introduction of the acid 7, 2-5% of a-amino ester 9a was observed and various 
amounts of a-imino ester and a-hydroxy ester 10a were also produced during the 
reduction (entries 2-5). A higher temperature of 50 °C or a higher hydrogen pressure of 
20 bar did not help either (entries 6 and 7). Changing the catalyst 5b to 5c, 5d or 6, the 
reduction only led to a 6% conversion and 10a was produced as well (entries 8-10 ). 
Further, DARA of methyl pyruvate 8b afforded 10% conversion with 9/10 =1/2 (entry 
11). To our delight, a 70% conversion (65% ee) was obtained by using the catalyst 5b 
in the DARA of methyl acetoacetate 8c (entry 12); and still better results were 
observed when using 5d (entry 13). However, the catalysts 5b, 5c, 5d and 6 were 
shown to be inefficient for the DARA of methyl 3-oxovalerate 8d and ethyl 
benzoylacetate 8e, even at a higher temperature of 50 °C or a higher hydrogen pressure 
of 20 bar (entries 14-23). In the DARA of 8d and 8e, [3-amino esters (3-9%) and 
P-hydroxy esters were recorded; emamine esters were also observed during the 
reduction.
Although the catalysts 5 and acid 7 have demonstrated excellent enantioselectivity 
and good activity for DARA of a range of ketones, only one keto ester has been 
successfully aminated. In the DARA of a-keto esters, the intermediate a-imino ester 
has a bulky planar structure, with conjugating C=N and C=0 double bonds. We 
speculate that the C=N bond reduction is rate-limiting for the DARA of a-keto ester 
because the intermediate a-imino ester was observed after the reduction. For the P-keto
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ester, the reason for no reaction is probably again the reduction step, because a large
amount of enamine ester was isolated after the reduction (Scheme 4-2).
Scheme 4-2. Intermediates in DARA of a-keto ester and (3-keto with p-anisidine.
3. Conclusion
In conclusion, we have developed a new catalytic system for DARA of ketones and 
investigated the catalytic system for DARA of keto esters. Hinging on the cooperative 
catalysis of a hydrogen-activating metal cation and a Bronsted acid, this mild and 
operationally easy amination has been successfully demonstrated with a wide spectrum 
of ketones. Remarkable features of the catalytic system include: a) clean, economic H2 
as a reductant, b) wide substrate scope with high yield and enantioselectivity, and c) 
independent tunability of catalyst components to meet substrates of diverse properties. 
Further mechanistic studies and extension into other carbonyl compounds are 
underway in the Xiao group
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4. Experimental Section 
General Information
Unless otherwise specified, the chemicals were obtained commercially and used 
without further purification. Toluene was dried over sodium and distilled prior to use. 4 
A Molecular sieves (MS) were dried in an oven at 160 °C for a minimum of 24 h. 'H 
NMR and 13C NMR spectra were recorded on a DRX-400 spectrometer at 400 ('H) 
and 100 MHz (13C) in ppm with TMS as the internal standard in CDCI3. The mass 
spectra were obtained by chemical ionization (Cl). HPLC analysis was performed on a 
Gilson UV/VIS-151 equipped with an OD-H, OB-H or OJ column purchased from 
Daicel Chemical Industries. Chromatographic purification was performed on silica gel 
(mesh 300-400) by the flash techinique. All the products were satisfactorily 
characterized by H and C NMR, HRMS and elemental analysis. When possible, 
comparison of their NMR spectra has been made with available literature data. 
Compound 7 was prepared following the procedure in Chapter 3. The configuration of 
the products in Table 4-2 (entries l ,6d’15'17 4 4-15 g 15 ¡g4-15) and Table 4-3 (entries 
I,i5-i9,4,2d 4J 7 5 15.17) was assigned by comparison with the literature, and that of the rest 
was based on analogy with the assignment for other compounds without verification.
Procedure for the preparation of complexes (S ,S ) -5 c  and (S ,S )-6  
The catalysts 5a-d and 6 were synthesized according to the procedure in the 
Experimental section of Chapter 3 by reacting the corresponding 16 e' species with 
phosphoric acid 7. 8a’14
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(S,S)-5c: 'H NMR (CDC13, 400 MHz) 5 (ppm): 0.89 (d, J =  6.8 Hz, 12H), 1.10 (d, J  =
6.8 Hz, 6H), 1.12 (d, J=  6.8 Hz, 6H), 1.16 (d, J=  6.8 Hz, 6H), 1.22 (d, J=  6.8 Hz, 6H), 
1.85 (s, 15H), 2.23 (S, 3H), 2.57-2.61 (m, 3H), 2.64-2.75 (m, 1H), 2.86-2.93 (m, 1H), 
2.97-3.06 (m, 1H), 4.31 (s, 1H), 4.32 (s, 1H), 5.48 (br, 1H), 6.79-7.41 (m, 29H); 13C 
NMR (CDC13, 100 MHz) 8 (ppm):10.3, 21.6, 23.7, 23.8, 24.6, 24.7, 25.5, 26.9, 31.1,
31.2, 34.7, 85.3, 86.0, 120.2, 121.0, 123.1, 124.7, 125.8, 126.7, 127.7, 128.3, 128.5,
130.7, 131.9, 133.2, 133.6, 133.9, 147.7, 147.8, 148.6; 31P NMR (CDCI3, 162 MHz) 8
(ppm): 5.5; MS (ES) for [C3iH36N20 2S193Ir]+: m/z calcd 693.2127; found 693.2115. 
(S,S)-6 : ’H NMR (CDCI3, 400 MHz) 8 (ppm): 0.91 (d, 6.4 Hz, 12H), 1.11 (d, J  =
6.8 Hz, 6H), 1.13 (d, J =  6.8 Hz, 6H), 1.18 (d, J =  6.8 Hz, 6H), 1.24 (d, J=  6.8 Hz, 6H), 
1.94 (s, 15H), 2.30 (s, 3H), 2.53-2.60 (m, 3H), 2.69-2.76 (m, 1H), 2.85-2.90 (m, 1H), 
2.91-2.96 (m, 1H), 4.19 (s, 1H), 4.44 (s, 1H), 5.48 (br, 1H), 6.99-7.86 (m, 24H); 13C 
NMR (CDCI3, 100 MHz) 8 (ppm): 9.9, 10.5, 23.8, 24.5, 24.7, 25.5, 26.9, 31.1, 31.2,
34.7, 41.3 45.8, 85.6 87.8, 120.3 121.0, 123.1, 124.9, 125.8, 126.8, 126.9, 127.3, 127.8,
128.4, 128.6, 130.7, 131.9, 133.2, 133.4, 133.8, 148.0, 148.6; 31P NMR (CDC13, 162 
MHz) 8 (ppm): 6.9; MS (ES) for [C25H32N202S193Ir]+: m/z calcd 617.1814; found 
617.1797.
General procedure for DARA
To a glass liner equipped with a stir bar was added 4 A MS (200 mg), 7 (19 mg, 25 
mol), aromatic ketone (0.6 mmol, unless otherwise specified), amine (0.5 mmol) and 
toluene (2 mL). After stirring for half minute, the catalyst 5b (5 pmol) was introduced.
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The glass liner was then placed into an autoclave, followed by degassing with H2 three 
times. The hydrogenation was carried out at 5 bar H2 with stirring at 35 °C for 15-24 h. 
The hydrogen gas was then carefully released in a fume hood, and the solution was 
filtered, transferred to a flask, and concentrated to afford the crude product. Flash 
chromatography purification with a column of silica gel eluted with petroleum 
ether/ethyl acetate ( 10/1 to 8/ 1) yielded the desired amine product.
Analytical data of products
4-Methoxy-/V-(l-phenylethyl)aniIine (Table 4-2, entry l )2b,4,6d,7a,8a’15'21 
The product (107 mg, 94% yield, 97% ee) was obtained according to the procedure 
from acetophenone (72 mg, 0.6 mmol) and /?-anisidine (62 mg, 0.5 mmol) in 15 h; 
'H NMR (CDCI3, 400 MHz) 5 1.49 (d, J =  6.8 Hz, 3H), 3.68 (s, 3H), 3.78 (brs, 1H), 
4.41 (q, J =  6.8 Hz, 1H ), 6.44-6.49 (m, 2H), 6.67-6.71 (m, 2H), 7.19-7.25 (m, 1H), 
7.29-7.37 (m, 4H); 13C NMR (CDC13, 100 MHz) 5 25.6, 54.7, 56.2, 115.0, 115.2, 126.3,
127.2, 129.0, 142.0, 145.9, 152.3; HRMS for Ci5Hi8NO [M +Hf: m/z Calcd: 228.1388; 
Found: 228.1395; Elemental analysis calcd (%) for C15H 17NO: C, 79.26; H, 7.54; N, 
6.16; Found: C, 79.10; H, 7.68; N, 6.05; HPLC (Chiralcel OD-H, hexane:isopropanol 
= 98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 24.7 min (minor), tR = 28.0 min 
(major).
OMe
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4-Methoxy-7V-(l-p-tolylethyl)aniline (Table 4-2, entry 2)2b’4,6d,7a,8a 
The product (112 mg, 93% yield, 97% ee) was obtained according to the procedure 
from 4’-methylacetophenone (80 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 15 h; 'H NMR (CDCI3, 400 MHz) 5 1.48 (d, J =  6.8 Hz, 3H), 2.32 (s, 3H), 3.69 (s, 
3H ), 4.39 (q, J =  6.8 Hz, 1H), 6.46-6.49 (m, 2H), 6.68-6.71 (m, 2H), 7.12 (d, J =  8.0 
Hz, 2H), 7.25 (d, J =  8.0 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 21.5, 25.5, 54.4,
56.2, 115.0, 115.2, 126.2, 129.7, 136.8, 142.0, 142.9, 152.3; HRMS for C i6H20NO 
[M+H]+: m/z Calcd: 242.1545; Found: 242.1544; Elemental analysis calcd (%) for 
C i6H i9NO: C, 79.63; H, 7.94; N, 5.80; Found: C, 79.50; H, 7.81; N, 5.70; HPLC 
(Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1.0 mL/min, X = 254 nm): tR = 
11.5 min (minor), tR = 13.5 min (major).
OMe
4-Methoxy-Ar-[l-(4-isobutylphenyI)ethyl]aniline (Table 4-2, entry 3)8a 
The product (132 mg, 93% yield, 95% ee) was obtained according to the procedure 
from 4’-isobutylacetophenone (106 mg, 0.6 mmol) andp-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDC13, 400 MHz) 5 0.88 (d, J =  6.4 Hz, 6H), 1.48 (d, J =  6.8 Hz, 
3H), 1.80-1.87 (m, 1H ), 2.43 (d, J=  1 2  Hz, 2H), 3.69 (s, 3H), 4.39 (q, J =  6.8 Hz, 1H), 
6.48-6.51 (m, 2H), 6.68-6.71 (m, 2H), 7.07 (d, J =  8.0 Hz, 2H), 7.25 (d, J =  8.0 Hz, 
2H); 13C NMR (CDC13, 100 MHz) 5 22.9, 25.3, 30.6, 45.5, 54.6, 56.2, 115.2, 126.1,
129.7, 140.7, 141.9, 142.9, 152.4; HRMS for C i9H26NO [M+H]+: m/z Calcd: 284.2014; 
Found: 284.2005; Elemental analysis calcd (%) for Ci9H2sNO: C, 80.52; H, 8.89; N,
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4.94; Found: C, 80.23; H, 9.04; N, 4.84; HPLC (Chiralcel OD-H, hexane:isopropanol
= 98:2, flow rate 1.0 mL/min, X = 254 nm): tR = 9.9 min (minor), tR = 11.4 min 
(major).
4-Methoxy-iV-[l-(4-methoxyphenyl)ethyl]aniline (Table 4-2, entry
^ 2 b ,4 ,6 d ,8 a ,  15 ,16 ,19 ,20
The product (120 mg, 93% yield, 95% ee) was obtained according to the procedure 
from 4’-methoxyacetophenone (90 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; ]H NMR (CDC13, 400 MHz) 5 1.45 (d, J =  6.8 Hz, 3H), 3.68 (s, 3H), 3.76 (s, 
3H), 4.36 (q, J=  6.8 Hz, 1H), 6.45-6.48 (m, 2H), 6.67-6.70 (m, 2H), 6.83-6.86 (m, 2H), 
7.25-7.28 (m, 2H); 13C NMR (CDC13, 100 MHz) 5 25.6, 54.1,55.7, 56.2, 114.4, 115.1,
115.2, 127.4, 138.0, 142.1, 152.3, 158.9; HRMS for Ci6H2oN02 [M+H]+: m/z Calcd: 
258.1494; Found: 258.1485; Elemental analysis calcd (%) for Ci6Hi9N0 2: C, 74.68; H, 
7.44; N, 5.44; Found: C, 74.32; H, 7.68; N, 5.32; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 32.2 min (minor), 
tR = 36.9 min (major).
/V-[l-(4-Bromophenyl)ethyl]-4-methoxyaniline (Table 4-2, entry 5)8a,ls
The product (143 mg, 94% yield, 94% ee) was obtained according to the procedure
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from 4’-bromoacetophenone (120 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'HNMRiCDCIs, 400 MHz) 5 1.45 (d, J = 6.8 Hz, 3H), 3.69 (s, 3H), 4.35 (q, J  
= 6.8 Hz, 1H), 6.41-6.44 (m, 2H), 6.67-6.71 (m, 2H), 7.23-7.25 (m, 2H), 7.41-7.45 (m, 
2H); 13C NMR (CDCb, 100 MHz) 8 25.6, 54.2, 56.1, 115.0, 115.2, 120.8, 128.1, 132.1, 
141.6, 145.1, 152.5; HRMS for Ci5H1779BrNO [M+H]+: m/z Calcd: 306.0494; Found: 
306.0488; Elemental analysis calcd (%) for CisHiöBrNO: C, 58.84; H, 5.27; N, 4.57; 
Found: C, 58.96; H, 5.32; N, 4.43; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, 
flow rate 1 mL/min, X 254 nm): tR = 17.4 min (minor), tR = 21.4 min (major).
O M e
/V-[l-(4-Chlorophenyl)ethyl]-4-methoxyaniline (Table 4-2, entry 6)4,2b,6d,8a’19 
The product (123 mg, 94% yield, 95% ee) was obtained according to the procedure 
from 4’-chloroacetophenone (93 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; *H NMR (CDCI3, 400 MHz) 5 1.43 (d, J=  6.8 Hz, 3H), 3.66 (s, 3H), 4.35 (q, J  
= 6.8 Hz, 1H), 6.41-6.44 (m, 2H), 6.66-6.70 (m, 2H), 7.23-7.28 (m, 4H); 13C NMR 
(CDCI3, 100 MHz) 5 25.6, 54.2, 56.2, 115.1, 115.2, 127.8, 129.2, 132.8, 141.7, 144.6, 
152.5; HRMS for C i5H i735C1NO [M+H]+: m/z Calcd: 262.0999; Found: 262.0993; 
Elemental analysis calcd (%) for C 15H 16CINO: C, 68.83; H, 6.16; N, 5.35; Found: C, 
69.12; H, 6.28; N, 5.14; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 
0.5 mL/min, X = 254 nm): tR = 34.8 min (minor), tR = 42.5 min (major).
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7V-[l-(4-Fluorophenyl)ethyl]-4-methoxyaniline (Table 4-2, entry 7)4,6d,8a 
The product (114 mg, 93% yield, 95% ee) was obtained according to the procedure 
from 4’-fluoroacetophenone (83 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDC13, 400 MHz) 5 1.45 (d, J = 6.8 Hz, 3H), 3.68 (s, 3H), 4.38 (q, J  
= 6.8 Hz, 1H), 6.44 (d, J =  8.4 Hz, 2H), 6.68 (d, J =  8.4 Hz, 2H), 6.98 (t, J =  8.4 Hz, 
2H), 7.31 (dd, J=  7.6, 6.0 Hz, 2H); l3C NMR (CDC13, 100 MHz) 5 25.6, 54.2, 56.1,
115.1, 115.2, 115.8 (d, JCf = 21.4 Hz), 127.8 (d, J Cf = 8.0 Hz), 141.5 (d ,J CF = 2.7 Hz),
141.7, 152.5, 162.2 (d, J Cf =  242.7 Hz); HRMS for C,5H,7FNO [M+H]+: m/z Calcd: 
246.1294; Found: 246.1295; Elemental analysis calcd (%) for C15H 16FNO: C, 73.45; H, 
6.57; N, 5.71; Found: C, 73.67; H, 6.68; N, 5.44; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 1.0 mL/min, X = 254 nm): tR = 16.5 min 
(minor), tR = 20.0 min (major).
O M e
4-Methoxy-7V-{l-[4-(trifluoromethyl)phenyl]ethyl}aniline (Table 4-2, entry
g y  5,18,20
The product (134 mg, 91% yield, 91% ee) was obtained according to the procedure 
from 4’-trifluoroacetophenone (132 mg, 0.7 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 24 h; 'HNM R (CDC13, 400 MHz) 5 1.48 (d, J=  6.8 Hz, 3H), 3.68 (s, 3H), 3.81 (brs,
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1H), 4.44 (q, J =  6.8 Hz, 1H), 6.40-6.44 (m, 2H), 6.67-6.71 (m, 2H), 7.46 (d, J =  8.0 
Hz, 2H), 7.55 (d, J  = 8.0 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 25.5, 54.5, 56.1,
115.0, 115.3, 124.7 (q, J cf = 270.2 Hz), 126.0 (q, J Cf = 3.4 Hz), 126.7, 129.4 (q, J Cf = 
32.4 Hz), 141.6, 150.3, 152.6; HRMS for C,6Hi7F3NO [M+H]+: m/z Calcd: 296.1262; 
Found: 296.1264; Elemental analysis calcd (%) for Ci6Hi6F3NO: C, 65.08; H, 5.46; N, 
4.74; Found: C, 65.27; H, 5.48; N, 4.49; HPLC (Chiralcel OD-H, hexane:isopropanol 
= 98:2, flow rate 1.0 mL/min, X = 254 nm): tR = 18.1 min (minor), tR = 25.1 min 
(major).
O M e
4-Methoxy-iV-[l-(4-nitrophenyl)ethyl]aniline (Table 4-2, entry 9)4,7a,8a 
The product (125 mg, 92% yield, 88% ee) was obtained according to the procedure 
from 4’-nitroacetophenone (116 mg, 0.7 mmol) and/7-anisidine (62 mg, 0.5 mmol) in 
24 h; 'H NMR (CDC13, 400 MHz) 5 1.40 (d, J =  6.4 Hz, 3H), 3.57 (s, 3H), 3.84 (brs, 
1H), 4.38 (q, J=  6.8 Hz, 1H), 6.28-6.32 (m, 2H), 6.56-6.60 (m, 2H), 7.41 (d, J =  8.8 
Hz, 2H), 8.04 (d, J =  8.8 Hz, 2H); 13C NMR (CDC13, 100 MHz) 5 25.3, 54.4, 56.1,
115.0, 115.3, 124.5, 127.3, 141.2, 147.4, 152.7, 154.1; HRMS for Ci5H 17N20 3 [M+H]+: 
m/z Calcd: 273.1239; Found: 273.1245; Elemental analysis calcd (%) for CisHi6N203: 
C, 66.16; H, 5.92; N, 10.29; Found: C, 66.38; H, 6.02; N, 10.08; HPLC (Chiralcel 
OD-H, hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 1 mL/min, X = 254 
nm): tR = 29.5 min (minor), tR = 33.1 min (major).
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4-[l-(4-Methoxyphenylamino)ethyl]benzonitrile (Table 4-2, entry 10)7a,8a
The product (116 mg, 92% yield, 86% ee) was obtained according to the procedure
from 4-acetylbenzonitrile (102 mg, 0.7 mmol) and/7-anisidine (62 mg, 0.5 mmol) in 24
h; ‘H NMR (CDCI3, 400 MHz) 5 1.47 (d, J=  6.8 Hz, 3H), 3.67 (s, 3H), 3.86 (brs, 1H),
4.43 (q, J  = 6.8 Hz, 1H), 6.38-6.41 (m, 2H), 6.67-6.70 (m, 2H), 7.45-7.48 (m, 2H), 
7.56-7.58 (m, 2H); 13C NMR (CDC13, 100 MHz) 5 25.4, 54.6, 56.1, 111.0, 114.9, 115.2,
119.5, 127.2, 133.0, 141.3, 151.9, 152.6; HRMS for C i6H i7N20  [M+H]+: m/z Caled: 
253.1341; Found: 253.1349; Elemental analysis caled (%) for C16H 16N2O: C, 76.16; H, 
6.39; N, 11.10; Found: C, 76.44; H, 6.45; N, 10.92; HPLC (Chiralcel OD-H, 
hexane:isopropanol: diethylamine = 90:10:0.1, flow rate 1 mL/min, X = 254 nm): tR =
28.9 min (minor), tR = 34.5 min (major).
4-Methoxy-7V-(l-m-tolylethyl)aniline (Table 4-2, entry l l ) 2b,6d,8a 
The product (112 mg, 93% yield, 94% ee) was obtained according to the procedure 
from 3’-methylacetophenone (80 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDCI3, 400 MHz) 5 1.47 (d, J  = 6.8 Hz, 3H), 2.32 (s, 3H), 3.68 (s, 
3H ), 4.36 (q, J  = 6.8 Hz, 1H), 6.47 (d, J  = 8.8 Hz, 2H), 6.69 (d, J  = 8.8 Hz, 2H),
7.03 (d, J=  7.2 Hz, 1H), 7.14-7.22 (m, 3H); 13C NMR (CDC13, 100 MHz) 5 22.0, 25.6,
54.7, 56.2, 115.0, 115.2, 123.3, 127.0, 128.1, 128.9, 138.6, 142.1, 146.0, 152.3; HRMS
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for C i6H20NO [M+H]+: m/z Calcd: 242.1545; Found: 242.1544; Elemental analysis 
calcd (%) for Ci6H i9NO: C, 79.63; H, 7.94; N, 5.80; Found: C, 79.88; H, 8.11; N, 5.68; 
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 
nm): tR = 21.1 min (minor), tR = 24.7 min (major).
OMe
4-Methoxy-iV-[l-(3-inethoxyphenyl)ethyl] aniline (Table 4-2, entry 12)2b 
The product (120 mg, 93% yield, 94% ee) was obtained according to the procedure 
from 3’-methoxyacetophenone (90 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDC13, 400 MHz) 5 1.47 (d, J =  6.8 Hz, 3H), 3.66 (s, 3H), 3.75 (s, 
3H), 3.93 (brs, 1H), 4.36 (q, J =  6.8 Hz, 1H), 6.46-6.49 (m, 2H), 6.65-6.69 (m, 2H), 
6.74 (dd, J =  8.0, 1.6 Hz, 1H), 6.93-6.95 (m, 2H), 7.21 (t, J  = 7.6 Hz, 1H); l3C NMR 
(CDCI3, 100 MHz) 5 25.4, 55.0, 55.6, 56.1, 112.2, 112.5, 115.1, 115.2 118.8, 130.1,
141.7, 147.7, 152.5, 160.4; HRMS for Ci6H2oN02 [M+H]+: m/z Calcd: 258.1494; 
Found: 258.1487; Elemental analysis calcd (%) for Ci6Hi9N0 2: C, 74.68; H, 7.44; N, 
5.44; Found: C, 74.52; H, 7.58; N, 5.33; HPLC (Chiralcel OD-H, hexane:isopropanol 
- 98:2, flow rate 0.5 mL/min, X -  254 nm): tR = 34.7 min (minor), tR = 40.5 min 
(major).
/V-[l-(3-bromophenyl)ethyl]-4-methoxyaniIine (Table 4-2, entry 13)20
The product (142 mg, 93% yield, 94% ee) was obtained according to the procedure
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from 3’-bromoacetophenone (119 mg, 0.6 mmol) and/?-anisidine (62 mg, 0.5 mmol) in 
20 h; 'H NMR (CDC13, 400 MHz) 5 1.46 (d, J=  6.8 Hz, 3H), 3.69 (s, 3H), 4.35 (q, J  =
6.8 Hz, 1H), 6.42-6.46 (m, 2H), 6.68-6.71 (m, 2H), 7.16 (t, J =  8.0 Hz, 1H), 7.28 (d, J  
= 8.0, 1H), 7.34 (d, J=  8.0, 1H), 7.51 (t, J=  1.6 Hz, 1H); ,3C NMR (CDC13, 100 MHz) 
5 25.6, 54.4, 56.2, 115.0, 115.2, 123.2, 125.0, 129.5, 130.4, 130.7, 141.6, 148.6, 152.5; 
HRMS for Ci5Ht779BrNO [M+H]+: m/z Calcd: 306.0494; Found: 306.0491; Elemental 
analysis calcd (%) for Ci5H 16BrNO: C, 58.84; H, 5.27; N, 4.57; Found: C, 58.96; H, 
5.33; N, 4.44; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 
mL/min, X, = 254 nm): tR 18.6 min (minor), tR = 22.6 min (major).
4-Methoxy-iV-{l-[3-(trifluoromethyl)phenyl]ethyl}aniline (Table 4-2, entry 14)
The product (139 mg, 94% yield, 93% ee) was obtained according to the procedure 
from 3’-trifluoromethylacetophenone (132 mg, 0.7 mmol) and p-anisidine (62 mg, 0.5 
mmol) in 24 h; *H NMR (CDC13, 400 MHz) 5 1.49 (d, J  = 6.8 Hz, 3H), 3.68 (s, 3H),
4.44 (q, J =  6.8 Hz, 1H), 6.41-6.45 (m, 2H), 6.67-6.71 (m, 2H), 7.40 (t, J = 7.6 Hz, 1H), 
7.47 (d, J=  7.6 Hz, 1H), 7.55 (d, J=  7.6 Hz, 1H), 7.63 (s, 1H); 13C NMR (CDC13, 100 
MHz) 8 25.6, 54.6, 56.1, 115.0, 115.2, 123.2 (q, JcF = 3.8 Hz), 124.2 (q, JcF = 3.8 Hz), 
124.7 (q, JCf = 270.6 Hz), 129.6, 129.7, 131.3 (q, J CF = 31.6 Hz), 141.6, 147.2, 152.6; 
HRMS for C i6H i7F3NO [M+H]+: m/z Calcd: 296.1262; Found: 296.1267; Elemental 
analysis calcd (%) for C16H i6F3NO: C, 65.08; H, 5.46; N, 4.74; Found: C, 65.33; H,
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5.55; N, 4.54; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1.0
mL/min, X = 254 nm): tR = 17.2 min (minor), tR = 25.9 min (major).
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4-Methoxy-iV-[l-(3-nitrophenyl)ethyl]aniline (Table 4-2, entry 15)8a
The product (120 mg, 88% yield, 81% ee) was obtained according to the procedure
from 3’-nitroacetophenone (116 mg, 0.7 mmol) and /»-anisidine (62 mg, 0.5 mmol) in
24 h; *H NMR (CDCI3, 400 MHz) 5 1.52 (d, J =  6.8 Hz, 3H), 3.68 (s, 3H), 3.86 (brs,
1H), 4.50 (q, J =  6.8 Hz, 1H), 6.41-6.45 (m, 2H), 6.67-6.71 (m, 2H), 7.47 (t, J=  8.0 Hz, 
1H), 7.71 (d, J =  8.0 Hz, 1H), 8.07 (ddd, J =  8.0, 2.0, 0.8 Hz, 1H), 8.24 (t, J=  1.6 Hz, 
1H); 13CNMR(CDC13, 100 MHz) 8 25.5, 54.3,56.1, 115.0, 115.3, 121.4, 122.5, 130.1,
132.7, 141.2, 148.6, 149.1, 152.7; HRMS for C 15H 17N2O3 [M+H]+: m/z Calcd: 
273.1239; Found: 273.1248; Elemental analysis calcd (%) for C15H 16N2O3: C, 66.16; 
H, 5.92; N, 10.29; Found: C, 65.84; H, 5.87; N, 10.36; HPLC (Chiralcel OD-H, 
hexane:isopropanol:diethylamine = 90:10:0.1, flow rate 1 mL/min, X = 254 nm): tR =
22.7 min (minor), tR = 30.0 min (major).
O M e
4-Methoxy-/V-[l-(naphthalen-2-yl)ethyl]aniline (Table 4-2, entry 16)2b’4,7a’8a’l5>,8>20 
The product (126 mg, 91% yield, 96% ee) was obtained according to the procedure 
from 2’-acetonaphthone (102 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 
24 h; 'H NMR (CDC13, 400 MHz) 5 1.57 (d, J  = 6.8 Hz, 3H), 3.67 (s, 3H), 4.56 (q, J  =
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6.8 Hz, 1H), 6.50-6.53 (m, 2H), 6.65-6.69 (m, 2H), 7.40-7.51 (m, 3H), 7.78-7.82 (m, 
4H); 13C NMR (CDC13, 100 MHz) 6 25.5, 55.0, 56.1, 115.2, 124.8, 124.9, 125.9, 126.4,
128.1, 128.2, 128.8, 133.2, 134.0, 141.9, 143.3, 152.4; HRMS for C i9H20NO [M+H]+: 
m/z Calcd: 278.1545; Found: 278.1546; Elemental analysis calcd (%) for C19H 19NO: C, 
82.28; H, 6.90; N, 5.05; Found: C, 82.01; H, 6.77; N, 5.21; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X, = 254 nm): tR = 38.2 min (minor), 
tR = 46.2 min (major).
iV-[l-(2, 3-Dihydro-l,4-benzodioxin-6-yl)ethyl]-4-methoxyaniline (Table 4-2, entry 
17)
The product (131 mg, 92% yield, 95% ee) was obtained according to the procedure 
from 1,4-benzodioxan-6-yl methyl ketone (107 mg, 0.6 mmol) and p-anisidine (62 mg, 
0.5 mmol) in 24 h; 'H NMR (CDC13, 400 MHz) 5 1.43 (d, J  = 6.8 Hz, 3H), 3.67 (s, 
3H), 4.18 (s, 4H), 4.28 (q, J  = 6.8 Hz, 1H), 6.45-6.48 (m, 2H), 6.67-6.70 (m, 2H), 
6.78-6.83 (m, 2H), 6.86 (d, J=  1.6 Hz, 1H); 13C NMR (CDCI3, 100 MHz) 5 25.6, 54.1,
56.2, 64.7, 64.8, 115.0, 115.1, 115.2, 117.7, 119.2, 139.5, 142.1, 142.8, 144.0, 152.3; 
HRMS for C 17H20NO3 [M+H]+: m/z Calcd: 286.1443; Found: 286.1437; Elemental 
analysis calcd (%) for C17H 19NO3: C, 71.56; H, 6.71; N, 4.91; Found: C, 71.73; H, 
6.82; N, 4.81; HPLC (Chiralcel OD-H, hexane:isopropanol:diethylamine = 90:10:0.1, 
flow rate 1.0 mL/min, X = 254 nm): tR = 16.0 min (minor), tR = 19.0 min (major).
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7V-[l-(3, 4-Dimethoxyphenyl)ethyl]-4-methoxyaniline (Table 4-2, entry 18)7a,8a 
The product (129 mg, 90% yield, 93% ee) was obtained according to the procedure 
from 3’,4’-dimethoxyacetophenone (108 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 
mmol) in 24 h; *H NMR (CDCI3, 400 MHz) 5 1.49 (d, J =  6.8 Hz, 3H), 3.70 (s, 3H), 
3.85 (s, 3H), 3.86 (s, 3H), 4.35 (q, J =  6.8 Hz, 1H), 6.48-6.51 (m, 2H), 6.68-6.72 (m, 
2H), 6.80-6.82 (m, 1H), 6.88-6.91 (m, 2H); 13C NMR (CDCI3, 100 MHz) 5 25.5, 54.6,
56.1, 56.2, 56.3, 109.5, 111.6, 115.0, 115.1, 118.2, 138.6, 142.1, 148.2, 149.5, 152.4; 
HRMS for C 17H22NO3 [M+H]+: m/z Calcd: 288.1600; Found: 288.1594; Elemental 
analysis calcd (%) for C17H21NO3: C, 71.06; H, 7.37; N, 4.87; Found: C, 71.23; H, 
7.42; N, 4.62; HPLC (Chiralcel OD-H, hexane:isopropanol:diethylamine = 90:10:0.1, 
flow rate 1.0 mL/min, X = 254 nm): tR = 18.8 min (minor), tR = 21.8 min (major).
The product (91 mg, 92% yield, 93% ee) was obtained according to the procedure 
from acetophenone (84 mg, 0.7 mmol) and aniline (47 mg, 0.5 mmol) in 24 h; *H 
NMR (CDCI3, 400 MHz) 6 1.49 (d, J=  6.8 Hz, 3H), 4.01 (brs, 1H), 4.47 (q, J=  6.8 Hz, 
1H), 6.48-6.51 (m, 2H), 6.61-6.65 (m, 1H), 7.06-7.10 (m, 2H), 7.18-7.23 (m, 1H), 
7.28-7.36 (m, 4H); ,3C NMR (CDC13, 100 MHz) 5 25.5, 53.9, 113.8, 117.7, 126.3,
127.3, 129.1, 129.6, 145.7, 147.8; HRMS for C i4H i6N [M+H]+: m/z Calcd: 198.1283;
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Found: 198.1282; Elemental analysis calcd (%) for C 14H 15N: C, 85.24; H, 7.66; N, 
7.10; Found: C, 85.26; H, 7.80; N, 6.95; HPLC (Chiralcel OD-H, hexane:isopropanol: 
= 98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 20.6 min (major), tR = 25.6 min 
(minor).
4-Chloro-iV-(l-phenylethyl)aniline (Table 4-3, entry 2)2d’16’18,21 
The product (99 mg, 86% yield, 87% ee) was obtained according to the procedure 
from acetophenone (84 mg, 0.7 mmol) and 4-chloroaniline (64 mg, 0.5 mmol) in 24 h; 
*H NMR (CDCI3, 400 MHz) 5 1.47 (d, J=  6.8 Hz, 3H), 4.04 (brs, 1H), 4.40 (q, J=  6.8 
Hz, 1H), 6.37-6.41 (m, 2H), 6.98-7.02 (m, 2H), 7.19-7.24 (m, 1H), 7.27-7.32 (m, 4H); 
13C NMR (CDCI3, 100 MHz) 6 25.5, 54.0, 114.9, 122.2, 126.2, 127.5, 129.2, 129.4,
145.2, 146.3; HRMS for C i4H i535C1N [M+H]+: m/z Calcd: 232.0893; Found: 232.0900; 
Elemental analysis calcd (%) for C14H 14CIN: C, 72.57; H, 6.09; N, 6.04; Found: C, 
72.38; H, 6.18; N, 5.97; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate
1.0 mL/min, X, = 254 nm): tR= 11.6 min (minor), tR = 14.5 min (major).
4-Bromo-iV-(l-phenylethyl)aniline (Table 4-3, entry 3)2d>8a-18 
The product (117 mg, 85% yield, 85% ee) was obtained according to the procedure 
from acetophenone (84 mg, 0.7 mmol) and 4-bromoaniline (86 mg, 0.5 mmol) in 24 h; 
JH NMR (CDCI3, 400 MHz) 5 1.48 (d, J=  6.8 Hz, 3H), 4.06 (brs, 1H), 4.41 (q, J=  6.8
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Hz, 1H), 6.33-6.37 (m, 2H), 7.11-7.15 (m, 2H), 7.18-7.25 (m, 1H), 7.28-7.32 (m, 4H); 
13C NMR (CDCI3, 100 MHz) 6 25.4, 53.9, 109.3, 115.4, 126.2, 127.5, 129.2, 132.2,
145.1, 146.6; HRMS for Ci4Hi579BrN [M+H]+: m/z Caled: 276.0388; Found: 276.0386; 
Elemental analysis caled (%) for CuHnBrN: C, 60.89; H, 5.11; N, 5.07; Found: C, 
70.02; H, 5.18; N, 5.00; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 
0.5 mL/min, X. = 254 nm): tR = 24.1 min (minor), tR = 30.2 min (major).
7V-[l-(4-Methoxyphenyl)ethyl]aniline (Table 4-3, entry 4)2d,8a’16"19 
The product (104 mg, 92% yield, 91% ee) was obtained according to the procedure 
from 4’-methoxyacetophenone (105 mg, 0.7 mmol) and aniline (47 mg, 0.5 mmol) in 
24 h; 'H NMR (CDCI3, 400 MHz) 5 1.47 (d, J  = 6.8 Hz, 3H), 3.75 (s, 3H), 3.93 (brs, 
1H), 4.43 (q, J  = 6.8 Hz, 1H), 6.49 (d, J  = 8.0 Hz, 2H), 6.63 (t, J  = 7.6 Hz, 1H), 
6.82-6.86 (m, 2H), 7.06-7.10 (m, 2H), 7.25-7.28 (m, 2H); 13C NMR (CDC13, 100 MHz) 
5 25.5, 53.3, 55.7, 113.8, 114.5, 117.6, 127.4, 129.6, 137.7, 147.8, 158.9; HRMS for 
CisHigNO [M+H]+: m/z Calcd: 228.1388; Found: 228.1388; Elemental analysis ealed 
(%) for C 15H 17NO: C, 79.26; H, 7.54; N, 6.16; Found: C, 78.42; H, 7.50; N, 6.04; 
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 
nm): tR = 25.3 min (major), tR = 28.5 min (minor).
/V-(l-[Naphthalen-2-yl)ethyI]aniline (Table 4-3, entry 5 )8a>15’n>i8,20
209
The product (114 mg, 92% yield, 91% ee) was obtained according to the procedure 
from 2’-acetonaphthone (119 mg, 0.7 mmol) and aniline (47 mg, 0.5 mmol) in 24 h; 'H 
NMR (CDC13, 400 MHz) 5 1.59 (d, J  = 6.8 Hz, 3H), 4.17 (brs, 1H), 4.63 (q, J  = 6.8 Hz, 
1H), 6.55 (d, J=  8.0 Hz, 2H), 6.63 (t, J=  7.2 Hz, 1H), 7.05-7.10 (m, 2H), 7.41-7.51 (m, 
3H), 7.78-7.82 (m, 4H); 13C NMR (CDC13, 100 MHz) 5 25.4, 54.2, 113.8, 117.8, 124.7,
124.8, 125.9, 126.4, 128.1, 128.3, 128.9, 129.5, 133.2, 134.0, 143.2, 147.7; HRMS for 
CigHigN [M+H]+: m/z Calcd: 248.1439; Found: 248.1449; Elemental analysis calcd (%) 
for CigHnN: C, 87.41; H, 6.93; N, 5.66; Found: C, 87.15; H, 6.89; N, 5.72; HPLC 
(Chiralcel OD-H, hexane:isopropanol:diethylamine = 90:10:0.1, flow rate 0.5 mL/min, 
X, = 254 nm): tR = 19.4 min (major), tR = 23.0 min (minor).
Br
4-Bromo-iV-[l-(naphthalen-2-yl]ethyl)aniline (Table 4-3, entry 6)
The product (122 mg, 75% yield, 83% ee) was obtained according to the procedure 
from 2’-acetonaphthone (119 mg, 0.7 mmol) and 4-bromoaniline (86 mg, 0.5 mmol) in 
24 h; 'HNM R(CDCl3, 400 MHz) 6 1.58 (d, J=  6.8 Hz, 3H), 4.18 (brs, 1H), 4.58 (q, J  
= 6.8 Hz, 1H), 6.39-6.43 (m, 2H), 7.11-7.15 (m, 2H), 7.42-7.48 (m, 3H), 7.77-7.82 (m, 
4H); 13C NMR (CDC13, 100 MHz) 5 25.4, 54.2, 109.4, 115.4, 124.6, 124.7, 126.1,
126.6, 128.1, 128.2, 129.0, 132.2, 133.2, 133.9, 142.5, 146.6; HRMS for CigHn79BrN 
[M+H]+: m/z Calcd: 326.0544; Found: 326.0551; Elemental analysis calcd (%) for 
CigHieBrN: C, 66.27; H, 4.94; N, 4.29; Found: C, 66.13; H, 5.08; N, 4.13; HPLC 
(Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1.0 mL/min, X = 254 nm): tR =
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17.6 min (minor), tR = 27.7 min (major).
4-Methoxy-iV-(l-phenylpropyl)aniline (Table 4-4, entry i)2b-6d>8a>18>21 
The product (112 mg, 93% yield, 92% ee) was obtained according to the procedure 
from propiophenone (81 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 20 h; !H 
NMR (CD CI3, 400 MHz) 5 0.94 (t, J =  7.6 Hz, 3H), 1.76-1.87 (m, 2H), 3.68 (s, 3H), 
4.14 (t, 7 =  6.8 Hz, 1H), 6.45-6.48 (m, 2H), 6.66-6.70 (m, 2H), 7.19-7.24 (m, 1H), 
7.28-7.34 (m, 4H); 13C  NMR ( C D C 13, 100 MHz) 5 11.2, 32.1,56.2,61.0, 114.9, 115.2,
127.0, 127.3, 128.9, 142.2, 144.5, 152.3; HRMS for C ,6H 2oNO [M+H]+: m/z Calcd: 
242.1545; Found: 242.1542; Elemental analysis calcd (%) for C16H 19NO: C, 79.63; H, 
7.94; N , 5.80; Found: C, 79.77; H, 7.97; N, 5.64; HPLC (Chiralcel O D -H , 
hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 nm): tR = 18.3 min (minor), 
tR = 20.5 min (major).
4-Methoxy-7V-(l-p-tolylpropyl)aniline (Table 4-4, entry 2)8a
The product (116 mg, 91% yield, 91% ee) was obtained according to the procedure 
from 4’-methylpropiophenone (89 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDCI3, 400 MHz) 5 (ppm): 0.92 (t, J =  1A  Hz, 3H), 1.74-1.81 (m, 
2H), 2.30 (s, 3H), 3.68 (s, 3H), 4.10 (t, J=  6.7 Hz, 1H), 6.44-6.48 (m, 2H), 6.65-6.69 
(m, 2H), 7.11 (d, J =  8.0 Hz, 2H), 7.21 (d, J =  8.0 Hz, 2H); I3C NMR (CDC13, 100
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MHz) 5 (ppm): 11.2, 21.4, 32.1, 56.1, 60.7, 114.7, 115.1, 126.8, 129.6, 136.7, 141.5,
142.2, 152.1; HRMS for C i7H22NO [M+H]+: m/z calcd 256.1701, found 256.1702; 
Elemental analysis calcd (%) for Ci7H2iNO: C, 79.96; H, 8.29; N, 5.49; Found: C, 
79.99; H, 8.35; N, 5.44; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 
0.5 mL/min, X = 254 nm): tR = 16.9 min (minor), tR = 18.7 min (major).
OMe
4-Methoxy-./V-[l-(4-inethoxyphenyl)propyl]aniline (Table 4-4, entry 3)
The product (123 mg, 91% yield, 92% ee) was obtained according to the procedure 
from 4’-methoxypropiophenone (99 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) 
in 20 h; 'H NMR (CDC13, 400 MHz) 5 0.91 (t, J =  7.6 Hz, 3H), 1.72-1.88 (m, 2H), 
3.68 (s, 3H), 3.77 (s, 3H), 4.09 (t, J  = 6.8 Hz, 1H), 6.48-6.52 (m, 2H), 6.66-6.70 (m, 
2H), 6.82-6.86 (m, 2H), 7.22-7.26 (m, 2H); 13C NMR (CDC13, 100 MHz) 5 11.2, 31.9,
55.6, 56.1, 60.9, 114.3, 115.1, 115.4, 128.1, 136.1, 141.6, 152.5, 158.9; HRMS for 
C i7H22N 0 2 [M+H]+: m/z Calcd: 272.1651; Found: 272.1642; Elemental analysis calcd 
(%) for CnH21N 0 2: C, 75.25; H, 7.80; N, 5.16; Found: C, 75.33; H, 7.86; N, 5.02; 
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, = 254 
nm): tR = 13.3 min (minor), tR = 14.9 min (major).
4-Methoxy-JV-(phenylpentyl)aniline (Table 4-4, entry 5)6d’24
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The product (67 mg, 50% yield, 75% ee) was obtained according to the procedure from
valerophenone (97 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 24 h; 'H
NMR (CDCI3, 400 MHz) 5 1.14 (t, J =  7.4 Hz, 3H), 1.54-1.64(m, 4H), 1.97-2.06 (m,
2H), 3.91 (s, 3H), 3.93 (br, 1H), 4.47 (t, J =  6.8 Hz, 1H), 6.69-6.74(m, 2H), 6.91-6.95
(m, 2H), 7.43-7.48 (m, 1H), 7.52-7.60 (m, 4H); 13C NMR (CDC13, 100 MHz) 5 14.0,
22.7, 28.8, 38.8, 55.7, 59.3, 114.5, 114.8, 126.5, 126.8, 128.5, 142.0, 144.7, 152.0
HRMS for C 18H24NO [M+H]+: m/z Calcd: 270.1858; Found: 270.1851; Elemental
analysis calcd (%) for C18H23NO: C, 80.26; H, 8.61; N, 5.20; Found: C, 80.42; H, 8.77;
N, 5.01; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X
= 254 nm): tR = 17.0 min (minor), tR = 18.4 min (major).
^ / O C H 3
./V-[Cyclopropyl(phenyl)methyl]-4-iiiethoxyaniline (Table 4-4, entry 6)8a 
The product (25 mg, 20% yield, 97% ee) was obtained according to the procedure from 
cyclopropyl phenyl ketone (88 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 24 
h; ‘HNM R (CDCI3, 400 MHz) 6 (ppm): 0.28-0.53 (m, 4H), 1.06-1.10 (m, 1H), 3.48 (d, 
J =  8.4 Hz, 1H), 3.58 (s, 3H), 4.02 (brs, 1H), 6.31-6.56 (m, 2H), 6.56-6.60 (m, 2H), 
7.11-7.16 (m, 1H), 7.20-7.24 (m, 2H), 7.29-7.32 (m, 2H); 13C NMR (CDC13, 100 MHz) 
5 (ppm): 3.9, 4.7, 20.3, 56.2, 64.3, 115.1, 115.2, 127.0, 127.5, 129.0, 142.4, 144.1, 
152.4; HRMS for Ci7H20NO [M+H]+: m/z calcd 254.1545, found 254.1546; Elemental 
analysis calcd (%) for C17H 19NO: C, 80.60; H, 7.56; N, 5.53; Found: C, 80.42; H, 7.62; 
N, 5.43; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min,
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X = 254 nm): tR = 21.8 min (minor), tR = 25.8 min (major).
7V-[l-(benzofuran-2-yl)ethyI]-4-methoxyaniline (Table 4-4, entry 7)
The product (124 mg, 93% yield, 91% ee) was obtained according to the procedure 
from the 2-benzofuranyl methyl ketone (96 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 
mmol) in 24 h; *H NMR (CDC13, 400 MHz) 5 1.59 (d, J =  6.8 Hz, 3H), 3.68 (s, 3H), 
4.63 (q, J =  6.8 Hz, 1H), 6.49 (s, 1H), 6.58-6.62 (m, 2H), 6.71-6.75 (m, 2H), 7.14-7.23 
(m, 2H), 7.41-7.46 (m, 2H); 13C NMR (CDCI3, 100 MHz) 5 21.6, 49.2, 56.1, 102.6,
111.5, 115.3, 115.6, 121.3, 123.1, 124.1, 128.9, 141.4, 153.0, 155.2, 160.9; HRMS for 
C 17H 18NO2 [M+H]+: m/z Calcd: 268.1338; Found: 268.1330; Elemental analysis calcd 
(%) for C 17H 17NO2: C, 76.38; H, 6.41; N, 5.24; Found: C, 76.44; H, 6.56; N, 5.12; 
HPLC (Chiralcel OD-H, hexane:isopropanol:diethylamine = 90:10:0.1, flow rate 1.0 
mL/min, X = 254 nm): tR = 9.6 min (minor), tR 10.8 min (major).
OMe
4-Methoxy-7V-[l-(naphthalen-l-yl)ethyl]aniline (Table 4-4, entry 8)2b 
The product (125 mg, 90% yield, 87% ee) was obtained according to the procedure 
from l ’-acetonaphthone (102 mg, 0.6 mmol) andp-anisidine (62 mg, 0.5 mmol) in 24 
h; 'H NMR (CDCI3, 400 MHz) 5 1.61 (d, J =  6.8 Hz, 3H), 3.63 (s, 3H), 3.99 (brs, 1H), 
5.19 (q, J = 6.8 Hz, 1H), 6.40-6.43 (m, 2H), 6.61-6.64 (m, 2H), 7.38 (t, J=  7.6 Hz, 1H), 
7.47-7.55 (m, 2H); 7.63 (d, J =  6.8 Hz, 1H), 7.72 (d, J =  8.0 Hz, 1H), 7.88 (d, J =  8.0
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Hz, 1H), 8.14 (d, J  = 8.0 Hz, 1H); 13C NMR (CDCI3, 100 MHz) 5 24.2, 50.6, 56.2,
114.8, 115.3, 122.8, 123.1, 125.9, 126.4, 126.5, 127.8, 129.6, 131.2, 134.6, 140.6,
141.8, 152.4; HRMS for C i9H20NO [M+H]+: m/z Calcd: 278.1545; Found: 278.1546; 
Elemental analysis calcd (%) for C19H 19NO: C, 82.28; H, 6.90; N, 5.05; Found: C, 
82.38; H, 6.78; N, 5.14; HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate
1.0 mL/min, X = 254 nm): tR = 17.9 min (minor), tR = 27.0 min (major).
OMe
4-Methoxy-Ar-(l-o-tolylethyl)aniline (Table 4-4, entry 9)2b,6d,7a’20 
The product (111 mg, 92% yield, 91% ee) was obtained according to the procedure 
from 2’-methylacetophenone (81 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 
20 h; 'H NMR (CDCI3, 400 MHz) 5 1.44 (d, J  = 6.8 Hz, 3H), 2.42 (s, 3H), 3.67 (s, 3H), 
4.59 (q, J  = 6.8 Hz, 1H), 6.38-6.41 (m, 2H), 6.66-6.69 (m, 2H), 7.11-7.16 (m, 3H), 
7.40-7.42 (m, 1H); 13C NMR (CDCI3, 100 MHz) 5 19.4, 23.5, 50.9, 56.2, 114.7, 115.3,
125.1, 127.0, 127.1, 131.0, 135.0, 142.0, 143.4, 152.3; HRMS for C i6H20NO [M+H]+: 
m/z Calcd: 242.1545; Found: 242.1546; Elemental analysis calcd (%) for C16H 19NO: C, 
79.63; H, 7.94; N, 5.80; Found: C, 79.78; H, 7.99; N, 5.66; HPLC (Chiralcel OD-H, 
hexane:isopropanol = 98:2, flow rate 1.0 mL/min, X = 254 nm): tR = 9.1 min (minor), 
tR = 11.8  min (major).
OMe
4-Methoxy-/V-[l-(2-methoxyphenyl)ethyl]aniline (Table 4-4, entry 10)2b,7a
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The product (120 mg, 93% yield, 86% ee) was obtained according to the procedure 
from T -methoxyacetophenone (90 mg, 0.6 mmol) and /?-anisidine (62 mg, 0.5 mmol) 
in 20 h; ]H NMR (CD CI3, 400 MHz) 5 1.45 (d, J  = 6.4 Hz, 3H), 3.67 (s, 3H), 3.87 (s, 
3H), 4.76 (q, J =  6.4 Hz, 1H), 6.46-6.49 (m, 2H), 6.65-6.69 (m, 2H), 6.86-6.89 (m, 2H), 
7.16-7.23 (m, 1H), 7.29-7.31 (m, 1H); 13C NMR (CD C I3, 100 MHz) 5 23.2, 49.5, 55.7,
56.1, 110.9, 115.1, 115.2, 121.2, 126.9, 128.1, 133.3, 142.0, 152.3, 157.2; HRMS for 
C 16H20NO2 [M+H]+: m/z Calcd: 258.1494; Found: 258.1490; Elemental analysis calcd 
(%) for C,6H i9N02: C, 74.68; H, 7.44; N, 5.44; Found: C, 74.82; H, 7.56; N, 5.40; 
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254 
nm): tR = 20.2 min (minor), tR = 24.9 min (major).
OMe
iV-[l-(2-Fluorophenyl)ethyl]-4-inethoxyaniline (Table 4-4, entry H )4>7a’20 
The product (113 mg, 92% yield, 96% ee) was obtained according to the procedure 
from 2’-fluoroacetophenone (83 mg, 0.6 mmol) and /»-anisidine (62 mg, 0.5 mmol) in 
20 h; 'H NMR (CDCI3, 400 MHz) 5 1.50 (d, J =  6.8 Hz, 3H), 3.67 (s, 3H), 4.73 (q, J  =
6.8 Hz, 1H), 6.45-6.49 (m, 2H), 6.66-6.70 (m, 2H), 6.99-7.05 (m, 2H), 7.14-7.19 (m, 
1H), 7.32-7.37 (m, 1H); 13C NMR (CDC13, 100 MHz) 5 23.8, 48.7, 56.1, 114.9, 115.2,
115.9 (d, J cf = 11-7 Hz), 124.8 (d, Jcf = 3.0 Hz), 127.7 (d, Jcf = 4.5 Hz), 128.7 (d, Jcf 
= 8.3 Hz), 132.4 (d, JcF = 12.9 Hz), 141.6, 152.5, 160.9 (d, JCF = 243.1 Hz); HRMS for 
C 15H 17FNO [M+H]+: m/z Calcd: 246.1294; Found: 246.1298; Elemental analysis calcd 
(%) for CisHieFNO: C, 73.45; H, 6.57; N, 5.71; Found: C, 73.34; H, 6.52; N, 5.82;
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HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 254
nm): tR = 18.5 min (minor), tR = 21.7 min (major).
7V-[l-(2-Chlorophenyl)ethyl]-4-methoxyaniline (Table 4-4, entry 12)22 
The product (120 mg, 92% yield, 83% ee) was obtained according to the procedure 
from 2’-chloroacetophenone (93 mg, 0.6 mmol) and /?-anisidine (62 mg, 0.5 mmol) in 
20 h; 'H NMR (CDC13, 400 MHz) 5 1.38 (d, 7  = 6.8 Hz, 3H), 3.58 (s, 3H), 3.78 (brs, 
1H), 4.74 (q, 7  = 6.8 Hz, 1H), 6.29-6.33 (m, 2H), 6.57-6.61 (m, 2H), 7.02-7.10 (m, 2H), 
7.25-7.27 (m, 1H), 7.35 (dd, 7  = 7.8, 2.0 Hz, 1H); 13C NMR (CDC13, 100 MHz) 5 23.5,
51.3, 56.1, 114.7, 115.3, 127.3, 127.8, 128.4, 130.1, 133.0, 141.5, 142.7, 152.4; HRMS 
for CisHi735ClNO [M+H]+: m/z Calcd: 262.0999; Found: 262.0997; Elemental analysis 
calcd (%) for Ci5H,6C1NO: C, 68.83; H, 6.16; N, 5.35; Found: C, 68.95; H, 5.99; N, 
5.42; HPLC (Chiralcel OD-H, hexane : isopropanol = 98:2, flow rate 0.5 mL/min, X, 
= 254 nm): tR = 18.6 min (minor), tR = 21.9 min (major).
OMe
NH
-COOMe
3-[(4-methoxyphenyl)amino]butanoate (Table 4-6, entry 13)
The product (98 mg, 88% yield, 80% ee) was obtained according to the procedure from 
methyl acetoacetate (70 mg, 0.6 mmol) and p-anisidine (62 mg, 0.5 mmol) in 24 h; 'H 
NMR (CDCI3, 400 MHz) 5 1.25 (d, J=  6.4 Hz, 3H), 2.41 (dd, 7 =  6.8, 15.2 Hz, 1H), 
2.62 (dd, 7 =  5.2, 15.2 Hz, 1H), 3.67 (s, 3H), 3.74 (s, 3H), 3.81-3.89 (m, 1H), 6.60-6.64
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(m, 2H), 6.76-6.80 (m, 2H); ,3C NMR (CDC13, 100 MHz) 5 21.0, 41.1, 47.7, 52.0, 56.1,
115.3, 115.9, 141.1, 152.9, 172.8; MS CI m/z (%): 224.1 [M + H]+; Elemental analysis 
calcd (%) for C12Hi7N 0 3: C, 64.55; H, 7.67; N, 6.27; Found: C, 64.65; H, 7.99; N, 
6.42; HPLC (Chiralcel OD-H, hexane : isopropanol = 98:2, flow rate 0.5 mL/min, X 
= 254 nm): tR = 41.5 min (major), tR = 44.1 min (minor).
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6. ‘H NMR Spectra (400 MHz, CDC13)
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